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ABSTRACT 
 Purpose: To examine potential effect modification by race-ethnicity of the relationship 
between physical activity (PA) and diabetes-related mortality risk using a sample of U.S. adults 
from the Third National Health and Nutrition Examination Survey (NHANES III). Methods: 
The sample (n=10,717) included adults (≥20 years) who attended the Mobile Examination 
Center (MEC). An age-standardized PA score (PAS) was calculated from the self-reported 
frequency and intensity of 12 leisure-time aerobic activities. The PA scores were then grouped 
into three categories: inactive (PAS = 0), insufficiently active (PAS >0 - <10), and active (PAS 
≥10). A PAS of 10 was chosen as a proxy cutoff for 5 bouts/wk of moderate-intensity activity, 
the 2007 American Heart Association/American College of Sports Medicine aerobic PA 
guideline. Diabetes-related mortality was defined as either death from diabetes mellitus as the 
primary cause or if diabetes was flagged on the death certificate as a contributing cause. Race-
ethnic groups included: non-Hispanic white (NHW), non-Hispanic black (NHB), and Mexican 
American (MA). SAS 9.4 survey procedures were used for all statistical analyses. Results: There 
was no interaction between PA and race-ethnicity (p=0.83). Compared to inactive NHW, there 
was a significantly lower risk for diabetes-related mortality for insufficiently active (Hazard 
Ratio [HR] 0.51, 95% Confidence Interval [CI] 0.29-0.89) and active (HR 0.57, 95% CI 0.33-
1.00) NHW adults. Statistical significance was not achieved for any level of activity for NHB 
and MA. A significant p-for-trend was revealed only for MA. Conclusions: The results of this 
study suggest that accumulation of any volume of PA is associated with a significantly lowered 
risk for diabetes-related mortality only in NHW. A significant dose-response relationship was 
only observed among MA. However, the interaction between race-ethnicity and PA did not attain 
statistical significance. Thus, the presence of effect modification could not be determined from 
vi 
 
the current study, but further investigation is warranted. Given longer follow-up time in the 
NHANES III cohort, the ability to estimate more precise risk reductions will become plausible.  
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Diabetes is a deleterious metabolic condition characterized by chronic hyperglycemia. 
Currently, diabetes is the seventh leading cause of mortality among adults in the United States; 
with the vast majority of these deaths being related specifically to type 2 diabetes (T2D) (1). 
Despite being a top ten cause of death, diabetes is more likely to be a contributing cause of death 
rather than the primary cause of death (2, 3). Furthermore, it is postulated that diabetes is 
underreported as a cause or contributing cause of death (2). On the death certificates of those 
with diabetes, approximately 35-40% have diabetes reported as a cause. Moreover, only 10-15% 
of people with diabetes who died have diabetes listed as the primary cause (2). Considering its 
strong link to cardiovascular disease (4, 5), cancers (6), kidney disease (7), and stroke (8); it is 
evident that diabetes plays a substantial role in mortality related to cardiovascular and metabolic 
causes.            
 Among race-ethnic groups, substantial disparities exist in the current, as well as the 
projected, prevalence of diabetes. American Indian/Alaskan Natives have the highest estimated 
prevalence of T2D (15.9%), with the next highest prevalence rates being found among Non-
Hispanic Blacks (NHB, 13.2%), Hispanics (12.8%), and Asians (9.0%) (2). Those who are non-
Hispanic White (NHW) have the lowest prevalence of T2D (7.6%) (2). Honeycutt et al. (9) 
reports the projected 50 year increase in prevalence of type 2 diabetes to be higher among NHBs 
(118%), Hispanics (149%) and other ethnicities (170%), as compared to NHW (104%).  
 The current mortality rates associated with diabetes also differ across race-ethnic groups 
(1). The age-adjusted death rate (per 100,000) attributable to diabetes is higher among Hispanics 
(25.1) and NHBs (38.2) compared to those who are NHW (18.6) (1). Moreover, compared to 
NHWs, NHBs and Hispanics are 2.3 and 1.5 times more likely to die from diabetes, respectively 
(1). It can be hypothesized that these disparities in diabetes-related mortality rates between race-
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ethnic groups may be influenced, in part, by differences in physical activity (PA) participation or 
physiological differences through which the same levels of PA have different levels of protection 
(10) .             
 Currently, two studies have investigated the relationship between PA and diabetes-
specific mortality (11, 12). Andersen et al. (11) found that participation in sports (Hazard ratio 
[HR] 0.34, 95% CI 0.21-0.55), cycling (HR 0.61, 95% CI 0.42-0.89), or gardening (HR 0.42, 
95% CI 0.28-0.62) resulted in significantly lower HRs for diabetes-related mortality compared to 
those reporting no participation in these activities. In those reporting walking, statistical 
significance was not attained (HR 0.77. 95% CI 0.44-1.33). Williams et al. (12) examined the 
relationship between MET-hrs/d of walking and diabetes-related mortality. MET-hrs/d of 
walking were categorized into four levels: <1.07 MET-hrs/d (category 1), 1.07-1.8 MET-hrs/d 
(category 2), >1.8-3.5 MET-hrs/d (category 3), and ≥3.6 MET-hrs/d (category 4). Only those in 
category 4 (HR 0.17, 95% CI 0.04-0.73) had a significant reduction in risk for diabetes-related 
mortality. In a separate analysis adjusting for reported BMI, a significant HR was found for 
category 4 (HR 0.17, 95% CI 0.04-0.80). While these two studies provide insight into PA and 
diabetes-related morality, there currently exists no literature examining this relationship 
specifically investigating the effect modification by race-ethnicity.      
 The National Health and Nutrition Examination Survey (NHANES), and the available 
National Data Index (NDI) linked data, provides a population based opportunity to examine the 
extent in which PA protects against diabetes-related mortality across several race-ethnic groups. 
Therefore, the purpose of this study was to examine the effect modification of race-ethnicity on 
the association between PA and diabetes-related mortality using the NHANES III and the 1999-
2006 NHANES, as well as the NDI. From the NHANES III and the 1999-2006 NHANES, self-
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report PA is available to examine the association between PA and diabetes-related mortality. 
Also, within the 2003-2006 NHANES, objectively-measured PA, via accelerometer, is available 
to further investigate this relationship. Along with the data from the NDI, the multiple measures 
of PA will allow for a comprehensive examination of the relationship between PA and diabetes-
related mortality.             
Definitions 
The following section provides details on commonly used nomenclature within the document 
1. Diabetes: a deleterious metabolic condition characterized by chronic hyperglycemia 
(inclusive of type 1 diabetes and type 2 diabetes) 
2. Type 2 Diabetes: Chronic hyperglycemia as a result of defects in insulin action and/or 
secretion (13). 
3. Race-ethnicity:  
a. NHANES race-ethnic groups 
- Non-Hispanic White: Those who are white and without Hispanic origin.  
- Non-Hispanic Black: Those who are black and without Hispanic origin 
- Mexican American: Those who are of Mexican origin 
- Other: Those who are of Hispanic/Latino origin other than Mexican; 
Asians, and Native Americans as well as those who are multi-racial  
b. Other studies included in the document 
- Hispanic: Those of any Hispanic/Latino origin i.e. Puerto Rican, Cuban, 
Central/South American, Mexican (1)  
4. Diabetes-related mortality: defined as either death caused by diabetes mellitus or if 
diabetes was flagged on the death certificate with multiple causes of death 
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Statement of the problem 
Currently, no prospective population-based study has examined effect modification by 
race-ethnicity on the relationship between PA and diabetes-related mortality. The purpose of this 
study was to investigate the dose-response associations between PA and diabetes-related 
mortality across race-ethnic groups using data from NHANES III, the 1999-2006 NHANES, and 
the NDI. Below are the specific research questions to be addressed in this study. 
 
Research questions 
Specific to adults (20-79 years of age) participating in the NHANES III, the following research 
question will be addressed: 
1. Is there a dose-response relationship between self-reported PA and diabetes-related 
mortality across race-ethnic groups? 
Specific to adult participants (20-79 years of age) in the 1999-2004 NHANES the following 
three questions will be addressed: 
2. Among the 1999-2004 NHANES, is there a dose-response relationship between self-
reported PA and diabetes-related mortality across race-ethnic groups?  
Questions specific to adult participants (20-79 years of age) within the 2003-2006 NHANES: 
3A. Is there a dose-response relationship between accelerometer-derived minutes of MVPA 
and diabetes-related morality across race-ethnic groups?  
3B. Is there a dose-response relationship between quartiles of accelerometer-derived total 
activity counts/day (TAC/d) and diabetes-related morality across race-ethnic groups?  
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Significance 
This study will add to the current literature by providing insight into the race-ethnic 
specific associations between PA and diabetes-related morality. This will be the first study to 
determine the extent in which PA relates to diabetes-related morality across several race-ethnic 
groups.  
Delimitations 
For research question 1, the analyses will be limited to adults 20-79 years of age that did 
not die within the first three years of follow-up. For analyses using the 1999-2006 NHANES, the 
analyses will be limited to adults 40-79 years of age. Within the 2003-2006 NHANES, 
participants with less than four days and ≤10 hours of accelerometer wear time per day were 
excluded. 
Limitations 
There are several limitations inherent to the design of the NHANES. The limitations are 
described below. 
1. The diabetes mortality variable includes death from type 1 diabetes, malnutrition-induced 
diabetes and other types thus the deaths from diabetes are not limited to just T2D 
(appendix 1, table 2)  
2. Duration of PA was not measured in NHANES III, thus limiting the interpretability of 
total volume of activity. 
3. Within the 2003-2006 NHANES, the ActiGraph 7164 model was used. A limitation with 
this device is limited onboard storage capacity thus devices were initialized to sample at 
60-second epochs to ensure 7-days of activity could be recorded. 
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4. The cutpoints used within the analyses may under or overestimate time spent across 
intensities thus the true time spent in MVPA may not be accurately captured. 
5. Self-reported PA found in both the NHANES III and 1999-2006 surveys are subject to 
recall bias.  
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Introduction 
Diabetes is characterized by a chronic state of hyperglycemia resulting from defects in 
insulin secretion, insulin action, or both (13). It is well known that diabetes is associated with 
other deleterious chronic conditions such as heart disease, stroke, obesity, and kidney disease 
(13). The association between PA and diabetes risk and mortality within populations, including 
multi-ethnic populations that have diabetes, has been extensively studied. A part of 
understanding the epidemiological impact of diabetes relates to understanding how race-ethnicity 
is associated with the disease. More specifically, it is important to understand the role of race-
ethnicity as an effect modifier of the relationship between PA and diabetes as well as diabetes-
related mortality. However, there currently are no studies examining the effect modification of 
race-ethnicity on the relationship between PA and diabetes-related morality.   
 The following review of literature will discuss: 1. diabetes; 2. the burden of diabetes; 3. 
physical activity behavior and race-ethnicity; 4. physical activity and diabetes risk; 5. physical 
activity and mortality in those with diabetes; and 6. physical activity and diabetes-related 
mortality.    
Diabetes 
History 
 The history of diabetes is both long in time as well as complex in nature. Dating back to 
as early as 1500 BC, there are records of individuals suffering from polydipsia and polyuria (14) 
which are common symptoms of chronic hyperglycemia. In early work of Greek physicians (1st 
and 2nd century AD), diabetes was classified by the symptoms of polydipsia and polyuria 
exclusively. The name diabetes was first introduced; arising from the word “diabaino” which 
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means “the condition that the fluid runs through” (14, 15). Further evidence of the long history of 
diabetes comes from the 5th century in the work of Sushruta who characterized “diabetes” by the 
honey-like smell and sticky consistency of one’s urine (14). However, it wasn’t until the 1800’s 
that the study of “diabetes” began to become a leading focus in the medical community.  
 Many discoveries in diabetes research were made in the 1800’s to early 1900’s (14, 15). 
Claude Bernard hypothesized that the excess secretion of glucose by the liver caused diabetes 
and he also discovered a link between glucose homeostasis and the central nervous system. 
Oskar Minkowski and Joseph Von Mering discovered the pancreas’ contribution to the 
development of diabetes. Paul Langerhans discovered the cells that secreted (what would later be 
known as) insulin; the islets of Langerhans.        
 Arguably the most important discovery in diabetes history was by Frederick Banting, 
John McLeod, Charles Best and James Collip, who all played roles in the discovery that the 
defect in secretion or lack of insulin caused diabetes to develop. It is important to note that 
Frederick Banting and James McLeod are credited with the discovery of insulin (as the Nobel 
Prize was awarded to them both), however both Best and Collip served as co-investigators in the 
process (14, 15). It was from this work that treatment of diabetes flourished beginning in the mid 
1950’s.            
 It was not until 1949, in an article authored by Himsworth (16), that the notion of 
different “types” of diabetes were discussed. Himsworth concluded that “abnormal 
hyperglycemia” was either a result of impaired carbohydrate metabolism (i.e. insulin secretion 
defects) or an inability to store carbohydrates. Further suggestion of two types was discussed by 
Yalow and Berson in 1960 (17), who noted that despite still making their own insulin, some 
study participants still had diabetes; suggesting that “insulin sensitivity” could be a cause of 
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diabetes and not just defects in insulin secretion. It was not until 1979 that the diabetes 
classification system was introduced to include the four types: insulin-dependent/type 1, non-
insulin-dependent/type 2, gestational, and environmental (18). 
Type 2 diabetes 
Type 2 diabetes (T2D) was formally known as non-insulin dependent diabetes mellitus 
until 1997 (18). It is characterized by defects in insulin action and is primarily driven by 
increasing resistance to insulin resulting in chronic hyperglycemia (13). Moreover, T2D makes 
up 90-95% of all cases of diabetes (13). Until 1997, T2D was diagnosed using one of two 
methods; a fasting plasma glucose (FPG) ≥140 mg/dL or a 2-hr plasma glucose ≥200 mg/dL 
following a 75-g oral glucose tolerance test (OGTT) (13). Beginning in 1997, the diagnostic 
criteria for T2D changed in regards to FPG; from ≥140 mg/dL to ≥126 mg/dL (13).   
 In 2009, the American Diabetes Association began recommending the use of 
glycosylated hemoglobin (A1c) to diagnose T2D, using a cutpoint of ≥6.5% (13). The 
justification for this recommendation is rooted in A1c having greater pre-analytical stability 
compared to FPG, no need for fasting to measure, better reflection of chronic glycemic status 
over the course of two to three months, and it is less affected by stress and illness (13). 
Furthermore, the International Expert Committee on Diabetes has highlighted the vast 
epidemiological evidence in support of the use of A1c to diagnose diabetes (13, 19). 
Improvements in A1c as a diagnostic tool have been recently highlighted as the assays are now 
standardized (13). It is important to note that both FPG and 2-hr OGTT are still validated 
methods to diagnose T2D.         
 Several criticisms have been raised in regards to using A1c as a diagnostic tool (20-22). 
Kilpatrick et al. (22) raised the point that A1c is higher in older adults compared to younger 
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adults despite similar glucose tolerance. Furthermore, there may be inherent differences across 
race-ethnic groups that could influence or potentially mis-represent true estimates of diabetes 
prevalence specific to race-ethnicity (21-23). Guo and colleagues (21) found differences in the 
relationship between A1c, FPG and 2-hr OGTT in a sample from the 2005-2010 NHANES. 
Results indicated discrepancies in FPG and A1c, as at a given A1c value, non-Hispanic blacks 
(NHB) had lower FPG and 2-hr OGTT values. In contrast, at given FPG or 2-hr OGTT, NHB 
had higher A1c values.           
 In a recent study conducted by Lacy and colleagues (23), A1c, FPG, and 2-hr OGTT 
values were compared in a sample of African Americans (AAs) with and without sickle cell trait 
(SCT). The results of the analysis indicated that A1C was significantly lower in those with SCT 
at a given FPG and 2-hr OGTT. Given that the prevalence of SCT is approximately 8-10% in 
AAs (24), it is possible that diabetes estimates in AAs are underestimated in population based 
studies when using A1c.           
The burden of diabetes 
Prevalence 
It is well known that the burden of diabetes (inclusive of type 1 and T2D) has increased 
since the late 1950’s quantified by increasing prevalence across years.  Moreover, these 
prevalence estimates have consistently been higher among minority groups compared to non-
Hispanic white (NHW). It is also projected that the disparities in diabetes prevalence estimates 
will continue to expand in the next 30+ years; which is a major public health concern. Along 
with the current and projected diabetes disparities, the diabetes-specific mortality rates differ 
across race-ethnic groups.           
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 Diabetes has increased in a linear fashion beginning in 1958 (0.93%) to the late 1990s 
(1998: 3.8%) (25). Since the late 1990’s, the prevalence of diabetes has increased drastically. 
According the Centers of Disease Control and Prevention (CDC), using self-report data from the 
National Health Interview Survey (NHIS),  the current national diabetes prevalence rates among 
adults is 9.3% (2, 25). It is important to note that the surveillance system used to track diabetes, 
as well as the definition (self-report vs measured values), influence prevalence estimates. For 
example, a study using the 2011-2012 NHANES (26), diabetes prevalence was 14.3% based on 
self-report diabetes, and measured A1c ≥6.5%, FPG ≥126 mg/dl, or 2-hr OGTT ≥200 mg/dl. 
 Disparities in the prevalence of diabetes exist across race-ethnic groups. Based upon self-
reported data from the 2010-2012 NHIS and 2012 Indian Health Service’s National Patient 
Information Reporting System (2), the current national prevalence estimates of diagnosed 
diabetes is higher among Asians (9.0%), Hispanics (12.8%), non-Hispanic blacks (NHBs) 
(13.2%), and American Indians/Alaskan Natives (15.9%) compared to NHWs (7.6%). These 
disparities in diabetes prevalence across race-ethnicity have been observed since the 1970’s. 
Using data from NHANES I (1971-1975), II (1976-1980), III (1988-1994) and 1999-2004, 
Zhang et al. (27) examined the prevalence of self-reported diabetes among NHW, NHB, and 
Mexican Americans (MA) (Table 2.1). This study found that the prevalence of diabetes 
increased across all race-ethnic groups over the course of the NHANES cycles.  
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Table 2.1. Prevalence of self-reported diabetes across cycles of the NHANES 
 NHANES 1 
1971-1975 
NHANES II 
1976-1980 
NHANES III 
1988-1994 
NHANES 
1999-2004 
NHW 2.9% 4.4% 5.9% 7.8% 
NHB 4.5% 9.0% 10.6% 13.8% 
MA 3.4% 7.2% 12.6% 13.2% 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American; NHANES: 
National Health and Nutrition Examination Survey  
Source: Zhang Q, Wang Y, Huang ES. Changes in racial/ethnic disparities in the prevalence of 
Type 2 diabetes by obesity level among US adults. Ethn Health. 2009;14:439-457.   
 
The current race-ethnic specific prevalence rates of diabetes differ dependent upon the 
definition used to denote diabetes. For example, Menke et al. (26) investigated the prevalence of 
total diabetes (diagnosed and undiagnosed) across race-ethnic groups using data from the 2011-
2012 NHANES. Total diabetes was defined as either: self-reported physician diagnosis, 
measured A1c ≥6.5%, FPG ≥126 mg/dL, or 2-hr OGTT ≥200 mg/dL. Those classified as NHB 
(21.8%) Asian (20.6%) or MA (23.8%) had significantly higher prevalence rates for total 
diabetes compared to NHW (11.3%). Moreover, these rates are all significantly higher than the 
aforementioned prevalence rates from the NHIS (2, 25).     
 The prevalence of diabetes is projected to vastly increase by the year 2050. Overall, in 
the U.S., the projected prevalence will increase to between 21% and 33% by the 2050 (28). Two 
studies have provided projected prevalence increases stratified by race-ethnicity (9, 29). Using 
data from the 1994-2000 NHIS, Honeycutt et al. (9) projected the 2050 prevalence rates of 
diabetes will be higher among NHBs (118%), Hispanics (149%) and other ethnicities (170%), 
compared to NHW (104%). A similar analysis and model by Narayan et al. (29), using the 1984-
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2004 NHIS, found similar 2050 projected prevalence rates; NHBs (107%), Hispanics (127%) 
and other ethnicities (158%), NHW (99%).   
Diabetes mortality and race-ethnicity 
 Race-ethnic disparities in diabetes-related mortality rates have been confirmed across 
multiple population-based surveys (1, 2, 30, 31). Historically, the percentage of mortality related 
to diabetes has been higher among ethnic minorities compared to NHW. Using data from the 
NHIS, the rates of mortality from diabetes was estimated between NHW and NHB males and 
females from 1980-2009 (31). While the incidence of death from diabetes declined across all 
groups, there was a distinct pattern in which mortality rates were higher in NHBs compared to 
NHWs. Furthermore, the rates were much higher across the years in NHB males compare to 
NHW males and females as well as NHB females (appendix 3). In a study by Beydoun et al. 
(30), utilizing data from the NHANES III (1988-1994), the mortality rate attributable to diabetes 
was significantly lower in NHWs compared to NHBs (NHW:8.4% vs NHB:10.8%, p<0.001), as 
well as in NHWs when compared to MAs (NHW:8.4% vs MA:13.9%, p=0.002). According to 
the 2014 final deaths report, the estimate of deaths attributable to diabetes (per 100,000) is higher 
among Hispanics (25.1) and NHBs (38.2) compared to NHW (18.6) (1). When compared to 
NHWs, NHBs and Hispanics are 2.3 and 1.5 times more likely to die from diabetes, respectively 
(1).            
 A recent analysis by Stokes et al. (32) examined the population-attributable fraction 
(PAF) of mortality related to diabetes, as well as the prevalence of diabetes-related mortality. 
Data from the NHIS (1997-2009) and NHANES (1999-2010) were used for this study. A total of 
282,322 participants aged 30-84 were used in the sample. The PAF for mortality from diabetes 
was 11.1% in NHW, 13.0% in NHB, and 13.0% in Hispanics. The prevalence of diabetes being 
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reported as the underlying cause was 2.6% in NHW, 5.0% in NHB, and 7.0% in Hispanics. The 
prevalence of diabetes being assigned as a contributing cause of death was 9.7% in NHW, 14.4% 
in NHB, and 15.7% in Hispanics. From these results it is evident that diabetes-related mortality 
affects those who are NHB and Hispanic more than those who are NHW.   
Physical activity behavior and race-ethnicity 
Physical activity (PA) behavior          
 PA is associated with a plethora of positive health outcomes and lower risk for T2D. In 
order to understand the population-level impact of PA on T2D, it is imperative to know the PA 
behavior of adults. Beyond this, it is important to know PA behavior across race-ethnic groups as 
this may explain disparities in different health outcomes. The following section will detail the 
prevalence of PA participation in the U.S.; comparing different survey methods, self-report vs. 
accelerometry-derived PA, and the differences in these across race-ethnicity.    
 Several survey systems, such as the NHIS, BRFSS and NHANES, examine the 
prevalence of meeting the 2008 Department of Health and Human Services (DHHS) aerobic 
physical activity guideline (PAG) to understand the PA behaviors in U.S. adults. Quantified, the 
aerobic PAG is either ≥150 min/wk of moderate-intensity PA or ≥75 min/wk of vigorous-
intensity PA (33). Furthermore, it is important to note that PA attributable to meeting these 
guidelines can come from all domains including: LTPA, transportational PA, occupational PA 
and domestic PA.           
 Using self-report data from the 2015 NHIS, the current national prevalence of adults 
meeting the 2008, through leisure-time PA (LTPA), is approximately 49% (34). However, 
depending upon the self-report survey, the current estimates of PA behavior vary in U.S. adults 
(35, 36). Using data from the 2013 Behavioral Risk Factor Surveillance System (BRFSS), the 
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national estimate for meeting the 2008 PAG (LTPA) was 50.2% in 2015 (37). In an analysis by 
Keadle et al. (38), using self-report data from three different population surveys, (2011-2012 
NHANES, 2013 NHIS, and 2013 BRFSS), the prevalence of older adults (≥65 years) meeting 
the 2008 DHHS aerobic PAG (using only LTPA) differed across surveys; 35.8% for NHIS, 
27.3% for NHANES, and 44.3% for BRFSS.        
 When examining PA participation including other domains (i.e. transportational and 
household), the prevalence estimates of PA increase. It is important to note that both the NHIS 
and BRFSS only assess LTPA. In a 2011 analysis using self-report data from the 2005-2006 
NHANES, Tucker et al. (39) compared the prevalence of meeting the 2008 DHHS PAG by 
summarizing PA participation across several domains of self-report PA (LTPA, transportation 
and household). The PAG were categorized in three ways: 150 minutes of moderate to vigorous 
PA (MVPAG), the second way was calculated by weighing each minute of vigorous activity as 
two minutes of moderate PA (MV2PAG), or 500 MET-min/wk (METPAG). For all three 
categories of PAG, three levels were denoted: none (no PA), insufficient (from 1 to <150 min or 
500 MET-min/wk), and meeting the PAG (≥150 min or ≥500 MET-min/wk). The prevalence of 
meeting the PAG was 59.6% (MVPAG), 62.0% (MV2PAG), and 65.7% (METPAG).   
 Differences in the estimation of PA behavior in population-based surveys exist when 
measuring PA with objective methodologies such as accelerometers (40-42). Furthermore, within 
accelerometer research, the use of different cut-points can impact the estimates of time spent in 
MVPA (40, 41, 43) further impacting the prevalence of meeting the PAG. In a study using the 
accelerometry data form the 2003-2006 NHANES, Boyer et al. (40) found significant differences 
in the mean bouted minutes of MVPA comparing the 2020 cpm (7.0 ± 0.4 minutes) to the 760 
cpm (15.2 ± 0.1 minutes) cutpoint. In an analysis by Watson et al. (43) using data from the 2003-
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2006 NHANES, investigators compared the prevalence of meeting the 2008 DHHS aerobic PAG 
using 12 different accelerometer cut-points commonly used to denote MVPA and estimates 
ranged from 6.3-98.3%.           
 As highlighted by the aforementioned studies as well as Price et al. (36), the methodology 
employed to measure PA will drastically affect prevalence estimates of PA behavior due to 
inherent limitations specific to the methodologies. Within the self-report data the prevalence of 
meeting the aerobic PAG ranges from 49.0% (35) to 65.7% (39). For accelerometry-derived PA, 
the prevalence ranges from 6.3% to 98.3% (43).  
Physical activity behavior and race-ethnicity      
 As mentioned previously, there are distinct disparities in the prevalence of diabetes 
across race-ethnic groups (2, 26, 27). Furthermore, it is equally important to note that these 
disparities are projected to increase through the year 2050 (9, 28, 29). To begin to understand 
how PA relates to T2D risk between different race-ethnic groups, it is important to grasp the 
population-level prevalence of PA behavior in these groups. As with national estimates, there are 
differences in PA behavior when examining PA by self-report vs. accelerometry methods. 
However, despite these differences specific to measurement method, PA participation tends to be 
lower in NHBs compared to other race-ethnic groups.         
 According to the estimates from the CDC using data from the 2015 NHIS, the prevalence 
of meeting the 2008 DHHS aerobic PAG differs across race-ethnicity; 42.4% (NHB), 43.0% 
(Hispanics), and 52.9% (NHW). Keadle et al. (38), examined the prevalence of meeting the 2008 
DHS aerobic PAG among older adults (≥65 years), stratified by race-ethnicity. This population-
level study used data from the 2011-2012 NHANES, the 2013 NHIS, and the 2013 BRFSSS. 
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Across the three surveys, the prevalence of meeting the PAG (via LTPA) was significantly lower 
in those who were Hispanic or NHB, compared to NHW (Table 2.2).   
Table 2.2. Prevalence of meeting the 2008 DHHS aerobic PAG via self-reported LTPA in older 
adults (≥65 years): stratified by race-ethnicity 
 NHIS BRFSS NHANES 
NHW 37.2% 46.4% 30.1% 
NHB 27.5% 33.5% 16.3% 
Hispanic 29.6% 33.5% 14.6% 
 
NHW: non-Hispanic white; NHB: non-Hispanic black;; NHANES: National Health and 
Nutrition Examination Survey; NHIS: National Health Interview Survey; BRFSS: Behavioral 
Risk Factor Surveillance System 
Source: Keadle SK, McKinnon R, Graubard BI, Troiano RP. Prevalence and trends in physical 
activity among older adults in the United States: A comparison across three national surveys. 
Preventive Medicine. 2016;89:37-43. 
 
In the aforementioned analysis by Tucker et al. (39), using self-reported data from the 
2005-2006 NHANES,  investigators stratified their analysis further across race-ethnicity (NHW, 
NHB and MA). Results revealed that meeting the prevalence of meeting the PAG (LTPA, 
transportational and household) was significantly lower in those who were MA or NHB 
compared to NHW (Table 2.3).  
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Table 2.3. Prevalence of meeting the 2008 DHHS aerobic PAG via self-reported PA (LTPA, 
transportational PA and household PA) stratified by race-ethnicity: 2005-2006 NHANES 
 MVPAG MV2PAG METPAG 
NHW 63.0% 65.0% 68.8% 
NHB 47.7% 52.1% 55.1% 
MA 40.7% 43.7% 48.4% 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American; NHANES: 
National Health and Nutrition Examination Survey; MVPAG: 150 minutes of moderate to 
vigorous PA; MV2PAG: weighing each minute of vigorous activity as two minutes of moderate 
PA; METPAG: 500 MET-min/wk.   
Source: Tucker JM, Welk GJ, Beyler NK. Physical activity in U.S.: adults compliance with the 
Physical Activity Guidelines for Americans. Am J Prev Med. 2011;40:454-461. 
 
In contrast to the self-report estimates, accelerometry estimates yield different results, 
both in prevalence as well as race-ethnic differences. For accelerometry-derived PA using the 
2003-2006 NHANES, Tucker et al. (39) showed that those who were categorized as MA had 
higher prevalence rates for meeting the 2008 DHHS PAG. When examining PA categorized as 
MVPAG (150 minutes of moderate to vigorous PA) the prevalence was 8.2% (NHW), 7.7% 
(NHB) and 9.1% in MA. For the MV2PAG (weighing each minute of vigorous activity as two 
minutes of moderate PA) the prevalence was 10.1% (NHW), 8.0% (NHB) and 9.9% in MA. For 
the METPAG (500 MET-min/wk) the prevalence was 46.1% (NHW), 37.6% (NHB) and 46.8% 
in MA.           
 Watson et al. (43) further stratified their analysis by race-ethnicity and reported the 
median prevalence of meeting the 2008 DHHS PAG measured via accelerometer. Several cut-
points denoting MVPA were used based on either studies examining walking and running (WR) 
or those using lifestyle activities. While not statistically different, there were differences in the 
 
 
21 
 
prevalence of meeting the PAG across race-ethnicity depending upon the cut-point used (WR: 
NHW: 12.0%, NHB: 9.9%, MA: 12.9%, other: 11.8%), (Lifestyle: NHW: 76.6%, NHB: 75.1%, 
MA: 84.6%, other: 77.8%). Similar to the results found by Tucker et al. (39), NHB had lower 
prevalence of meeting the PAG.         
 To summarize, there are distinct differences between race-ethnic groups when examining 
PA behavior specifically when using self-report methodologies to measure PA. Consistently, 
NHW have been shown to report higher prevalence of meeting the 2008 DHHS aerobic PAG 
compared to other race-ethnic groups. In contrast to self-report estimates, accelerometry-derived 
PA consistently showed higher estimates in MA. However, similar to self-report, NHB 
consistently have lower participation in PA.          
Physical activity and diabetes risk 
There is a well-researched and defined inverse association between PA and T2D risk (44, 
45). Two recent meta-analyses (44, 45) have provided a thorough and detailed examination of 
this association across over 100 different prospective cohort studies. From these two studies  
evidence of significant reductions in risk for T2D are associated with total PA (44, 45), LTPA 
(44, 45), vigorous PA (44), moderate PA (44), light PA (44), walking (44), resistance training 
(44), and occupational PA (OPA) (44). Furthermore, a clear, non-linear dose-response was found 
in a meta-analysis by Smith et al. (45), indicating that a doubling in PA volume does not 
necessarily equate to a double in risk reduction. However, it is evident that more PA is associated 
with a more pronounced reduction in risk. This section will detail the results of these meta-
analyses.           
 In 2015, Aune et al. (44) systematically reviewed and conducted a meta-analysis across 
81 prospective cohort studies examining the relationship between PA and T2D risk. Domains of 
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PA examined included: total PA, LTPA, vigorous PA, moderate PA, light PA, walking, 
resistance training, and OPA (Table 2.4).  
Table 2.4. Domains of PA and T2D risk: Results of Aune et al. (34) comparing the most vs least 
active. 
PA Domain RR for T2D 
(RR, 95% CI) 
Total PA 0.65 (0.59-0.71) 
LTPA 0.74 (0.70-0.79) 
Vigorous PA 0.61 (0.51-0.74) 
Moderate PA 0.68 (0.52-0.90) 
Light PA 0.66 (0.47-0.79) 
Walking 0.85 (0.79-0.91) 
Resistance 
training 
0.72 (0.58-0.84) 
Occupational 
PA 
0.85 (0.79-0.92) 
 
PA: Physical Activity; RR: Relative Risk; CI: Confidence Interval 
Source: Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of 
type 2 diabetes: a systematic review and dose-response meta-analysis. European Journal of 
Epidemiology. 2015;30:529-542. 
 
In order to examine the potential dose-response relationship between PA and T2D, Aune 
et al. (44) conducted additional analyses for studies reporting LTPA. For the dose-response 
analyses, PA was categorized in three ways: Every 20 MET-hrs/wk, every 5 MET-hr/wk, and 
every 1000 kcals/wk. For every 20 MET-hrs/wk of LTPA, there was a significant summary 
reduction in the risk for T2D (RR 0.85, 95% CI 0.81-0.89). For every 5 hrs/wk of LTPA, there 
was a significant summary reduction in risk for T2D (RR 0.75, 95% CI 0.67-0.85). For every 
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1000 kcals/wk, a significant summary reduction in risk for T2D (RR 0.87, 95% CI 0.79-0.95) 
was found.           
 In the same study, separate dose-response analyses were conducted for vigorous PA, light 
PA, resistance training and walking. For vigorous PA, light PA, and resistance training, PA was 
examined in increments of 5 hrs/wk. For walking, three PA methods were used: every 5 hrs/wk, 
every 2 hrs/wk, and every 10 MET-hrs/wk. Specific to vigorous PA, for every 5 hrs/wk a 
significant summary reduction is risk for T2D was found (RR 0.69, 95% CI 0.58-0.82). For light 
PA, a significant summary reduction is risk for T2D was revealed per every 5 hrs/wk (RR 0.60, 
95% CI 0.44-0.82). For every 10-MET hrs/wk of walking, no significant relationship was found 
(RR 0.95, 95% CI 0.88-1.02). For every 2 hrs/wk of walking, a significant association was found 
(RR 0.92, 95% CI 0.85-0.99). In studies examining resistance training, every 5 hrs/wk of 
resistance training was associated with a significantly lower risk of T2D (RR 0.70, 95% CI 0.58-
0.84).            
 In a 2016 meta-analysis, Smith et al. (45) expanded on the results from Aune et al. (44) 
by conducting a more harmonized dose-response analysis examining PA and T2D. A total of 28 
cohort studies were included in the meta-analysis. Significant summary effects for every 10 
MET-hrs/wk accumulated of total PA (RR 0.95, 95% CI 0.93-0.98) and LTPA (RR 0.83, 95% CI 
0.79-0.87). In a separate analysis, a non-linear dose-response was investigated by examining PA 
in relation to the 2008 aerobic PA guidelines (11.25 MET-h/wk) and volumes equating to double 
that of the 2008 PA guidelines (22.5 MET-hr/wk). Significant summary effects were found for 
11.25 MET-hr/wk (RR 0.74, 95% CI 0.69-0.80) and 22.5 MET-hr/wk (RR 0.64, 95% CI 0.54-
0.73). At volumes of 60 MET-hr/wk, a significant summary effect was found (RR 0.47, no CI 
reported).           
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 It is evident from both of the aforementioned meta-analyses (44, 45) that a clear inverse 
relationship exists between PA and T2D. More specifically, Aune et al. (44) showed that total 
PA, LTPA, vigorous PA, moderate PA, light PA, walking, resistance training, and OPA are all 
associated with reductions in the risk of T2D. Furthermore, there is a significant dose-response 
relationship between vigorous PA, light PA, hrs/wk of walking and hrs/wk of resistance training. 
No relationship was found between MET-hrs/wk of walking and T2D risk. Smith et al. (45) 
further added to this relationship, specifically for total PA and LTPA, by showing a non-linear 
dose-response between MET-hrs/wk and T2D risk. 
Physical activity and the risk of type 2 diabetes: the effect modification by race-ethnicity 
 A recent meta-analysis by Boyer et al. (10) (appendix 2) examined how race-ethnicity 
modifies the established association between PA and T2D. Both PubMed and Embase databases 
were systematically searched up to June 2016. Studies met the following inclusion criteria: 
human participants who were without T2D at the start of the studies and were adults (≥18 years) 
at the time of follow-up; assessed aerobic-based PA; published or available in English; were 
prospective cohort studies; assessed and reported the race-ethnicity specific relative risks (RR) 
for T2D; adjusted risk estimates for age; and allowed for the determination of a most versus least 
physically active group. The race-ethnic groups included were as follows: NHW, NHB, Asian, 
Hispanic and American Indian. Individual study RRs (n=27) were extracted and analyzed to 
assess the relationship between PA and T2D that compared the most to the least active group 
across the chosen race-ethnic groups. Moreover, the effect modification of race-ethnicity was 
analyzed in those meeting the current 2008 DHHS moderate-intensity PA recommendations 
compared to those not meeting the recommendations.         
 A statistically significant summary effect was found for NHWs (RR 0.71, 95% CI 0.60-
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0.85), Asians (RR 0.76, 95% CI 0.67-0.85), Hispanics (RR 0.75, 95% CI 0.64-0.89), and 
American Indians (RR 0.73, 95% CI 0.60-0.88). The summary effect for NHB (RR 0.91, 95% CI 
0.76-1.08) was non-significant. For analyses examining the 2008 aerobic PAG, there was a trend 
towards significance for NHWs (RR 0.75. 95% CI 0.55-1.01, p=0.06) and Asians (RR 0.80, 95% 
CI 0.64-1.01, p=0.06), but the estimates did not attain statistical significance. The results for 
NHBs (RR 1.26, 95% CI 0.84-1.90) and Hispanics (RR 0.95, 95% CI 0.66-1.65) did not attain 
statistical significance.           
 Several physiological mechanisms have been proposed that could explain the lack of 
significance found for NHBs in this study. In short, these include: 1) genetic predisposition, 2) 
compromised hepatic suppression of endogenous glucose production in response to insulin, 3) 
lower insulin sensitivity in the peripheral tissues (specifically skeletal muscle) despite similar 
volumes of aerobic PA, 4) a down regulation of insulin receptors driven by hyperinsulinemia and 
decreased hepatic insulin clearance, 5) increases in intramuscular adipose tissue and intra-
myocellular lipid content deposits, and 6) skeletal muscle fiber type differences. Appendix 2 
greatly expands on these mechanisms.     
Summary of the effect modification of race-ethnicity on PA and T2D risk   
 The recent meta-analysis by Boyer et al. (10)(appendix 2) provided detailed and much 
needed insight into the effect modification of race-ethnicity on the established relationship 
between PA and T2D. The results indicate that those who identify as NHW, Asian, American 
Indian, or Hispanic had similar risk reductions ranging from 24% to 29%. Furthermore, those 
who identified as NHB had no significant reduction in risk. The results of this study can be 
postulated to also be reflective of how race-ethnicity modifies the relationship between PA and 
mortality; more specifically diabetes-related mortality. However, research is needed. 
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Physical activity and mortality in those with diabetes 
From a public health perspective, it is equally important to understand how PA, T2D and 
mortality are associated, as the results from Boyer et al (appendix 2) indicate that protection from 
T2D is not equally shared across other race-ethnic groups. Considering the strong association 
between T2D and mortality (46-48), it is necessary to examine if an effect modification by race-
ethnicity exists when considering mortality. To further understand the impacts of PA and T2D, 
the next section will provide a comprehensive examination of the literature investigating: a) the 
relationship between PA and mortality in those with diagnosed T2D, b) the effect modification 
of this relationship by race-ethnicity, and c) the relationship between PA and diabetes-related 
mortality. 
Physical activity, all-cause and cardiovascular (CVD) mortality in those with diabetes 
  For this review, a total of 13 studies (49-61) were identified that examined the 
relationship between physical activity and mortality (all-cause and CVD) specifically among 
those with T2D. To understand this relationship, PA has been examined using total PA (PA 
across multiple domains) as well as individual domains (occupational, transportational, and 
LTPA) and walking. Among these 13 studies, seven examined total PA (50, 52-54, 56, 57, 60), 
seven examined LTPA (49, 51, 55-57, 59, 61), one examined occupational PA (51), one 
examined transportational PA (51), one examined domestic PA (56), and five examined walking 
(50, 56-59). The following section will discuss the relationship between PA and all-cause or 
CVD mortality in participants with diabetes; organized by domain. A summary and meta-
analysis is presented at the end of this section to provide insight into the overall relationship 
between PA and mortality in those with diabetes.   
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Total PA 
 All seven studies examining total PA and mortality among those with T2D examined all-
cause mortality (50, 52-54, 56, 57, 60) and four examined CVD mortality (50, 52, 56, 57). Gregg 
et al. (50) investigated the relationship between total PA and mortality in 2,896 adults with T2D 
who participated in the 1990-1991 NHIS. Three categories were created for total PA (low: 0 
hr/wk, moderate: 0-1.9 hr/wk, and high: ≥2 hr/wk). Following adjustment for age, gender, race, 
body mass index, self-rated health, smoking, weight loss approaches, hospitalizations, 
hypertension and use of antihypertensive medications, physician visits, limitations caused by 
CVD and cancer, and level functional limitation, significantly lower risk for all-cause mortality 
was revealed in those who were categorized as high total PA (HR 0.71, 95% CI 0.59-0.87). No 
association was found for total PA and CVD mortality.      
 In another study by Hu and colleagues (52), using 3,708 Finnish adults with T2D, the 
relationship between PA (LTPA and occupational) and mortality was examined. Physical activity 
was defined as low (light levels of occupational, commuting (<1 min), and leisure-time PA), 
moderate (reported only one of the all three types of moderate to high PA) or high (reported two 
or three types of moderate to high PA). Following adjustment for age, gender, study year, 
education, BMI, systolic blood pressure, total cholesterol level, and smoking, significantly lower 
risks for all-cause mortality was found in those reporting PA in the moderate (HR 0.61, 95% CI 
0.51-0.73) or high (HR 0.55, 95% CI 0.47-0.66) categories. Similar results were found for CVD 
mortality.           
 Jonker et al. (53) examined the risk of all-cause mortality in 5,209 participants from the 
Framingham Heart study with T2D.  Physical activity was assessed via self-reported time spent 
in light, moderate or vigorous activities over a week. Time spent (hrs/wk) were then multiplied 
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by the metabolic cost of activity (i.e. 0.25 l/min for sleep) and then weighted according to 
intensity (1.1: sedentary, 1.5: light PA, 2.4: moderate PA, and 5: vigorous PA). The weighted 
hours were then converted into tertiles to examine a dose-response relationship. Significantly 
lower risk for all-cause mortality was found for those in tertile 3 (HR 0.53, 95% CI 0.39-0.72) 
compared to tertile 1.           
 In 712 adults with T2D, Loprinzi (54) examined the relationship between objectively-
measured PA and the risk of all-cause mortality within the 2003-2006 NHANES. Activity was 
categorized as minutes spent above 100 counts per minute (cpm). After adjustment for age, 
gender, race-ethnicity, serum cotinine, poverty-to-income ratio (continuous); C-reactive protein 
(CRP), cholesterol medication use, blood pressure medication use, diabetes medication, 
glycosylated hemoglobin A1C and other illness, a significantly lower risk for mortality was 
found (HR 0.68, 95% CI 0.56-0.83) for every 60 min of accrued activity above 100 cpm.  
 Sadarangani et al. (56) examined the dose-response relationship between PA and all-
cause mortality and CVD mortality in a sample with T2D. PA was categorized into three levels: 
none (no reported activity), some (0.1–7.4 MET-hr/wk) and meeting the recommendations (≥7.5 
MET-hr/wk). Those reporting some activity had significantly lower risk for both all-cause (HR 
0.74, 95% CI 0.61-0.89) and CVD mortality (HR 0.68, 95% CI 0.51-0.92). Those reporting 
meeting the recommendations had significantly lower risk for both all-cause (HR 0.65, 95% CI 
0.53-0.79) and CVD mortality (HR 0.60, 95% CI 0.44-0.82) compared to those reporting none. 
 Using data from the European Prospective Investigation into Cancer and Nutrition study 
(EPIC) study, Sluik et al. (57) investigated the relationship between LTPA and all-cause 
mortality in participants with T2D. Participants reported the time spent in activity and quartiles 
(inactive, moderately inactive, moderately active, and active) were created based off of the sum 
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MET-hr/wk for total PA. Those who were categorized as moderately inactive (HR 0.68, 95% CI 
0.54-0.76) and moderately active (HR 0.58, 95% CI 0.43-0.77) had significantly lower risk for 
all-cause mortality.  Moderately inactive (HR 0.46, 95% CI 0.28-0.74), moderately active (HR 
0.31, 95% CI 0.15-0.60), and active participants (HR 0.48, 95% CI 0.25-0.94) all had lower risk 
for CVD mortality compared to inactive participants.     
 Using data from 1,013 participants with T2D in the Greek EPIC study, Trichopoulou et 
al. (60) examined the relationship between total PA and the risk of all-cause mortality. Activity 
was categorized into quintiles (1: <30, 2: 30 to <32, 3: 32 to <34, 4: 34 to <37, 5: ≥37) of MET-
hrs/d based on self-reported PA. A summary dose-response analysis was conducted per 1 unit 
increase in quintile. A significant dose-response relationship was found for every 1-unit increase 
in quintile and all-cause mortality (HR 0.76, 95% CI 0.63-0.92).      
Leisure-time PA 
Seven studies examined LTPA and all-cause mortality risk (49, 51, 55-57, 59, 61) and 
four examined LTPA and CVD mortality (49, 51, 57, 59) in participants with T2D. Using data 
from the NHANES I, Ford et al. (39) examined the risk for all-cause and CVD mortality among 
602 participants with T2D. Leisure-time PA was categorized from a single question: “Do you get 
much exercise in things you do for recreation?”.  Three categories were used: much exercise, 
moderate exercise, or little to no exercise. There were no significant reductions in risk for all-
cause mortality or CVD mortality across LTPA categories.      
 In a 2004 study conducted by Hu et al. (51) the relationship between LTPA and the risk 
of all-cause and CVD mortality was examined among 3,316 Finnish adults with T2D. LTPA was 
categorized into three levels: 1) low (almost completely inactive), 2) moderate (some physical 
activity for ≥4 h/wk) and 3) high ((vigorous physical activity for ≥3 h/wk) Following adjustment 
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for age, gender, study year, body mass index, systolic blood pressure, cholesterol, smoking, and 
other types of PA, significantly lower risks for all-cause mortality were found for moderate (HR 
0.86, 95% CI 0.75-0.98) and high (RR 0.72, 95% CI 0.55-0.95) LTPA. For CVD mortality, those 
categorized as moderate (HR 0.84, 95% CI 0.71-0.99) or high (HR 0.69, 95% CI 0.49-0.99) 
LTPA had significantly lower risk.        
 Using data from NHANES III, Nelson and colleagues (55) investigated the association 
between LTPA and all-cause mortality in 1,507 adults with T2D. PA was assessed via self-
reported time spent across several activities which was then converted to MET-min/wk based on 
intensity specific levels. Leisure-time PA was dichotomized: those reporting none or those 
reporting any LTPA. In participants reporting any LTPA participation, a significantly lower risk 
for all-cause mortality was found (HR 0.63, 95% CI 0.49-0.80).    
 Sadarangani et al. (56) investigated the relationship between LTPA (sport and exercise 
participation) and all-cause and CVD mortality in a sample with T2D. Participants reported 
frequency, duration and type of activity; with at least 15 min per bout of activity. Intensity was 
examined by asking if the participants were out of breath, or sweaty when performing the 
activity. Activity was categorized in three levels based on the calculated MET-minutes for 
reported activities: none, below median, or above median. Significant reductions in risk for all-
cause mortality were found for those in the median (HR 0.74, 95% CI 0.55-0.99) and above 
median (HR 0.71, 0.51-0.99) groups compared to those with no reported activity. No significant 
associations were found for LTPA and CVD mortality.         
 Using data from the EPIC study, Sluik et al. (57) investigated the relationship between 
PA and all-cause mortality in participants with T2D. Participants reported time spent in activity 
and quartiles (inactive, moderately inactive, moderately active, and active) were created based 
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off of the sum MET-hr/wk for LTPA.  Following adjustment for covariates, moderately inactive 
(HR 0.77, 95% CI 0.60-0.99) and active (HR 0.62, 95% CI 0.46-0.85) participants had lower risk 
for all-cause mortality. Only active participants had lower risk for CVD mortality (HR 0.30, 95% 
CI 0.14-0.64).           
 Tanasescu et al. (59) examined the association between PA and all-cause mortality in a 
sample of 3,058 men with T2D from the Health Professionals’ follow-up study. Quintiles of PA 
were created based on MET-hr/wk calculated from self-reported participation in LTPA. 
Significantly lower risk for all-cause mortality was found in those categorized into the third (HR 
0.64, 95% CI 0.45-0.91), fourth (HR 0.64, 95% CI 0.45-0.90) and fifth (HR 0.65, 95% CI 0.45-
0.93) quintiles. It is evident that a threshold effect was found with no significant decreases in 
mortality risk existing past the third quintile. No significant relationship was found for CVD 
mortality.            
 In an analysis using data from the Aerobics Center Longitudinal Study (ACLS), Wei et 
al. (61) examined the relationship between LTPA and all-cause mortality in participants with 
T2D. Activity was defined as reporting any participation in walking, jogging, or aerobic exercise 
in their leisure-time in the 3 months before examination. Following adjustment for age, 
examination year, smoking, alcohol, baseline CVD, family CVD, high cholesterol, diabetes 
status, glucose, blood pressure, and overweight status, those who reported any activity had 
significantly lower risk for all-cause mortality (HR 0.56, 95% CI 0.40-0.78) compared to 
inactive participants.   
Occupational PA, transportational PA, and domestic PA      
 In the single study examining occupational PA, Hu et al. (51) examined the relationship 
between PA and the risk of all-cause and CVD mortality in 3,316 Finnish adults with T2D. 
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Occupational PA was categorized as light (physically very easy, sitting office work), moderate 
(standing and walking) or active (walking and heavy lifting). Following adjustment for age, 
gender, study year, BMI, systolic blood pressure, cholesterol, smoking, and the two other types 
of PA (transportational and LTPA), significantly lower risks for all-cause mortality (HR 0.67, 
95% CI 0.57-0.78) and CVD mortality (HR 0.69, 95% CI 0.57-0.85) were found, only in the 
active group compared to the light group.        
 The single study examining transportational PA and the risk for all-cause and CVD 
mortality was also conducted by Hu et al. (51) using the same participants as the previously 
mentioned study. Transportational PA was categorized into three levels: 1) motorized 
transportation or no work (0 minutes of walking or cycling), 2) walking or bicycling 1 to 29 
minutes, and 3) walking or bicycling for ≥30 minutes. In the full-adjusted models, no significant 
reduction in mortality risk was found for any volume of transportational PA.   
 In an analysis of 3,038 participants with T2D from the Scottish Health Survey and Health 
Survey for England, Sadarangani et al. (56) examined the dose-response relationship between 
domestic PA and all-cause mortality and CVD mortality. Participants reported time spent in 
household or housework activities for at least 30 minutes. PA was categorized into three gender-
specific levels: none (no reported activity), below median and above median PA. For all-cause 
mortality, those categorized as being below median MET-hr/wk had a significant reduction in 
all-cause mortality risk (HR 0.77, 95% CI 0.61-0.97). No significant relationships were found for 
domestic PA and risk of CVD mortality.    
Walking  
Gregg et al. (50) investigated the relationship between walking and mortality in 2,896 
adults with T2D who participated in the 1990-1991 NHIS. Three categories were created for 
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both walking (low: 0 hr/wk, moderate: 0-1.9 hr/wk, and high: ≥2 hr/wk). Following adjustment 
for age, gender, race, BMI, self-rated health, smoking, weight loss approaches, hospitalizations, 
hypertension and use of antihypertensive medications, physician visits, limitations caused by 
CVD and cancer, and level functional limitation, significantly lower risk for all-cause mortality 
was revealed in those who were categorized as high walking (HR 0.61, 95% CI 0.48-0.78).  
High walking was also associated with reduced CVD mortality risk (HR 0.66, 95% CI 0.45-
0.96).            
 In the aforementioned analysis by Sadarangani et al. (56), investigators also examined the 
relationship between walking and both all-cause and CVD mortality. Walking was categorized 
into three levels (none, below median, above median) based on calculated MET-hrs/wk from 
reported time spent walking and pace (i.e. slow, average, brisk, or fast). Brisk and fast were 
considered moderate intensity. Those categorized as above median for walking had a 
significantly lower risk for all-cause mortality (HR 0.68, 95% CI 0.54-0.85). No relationship was 
found across categories of walking and CVD mortality.        
 Using data from the EPIC study, Sluik et al. (57) investigated the relationship between 
walking and all-cause mortality and CVD mortality in participants with T2D. Walking was 
categorized into quartiles by hr/wk (inactive, moderately inactive, moderately active, and active). 
Walking was only associated with lower risk for CVD mortality in moderately inactive (HR 
0.40, 95% CI 0.22-0.74) and moderately active (HR 0.44, 95% CI 0.24-0.79) adults.  
 Smith et al. (58) examined the relationship between walking and CVD mortality in a 
group of adults with T2D from the Rancho Bernardo Study. Participants self-reported the volume 
of walking in miles/wk. Walking ≥1 mile/wk was associated with lower risk for all-cause 
mortality (HR 0.54, 95% CI 0.33-0.88). No associations were found for CVD mortality.    
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 Using data from the Health Professionals’ follow-up study, Tanasescu et al. (59) 
examined the association between PA and all-cause mortality in a sample of 3,058 men with 
T2D. Walking quintiles were created based on MET-hr/wk calculated from self-reported 
participation in PA. Only those in quintile 5 (≥16.1 MET-hrs/wk) of walking had a significant 
reduction in risk for all-cause mortality (HR 0.60, 95% CI 0.41-0.88).    
Summary of studies investigating physical activity and mortality in participants with diabetes 
 The relationship between PA and all-cause or CVD mortality has been examined across 
several domains (Total, LTPA, occupational, transportational, domestic, and walking). It is 
evident from the literature presented there is a severe paucity of studies specifically for 
occupational PA (51), transportational PA (51) and domestic PA (56). Regarding total PA, LTPA 
and walking, a 2012 meta-analysis by Sluik et al. (57) summarized the results of several of the 
aforementioned studies (49-53, 55, 58, 60, 61). For analyses examining total PA, a significant 
summary effect was found for both all-cause (HR 0.60, 95% CI 0.49-0.73) and CVD (HR 0.58, 
95% CI 0.50-0.66) mortality when comparing the most active to least active groups. For LTPA, 
significant summary effects were found for both all-cause (HR 0.64, 95% CI 0.57-0.72) and 
CVD (HR 0.64, 95% CI 0.51-0.80) mortality comparing the most active to least active groups. 
Walking (comparing the most active vs. least active) was associated with lower risk for all-cause 
(HR 0.68, 95% CI 0.59-0.78) and CVD (HR 0.59, 95% CI 0.46-0.76) mortality.   
 From the studies presented it is evident that PA is associated with a similar decreased risk 
for all-cause and CVD mortality, specifically in those with T2D. However, due to the vast 
differences in PA measurement, it cannot be determined the minimum dose needed to see 
significant risk reductions for mortality. Therefore, future research should focus on dose-
response analysis structured around the 2008 DHHS aerobic PAG to determine minimum dose 
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required. Nonetheless, PA, especially total, LTPA and walking, are effective in reducing 
mortality risk in those with T2D.       
Physical activity and mortality in those with diabetes; effect modification by race/ethnicity 
One study (62)  has examined the relationship between PA and mortality in those with 
T2D while subsequently examining the effect modification by race-ethnicity. One study (63) 
examined cardiorespiratory fitness and mortality.  A 2015 study by Glenn et al. (62) examined 
the association between self-reported PA, sedentary time, and mortality among NHB and NHW 
adults from low-income households. Physical activity was categorized into quartiles based on 
calculated MET-hrs/d from self-reported time spent across several activities. Following 
adjustment for age, gender, BMI, income, education, history of comorbidities (hypertension, 
high cholesterol, myocardial infarction, and stroke), smoking, T2D characteristics (insulin use 
and time since diabetes diagnosis), and sedentary time, both NHBs and NHWs had significantly 
lower HRs for all-cause mortality across quartiles 2, 3, and 4 of PA compared to quartile 1 
[NHW (2: HR 0.66, 95% CI 0.54-0.82, 3: HR 0.64, 95% CI 0.51-0.79, 4: HR 0.55, 95% CI 0.43-
0.70); NHB (2: HR 0.83, 95% CI 0.73-0.95, 3: HR 0.68, 95% CI 0.59-0.79, 4: HR 0.69, 95% CI 
0.60-0.80)]..           
 Kokkinos et al. (63) examined the relationship between cardiorespiratory fitness and all-
cause mortality in a sample of male NHB and NHW adults with T2D. Tertiles of fitness were 
crated specific to the sample based on peak METs from a Bruce treadmill test. Following 
adjustment for age, BMI, blood pressure medications, statins, hypertension, dyslipidemia, 
smoking, and mortality in the first year of follow-up, significantly lower risk for mortality was 
found in NHBs who were in fitness tertiles 2 (RR 0.65, 95% CI 0.53-0.79) and 3 (RR 0.56, 95% 
CI 0.40-0.77).  Similar results were found in NHWs in tertiles 2 (RR 0.57, 95% CI 0.544-0.73) 
 
 
36 
 
and 3 (RR 0.34, 95% CI 0.23-0.51).         
 The results of these studies indicate that there seems to be no effect modification of race-
ethnicity on the relationship between PA and all-cause mortality in those with type 2 diabetes.  
Physical activity and diabetes-related mortality 
 While there are many studies that have shown an inverse relationship between PA and 
mortality among those with T2D; only two studies (11, 12) have examined the relationship 
between PA and diabetes-related mortality. In addition, only a single study has examined 
cardiorespiratory fitness and diabetes-related mortality (61). For this section, diabetes-related 
mortality is defined as mortality related to any type of diabetes.      
 Using participants in the Danish Diet, Cancer, and Health study, Andersen et al. (11) 
examined the relationship between PA and diabetes-related mortality. Participants were 50-65 
years of age and self-reported demographic information, dietary and health behaviors such as 
smoking, alcohol consumption and PA. Physical activity was assessed via questionnaire that 
asked about weekly hours spent participating in sports, cycling, gardening, walking, housework 
(cleaning), and household chores (house repairs). Physical activity was then dichotomized 
according to reported participation in sports, cycling, gardening or walking. Diabetes-related 
mortality was defined using the ICD-10 codes E10-E14. Following adjustment for air pollution, 
gender, calendar year, other PA, OPA, smoking status, smoking intensity, smoking duration, 
alcohol intake, environmental tobacco smoke, education, fruit and vegetable intake, fat intake, 
risk occupation, mean income in municipality, and marital status, those reporting any 
participation in sports (HR 0.34, 95% CI 0.21-0.55), cycling (HR 0.61, 95% CI 0.42-0.89), or 
gardening (HR 0.42, 95% CI 0.28-0.62) had significantly lower HRs for diabetes-related 
mortality compared to those reporting no participation. In those reporting walking, statistical 
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significance was not attained (HR 0.77. 95% CI 0.44-1.33).       
 Williams et al. (12) examined the relationship between MET-hrs/d of walking and 
mortality, including mortality from diabetes. Study participants were from the National Walker’s 
Health Study. Participants reported demographic characteristics, dietary behaviors, health 
behaviors, medication use, and weekly walking participation (distance and average speed). 
Mortality was classified using the ICD-10 mortality codes. Walking (MET-hrs/d) was 
categorized into four categories: <1.07 (category 1), 1.07-1.8 (category 2), >1.8-3.5 (category 3), 
and ≥3.6 (category 4). Following adjustment for age, race, gender, education, prior heart attack, 
aspirin use, and intakes of red meat, fruit, and alcohol, those in category three (HR 0.36, 95% CI 
0.18-0.73) and category four (HR 0.09, 95% CI 0.2-0.4) had significantly lower HRs for 
diabetes-related mortality compared to category one. Following further adjustment for 
medication use and baseline BMI, results remained significant for category four only (HR 0.17, 
95% CI 0.04-0.73). In a separate analysis adjusting for reported BMI when started walking, a 
significant HR was found for category four (HR 0.17, 95% CI 0.04-0.80); with those in category 
three were trending towards significance (HR 0.41, 95% CI 0.16-1.03, p=0.06).    
 A separate survival analysis using the same sample from Williams et al. (12) examined if 
the HR for the underlying cause of death was changed when including risk from other causes. In 
other words, would risk for diabetes-related mortality change in someone whose underlying 
cause of death was not from diabetes. Following adjustment for covariates, medication use, and 
baseline BMI, those in categories three (HR 0.59, 95% CI 0.38-0.90) and four (HR 0.41, 95% CI 
0.23-0.71) had significantly lower HRs for mortality from diabetes compared to category one. 
When adjusting for BMI, results remained significant. These results indicate that despite diabetes 
not being the primary cause of death, higher volumes of walking are significantly associated with 
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a lower risk for diabetes-related mortality.         
 In an analysis of 1,188 men with T2D from the ACLS, Wei et al. (61) examined the 
relationship between fitness and diabetes-related mortality. Following adjustment for age, 
examination year, smoking, alcohol, baseline cardiovascular disease, family history of CVD, 
high cholesterol, diabetes status, glucose level, high blood pressure, and overweight status, those 
who were classified as unfit had a significantly greater risk for death from diabetes (RR 7.4, 95% 
CI 1.4-39.6) compared to those who were fit.      
 It is evident from the presented studies that an inverse relationship exists between PA and 
the risk of diabetes-related mortality. Andersen et al. (58) revealed significant protection from 
diabetes-related mortality in those reporting sports, cycling, gardening or walking; indicating that 
different types of PA can protect against diabetes-related mortality. Williams et al. (59) revealed 
that ≥3.6 MET-hrs/d of walking was significantly associated with lower risk for diabetes-related 
mortality independent of several important covariates including race. Moreover, walking was 
significantly associated with reduced risk for diabetes as a secondary cause of death independent 
of race. Cardiorespiratory fitness was also found to be significantly associated with increased 
risk for diabetes-related morality in those who were unfit compared to fit.    
Summary 
 Diabetes (the vast majority being T2D) is a complex, deleterious metabolic disease that is 
reaching epidemic proportions in the U.S. Currently, the prevalence estimates range from 9.3% 
(13, 14) to 14.5% (15). More importantly, the prevalence of diabetes is consistently higher 
among minority groups when compared to NHWs, independent of the survey method and 
diagnostic criteria used.          
 It is well established there is an inverse association between PA and risk of T2D. These 
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results were further extended by Boyer et al. (10) (appendix 2); who examined the effect 
modification of race-ethnicity on this relationship. When comparing the most to the least active, 
significant and similar risk reductions were seen in all race-ethnic groups (NHW, Asians, 
Hispanic, and American Indian) with the exception of NHB. Several mechanisms were 
postulated by Boyer et al. (10) (appendix 2) to provide physiological rationale for the results 
seen.             
 The relationship between PA and mortality in those with T2D is well established, with an 
inverse association being found across most studies. When examining the effect modification of 
race-ethnicity on this relationship, the two studies examined reveal a more pronounced reduction 
in mortality risk in NHWs compared to NHBs. However, more research is needed. Specific to 
diabetes-related mortality, only two studies have been conducted examining PA and risk. 
Moreover, these studies did not examine this relationship specific to different race-ethnic groups. 
Knowing that PA does not reduce the risk for T2D equally across race-ethnicity (specifically 
NHB), it is necessary to further extend the body of literature to diabetes-related mortality.      
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The purpose of this study was to examine the effect modification of race-ethnicity on the 
association between PA and diabetes-related mortality in two nationally representative samples 
of U.S. adults. The study will utilize data from both the National Health and Nutrition 
Examination Survey (NHANES) III and the 1999-2006 continuous NHANES that are linked to 
the National Death Index (NDI). The following section provides a detailed description of the 
methodology to be used for this study including: a description of the participants, the 
methodology behind NHANES data collection, a description of the NDI and linkage to 
NHANES,  a description of the variables of interest, and data analysis.   
Participants 
 The participants included in this study participated in either the NHANES III or the 1999-
2006 NHANES and are described below. 
NHANES III 
 The study participants for all analyses in research question 1, using the NHANES III, will 
meet the following inclusion criteria:  
 Adults 20-79 years of age. 79 years was chosen as the upper end cutpoint for age as 
previous research has shown that the role of diabetes becomes ambiguous in its 
contribution to mortality at higher ages (32).  
 Did not die within the first three years of follow-up. Within the NHANES III, the cut off 
of three years has been previously used (12).   
 Completed testing at the mobile examination center (MEC).  
 Had complete data for all variables of interest. 
 If female, were not pregnant or lactating.   
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1999-2006 NHANES 
 The study participants for all analyses for research questions 2A-2C using the 1999-2006 
NHANES met the following inclusion criteria:  
 Adults 40-79 years of age. 79 years was chosen as the upper end cutpoint for age as 
previous research has shown that the role of diabetes becomes ambiguous in its 
contribution to mortality at higher ages (32).  
 Completed testing at the mobile examination center (MEC).  
 Had complete data for all variables of interest. 
 If female, were not pregnant or lactating.   
The age-range for research questions 2A-2C has been previously used in a continuous 
NHANES mortality analysis (64). Due to the vast majority of diabetes diagnoses occurring 
between the ages of 40 and 64 years (65) and the prevalence of those below 40 being low (65), 
we elected to use the age cutoff of 40-79 years of age. 
NHANES data collection 
 The NHANES studies, conducted by the National Center for Health Statistics (NCHS) , 
began forty-one years ago in 1976 and were designed to provide population based estimates of 
health, health behaviors and disease via a representative sample of the U.S. (66). Several cycles 
of the NHANES have been conducted; beginning in 1976 with the first phase (NHANES I) (67). 
NHANES II was conducted between 1976 and 1980 (67). NHANES III was conducted in two 
phases; the first from 1988 to 1991 and the second form 1991 to 1994 (68). Beginning in 1999, 
the NHANES moved to a continuous two-year cycle with a focus on emerging health issues 
within the U.S. (69).            
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 The NHANES is cross-sectional in nature and uses a complex, multi-stage sampling 
design to obtain its participants (70). Furthermore, all participants are non-institutionalized 
residents within the 50 states or the District of Columbia and over the age of two months. The 
stages of sampling are broken into four parts (70). The first is the selection of primary sampling 
units (PSUs), which are usually single counties but are sometimes combined, adjacent counties 
to ensure the PSU’s meet the minimum population size requirement (68). The second stage is 
characterized by dividing the PSUs into segments the size of a city block. The third stage is 
characterized by a random sampling of households within the divided segments. A component of 
the NHANES is the oversampling of minority groups (i.e. African Americans, adolescents [12-
19 years], and adults ≥60 years of age) to ensure adequate representation within the sample (70). 
Within stage 3 of the sampling methods, a higher probability exists for sampling in regions 
where oversampled participants reside. Stage four is characterized by randomly selecting at least 
one participant from each household selected.         
 Within the NHANES, several different assessments and measurements are conducted. All 
NHANES participants are assessed via the household interview in which demographic 
characteristics, socioeconomic status, self-reported health behaviors, and health issues are 
collected (66). A subsample of participants undergo a detailed health examination and laboratory 
tests at the MEC in which several physiological variables are measured such as blood pressure, 
cardiorespiratory fitness and glycosylated hemoglobin (HbA1c) (66, 71).       
National Death Index Data Linkage 
 The National Death Index (NDI) is a national database run by the NCHS that maintains 
the records of all U.S. deaths starting in 1979 (72). From the data available at the NDI, it is 
possible to link those records to participants within NCHS surveys, such as the NHANES, using 
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the  identifying information (such as name, social security number, gender, race, and marital 
status)  (72). Death records are then matched to NHANES data based upon seven specific criteria 
(72): 
“1. Social Security Number (SSN)” 
“2. First and last name, exact month of birth, year of birth within 1 year” 
“3. Last name, first initial and middle initial, exact month of birth, year of birth within 1 
year” 
“4. First and last name, exact month of birth, exact day of birth” 
“5. Last name, first initial and middle initial, exact month of birth, exact day of birth” 
“6. First name, father’s surname, exact month of birth, exact year of birth” 
“7. For females only, first name, exact month and year of birth, and last name from the  
survey record matching birth surname on the NDI record (for females who change their  
name after marriage but don’t supply a birth surname)” 
Death records matching with survey data are then scored on a 1-5 “class” scale to assess the 
strength of matching (72). The class scale taken from the NDI documentation is as follows (72): 
“Class 1: Agreed on at least 8 (of 9) or 4 (of 4) digits of SSN, first name, middle initial, 
last name birth year (+/- 3 years), birth month, sex, and state of birth” 
“Class 2: Agreed on at least 7 (of 9) or 4 (of 4) digits of SSN at least 5 more of the 
following items: first name, middle initial, last name, birth year (+/- 3 years), birth 
month, sex, and state of birth.” 
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“Class 3: There were two types of Class 3 matches:” 
“Type A: SSN is unknown, but last name matched and at least 7 of the following 
items agreed: first name, middle initial, last name, birth year (+/- 3 years), birth 
day, sex, race, marital status and state of birth.”  
“Type B: Records in this category were initially put in Class 5 but switched to 
Class 3 if after review, there was the possibility that SSN was either recorded 
incorrectly or that the spouse’s SSN was recorded instead of the subject’s SSN.  
In this category, SSN was known but 3 or more (of 9) and 1 or more (of 4) digits 
did not agree, but at least 8 of the following items agreed: first name, middle 
initial, last name, birth year, birth day, sex, race, marital status, and state of birth.  
All total scores were adjusted to reflect the final class code for the potential 
matches.  For example, any record that was switched from Class 5 to Class 3 had 
its score adjusted to reflect that SSN is missing, with the value of 0 assigned to 
SSN.” 
“Class 4: SSN was unknown on either the NCHS survey submission record or the NDI 
record and fewer than 8 of the items listed in Class 3 matched.”  
“Class 5: SSN was present but fewer than 7 (of 9) or 4 (of 4) digits on SSN agreed.” 
Following class scoring, all class 1 records were included; and record classes 2-4 used a specific 
cut-off point to clarify true matches (72). Those who did not meet class 1 or the specific criteria 
for classes 2-4 were considered no matches and were thus de-identified. Specific to NHANES, 
participants with matched NDI records were linked by their respondent sequence number 
(SEQN), which is the individual identifier variable within the NHANES datasets found within 
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the demographic file. The public-release version of the NDI mortality records (73) were used to 
merge and link the NHANES individual records by SEQN in both the NHANES III and the 
1999-2006 NHANES components of the current study.     
Measures 
The following section details the variables used. 
Effect Modification: Race/Ethnicity 
All analyses were stratified by race-ethnicity to answer all research questions. Race-
ethnicity, contained with the demographic data files, will be categorized and defined by the 
variables DMARETHN (NHANES III) and RIDRETH1 (1999-2006 NHANES) which uses four 
categories to classify race-ethnicity (non-Hispanic white, non-Hispanic Black, Mexican 
American and Other). For analyses in NHANES III, non-Hispanic white, non-Hispanic Black, 
and Mexican American were used. For the 1999-2006 NHANES, non-Hispanic white and non-
Hispanic Black were used. 
Dependent Variable: Diabetes-related mortality 
The dependent variable in this study was diabetes-related mortality obtained from the 
NDI. The public-use mortality codes available are derived from the restricted-use mortality files 
which provides detailed information about causes of death (73) (Appendix 1, table 2). From this 
list, mortality from many different diseases is recoded into all-encompassing diseases such as 
disease of the heart or malignant neoplasms (Appendix 1, table 2) (73). This allows for a more 
general examination of mortality from a population-based standpoint and ensures that no 
sensitive information is attained from the study participants. Furthermore, within the linked-
mortality data, to ease statistical analysis across multiple years or data sets, all causes of death 
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codes before 1999 (International Statistical Classification of Diseases, Injuries, and Causes of 
Death [ICD-9]) were recoded to match the ICD-10 causes of death.        
 For research questions 1-2C, diabetes-related mortality was determined from the public-
use mortality data files using the ICD-10 (E10-E14) codes (73). Table 1 in appendix 1 provides 
the descriptions of each ICD-10 code used to classify diabetes mortality. In order to include 
those who had diabetes as an underlying or non-primary cause, diabetes-related mortality was 
defined as either death from diabetes mellitus or if diabetes was flagged on the death certificate 
with multiple causes of death.  
Primary independent variables: Self-Report and Accelerometer Physical Activity 
Physical activity was the primary independent variable in the analyses. Several different 
measures of PA were used across the research questions depending upon the specific year and 
cycle of NHANES.  
NHANES III (Self-Reported Physical Activity) 
The following describes the methodology used to classify and categorize PA for research 
question 1 specific to NHANES III.  Within the NHANES III, intensity and frequency of 13 
possible leisure-time activities were reported. Leisure-time PA (LTPA) was assessed via 
questionnaire inquiring about participation in eight specific aerobic activities (walking, 
running/jogging, cycling, swimming, aerobics, calisthenics, swimming, and lawn 
work/gardening) (68). Furthermore, four open-ended PA questions were also asked to assess 
activity beyond the nine specific activity questions. The intensity of each activity, denoted by a 
specific metabolic equivalent (MET), was defined and classified according to the Compendium 
of Physical Activities (74). One MET is defined as 3.5 ml/kg/min and equates to the energy cost 
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of rest (75). Participants also self-reported the monthly frequency of each activity reported. 
Duration was not assessed in the NHANES III PA component. Furthermore, activity associated 
with lifting weights was excluded as the study purpose was specifically examining aerobic PA.  
 The primary independent variable in this study was a three category, physical activity 
guideline index (PAGI); using the 2007 PA guidelines (76) as the criteria for meeting the 
recommendations (≥ 5 d/wk of moderate-intensity PA or ≥3 d/wk of vigorous-intensity PA). 
Initially, each reported activity was categorized into one of five intensity categories based upon 
the age-specific MET cut-points in the 1996 Surgeon General's Report on Physical Activity and 
Health (77)(appendix 4). Categories were adjusted based on the relative intensities for the 
following age groups: 20-39, 40-59, and 60-79.  The five categories were as follows: very light 
(level 1), light (level 2), moderate (level 3), hard (level 4), and very hard (level 5). Intensity 
levels 2 and 3 were classified as moderate-intensity activity; intensity levels 4 and 5 were 
classified as vigorous-intensity activity. The weekly frequency for each activity (calculated by 
dividing the monthly frequency by 4.3) was multiplied by its coinciding relative-intensity 
activity level (1-5); creating a physical activity score (PAS) for each individually reported 
activity. The individual PAS were then summed to create an age-adjusted overall total PAS.  
 The three categories for the PAGI are as follows: inactive, insufficiently active, and 
active. Inactive was defined as a total PAS of 0 or those who’s PAS only included “very light” 
activity. Across the 13 potential activities reported, only 10 participants reported only “very 
light” activity. Thus, they were categorized as inactive. Insufficiently active was defined as a 
total PAS ranging between >0 and <10. Active was defined as a PA score of ≥10. The cutoff of 
10 was used as it is a proxy cutoff that equates to 5 bouts/wk of moderate-intensity activity (78, 
79). For the purpose of the PAGI, bouts were assumed to be reflective of days/week (d/wk). For 
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example: The NHANES III MET value associated with the walking question was 3.5 METs. In 
an adult aged 38, this would categorize them into PA intensity level 2; which would be 
considered a moderate-intensity activity (see appendix 4) for that age-group. If at least 5 d/wk of 
walking are reported then this participant would be classified as active (i.e. PA intensity level 2 x 
5 d/wk = PA score 10).   
1999-2004 NHANES (Self-Reported Physical Activity) 
The following details the methodology that will be used to classify and categorize PA for 
research question 2A. Self-reported LTPA, transportational PA and domestic PA over the past 
month were assessed with data being reported in two data files -- the Physical Activity 
Questionnaire (PAQ) and the PA individual activities file (PAQIAF)(80). Data from these files 
provide the following information specific to 43 different activities: type, frequency (times per 
week), and duration (minutes per bout) for each activity. A MET score will be calculated and 
assigned for each activity as well (81). From these variables MET-minutes per week will be 
calculated for three domains: LTPA, transportational PA and domestic PA.  A summary MET-
minute score will then be calculated by adding the total MET-minutes from each domain. From 
the total MET-minutes variable, two different classification methods will be used to examine the 
dose-response association between PA and diabetes-specific mortality. The first is the creation of 
age-adjusted, sample-specific PA MET-minutes quintiles. This method has been used in previous 
NHANES analyses (82). The second method will directly examine the association between PA 
and diabetes-specific mortality using the 2006 Department of Health and Human Services 
(DHHS) aerobic PA guideline (33).  Three categories will be created: 0 MET-minutes/wk 
(Inactive), <500 MET-minutes/wk (Irregular PA), 500-999 MET-minutes/wk which equates to 
meeting the 2008 DHHS aerobic PA guidelines of 150 minutes of MVPA/wk, and ≥1000 MET-
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minutes/wk which equates to volumes exceeding the recommendations of  ≥300 minutes/wk of 
MVPA. This method has also been used in past studies (83, 84).  
2003-2006 NHANES (Objective Physical Activity) 
The following details the methodology, specific to accelerometer-measured PA, to be 
used to classify and categorize PA for research questions 2B and 2C. Within the 2003-2006 
NHANES, accelerometer data was collected using an ActiGraph model 7164 accelerometer. 
Participants were instructed to wear the accelerometer on the right hip for seven consecutive 
days and to remove the accelerometer when participating in water activities such as bathing or 
swimming as well as sleeping (85). A valid day of wear time was defined as ≥10 hours of wear 
time per day (86). In order to be utilized in the analysis, at least four days of valid wear time 
were needed, with ≥60 minutes of zero accelerometer counts defined as non-wear time. Two 
different common cutpoints (87) will be used to quantify minutes spent in MVPA per day; ≥2020 
counts per minute (cpm) (86) and ≥760 cpm (88). Minutes to be included in the analyses 
reflected all minutes spent above the MVPA thresholds.         
 To answer research question 3A, the dose-response relationship between PA and 
diabetes-related morality will be examined for every 10 minutes of moderate-to-vigorous PA 
(MVPA) accumulated per day. This incremental 10 minute increase in MVPA has been used in 
previous analysis (89).          
 To examine the dose-response relationship between PA and diabetes-related mortality as 
mentioned in research question 3B, we will use the Wolff-Hughes et al. (90) population-
referenced total activity count/day (TAC/d) percentiles. Briefly, the “activity counts” utilized in 
this analysis are a reflection of what the accelerometer actually measures, and are created by 
filtering, full-wave rectifying and integrating the raw acceleration across the 1-minute epochs. 
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The TAC/d variable was specifically created by summing up the total activity counts and 
dividing them by the number of valid wear days (42). These percentiles are demarcated at the 5th, 
10th, 25th, 50th, 75th, 90th, 95th and 97th percentiles. From these percentiles, quartiles (25th, 50th and 
75th) will be used to examine a more precise dose-response relationship and to ensure sufficient 
power across quartiles.         
Covariates 
Several potential confounding measures will be used as covariates in this study. The following 
list details the covariates used in the study: 
 Age: Age was examined continuously.  
 Gender: Categorized as male or female.  
 Education: Four categories of education will be used: < high school, high school 
graduate, some college and college graduate.  
 Family history of diabetes: A family history of diabetes is linked to increased risk for 
T2D and, thus, an increased risk for diabetes-related mortality (91). Participants self-
reported family history of diabetes will be dichotomized as either yes or no. The 2005-
2006 NHANES removed the family history questions specific to diabetes, therefore the 
2003-2006 analyses did not include family history as a covariate.  
 Smoking: Smoking will be categorized as either current smoker, previous smoker, or 
non-smoker based on self-report.  
 Alcohol consumption: Previous research has shown alcohol consumption to be inversely 
associated with the risk of T2D (92) and, thus, could be linked to diabetes-related 
mortality. For NHANES III, alcohol consumption was categorized as either non-drinker 
or drinker by responding yes or no to the question “In the past 12 months did you 
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MAPE2 have at least 12 drinks of any kind of alcoholic beverage”. For the 1999-2004 
NHANES, a three-level categorical variable will be used to categorize alcohol 
consumption based on the  United States Department of Agriculture (USDA) and DHHS 
gender specific cut-points (93): non-drinker (0 drinks/day), moderate (>0 and ≤1 
[women], >0 and ≤2 [men] drinks/day), and above moderate (>1 [women], >2 [men] 
drinks/day). 
 Glycemic Index: A three-category variable was created based on the current American 
Diabetes Association glycosylated hemoglobin (HbA1c) recommendations (13) to 
establish euglycemic (HbA1c <5.7%), those with pre-diabetes (HbA1c 5.7 - <6.5%), and 
those with diabetes (HbA1c ≥6.5%).   
 Body mass index (BMI): BMI will be examined as a continuous variable 
 The Healthy Eating Index (HEI): The HEI is a quantitative reflection of overall dietary 
quality and has been validated for use in the NHANES (94). The HEI is based upon 10 
dietary components that are summed on a 0-100 scale; the higher the score being 
indicative of a better dietary quality (95). HEI will be examined continuously.  
 
Data analysis 
All analyses were conducted using SAS 9.4 (96), which allows for the incorporation of 
the sampling weights in the multi-staged, complex sampling design inherent to NHANES. 
Sampling weights are used in analyses to account for the complex survey design, oversampling 
of certain groups, non-response, and post-stratification (97). These weights are utilized to ensure 
the correct representative sample is used in analyses.      
 For NHANES III, sampling weights are provided and are used based upon the sample 
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participant characteristics and variables in the analysis (68). For the current study, due to use of 
variables from the household interview and MEC examination, the final MEC weight 
(WTPFEX6) will be used (68). For the continuous NHANES, 2-year sampling weights for the 
interview, MEC and fasted laboratory files are provided by the NCHS. These weights can be 
combined and calculated based on the cycles used (97). For the current study, a fasted 6-year 
weight will be created for analyses using the 1999-2004 NHANES by combining the 4-year 
sampling weights from the 1999-2002 NHANES and the 2-year fasted weights from the 2003-
2004 NHANES. For analyses utilizing the 2003-2006 NHANES, a similar method was employed 
by combining the fasted weights from the 2003-2004 NHANES and the 2005-2006 NHANES.    
Statistical Analysis 
SAS 9.4 (96) was used to manage all data inclusive of all complex variable recodes and 
to validate recoding. Weighted prevalence estimates were generated using PROC 
SURVEYFREQ. All research questions were analyzed using two SAS survival analysis features: 
PROC LIFETEST and PROC SURVEYPHREG. PROC LIFETEST was used to estimate the 
survivorship related to diabetes-related mortality via Kaplan-Meier (KM) curves. Specific KM 
curves were generated across race-ethnic groups as well as the PA variables for the NHANES III 
and the 1999-2004 NHANES. Furthermore, KM curves were created across the PA variables 
specific to each race-ethnic group. PROC SURVEYPHREG was used to test the null hypothesis 
that the individual Cox proportional hazard ratios are equal to 1 across PA measures within each 
race-ethnic group. This procedure allows for the incorporation of sampling weights inherent with 
the sampling design of NHANES. For all four research questions two models were created:  
unadjusted and fully adjusted using the aforementioned covariates.   
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PART 4 
EFFECT MODIFICATION OF THE ASSOCIATION BETWEEN LEISURE-TIME 
AEROBIC PHYSICAL ACTIVITY AND DIABETES-RELATED MORTALITY BY 
RACE-ETHNICITY: NHANES III 
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Abstract 
Purpose: To examine potential effect modification by race-ethnicity of the relationship between 
physical activity (PA) and diabetes-related mortality risk using a sample of U.S. adults from the 
Third National Health and Nutrition Examination Survey (NHANES III). Methods: The sample 
(n=10,717) included adults (≥20 years) who attended the Mobile Examination Center (MEC). An 
age-standardized PA score (PAS) was calculated from the self-reported frequency and intensity 
of 12 leisure-time aerobic activities. The PA scores were then grouped into three categories: 
inactive (PAS = 0), insufficiently active (PAS >0 - <10), and active (PAS ≥10). A PAS of 10 was 
chosen as a proxy cutoff for 5 bouts/wk of moderate-intensity activity, the 2007 American Heart 
Association/American College of Sports Medicine aerobic PA guideline. Diabetes-related 
mortality was defined as either death from diabetes mellitus as the primary cause or if diabetes 
was flagged on the death certificate as a contributing cause. Race-ethnic groups included: non-
Hispanic white (NHW), non-Hispanic black (NHB), and Mexican American (MA). SAS 9.4 
survey procedures were used for all statistical analyses. Results: There was no interaction 
between PA and race-ethnicity (p=0.83). Compared to inactive NHW, there was a significantly 
lower risk for diabetes-related mortality for insufficiently active (Hazard Ratio [HR] 0.51, 95% 
Confidence Interval [CI] 0.29-0.89) and active (HR 0.57, 95% CI 0.33-1.00) NHW adults. 
Statistical significance was not achieved for any level of activity for NHB and MA. A significant 
p-for-trend was revealed only for MA. Conclusions: The results of this study suggest that 
accumulation of any volume of PA is associated with a significantly lowered risk for diabetes-
related mortality only in NHW. A significant dose-response relationship was only observed 
among MA. However, the interaction between race-ethnicity and PA did not attain statistical 
significance. Thus the presence of effect modification could not be determined from the current 
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study, but further investigation is warranted. Given longer follow-up time in the NHANES III 
cohort, the ability to estimate more precise risk reductions will become plausible.  
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Introduction 
Diabetes is a deleterious metabolic condition characterized by chronic hyperglycemia. 
Currently, diabetes is the seventh leading cause of mortality among adults in the United States 
(U.S.)(approximately 2.8% of all deaths); with the vast majority of these deaths being related 
specifically to type 2 diabetes (1, 2, 32). Despite being a top ten cause of death, diabetes is more 
likely to be a contributing cause of death rather than the primary cause of death; accounting for 
approximately 10.8% of deaths (2, 3, 32). Using data from the 1997-2009 National Health 
Interview Survey (NHIS) and the 1999-2010 National Health and Nutrition Examination Survey 
(NHANES), Stokes and Preston (32) found the population-attributable fraction (PAF) of death 
from diabetes was approximately 11.5%; suggesting that diabetes is the third leading cause of 
death in U.S. adults. Considering its strong link to cardiovascular disease (4, 5), cancers (6), 
kidney disease (7), and stroke (8); it is evident that diabetes plays a substantial role in mortality 
related to cardiovascular and metabolic causes.        
 The current mortality rates associated with diabetes differ across race-ethnic groups (1). 
The age-adjusted mortality rate attributable to diabetes is higher among Hispanics (25.1 per 
100,000) and non-Hispanic blacks (NHB) (38.2 per 100,000) compared to those who are non-
Hispanic white (NHW) (18.6 per 100,000) (1). Moreover, compared to NHW, NHB and 
Hispanics are 2.3 and 1.5 times more likely to die from diabetes, respectively (1). In the 
aforementioned analysis by Stokes and Preston (32), the percent of deaths from diabetes as the 
primary cause, as well as a contributing cause, were significantly higher in NHB and Mexican 
Americans (MA) compared to NHW. However, the PAFs were not statistically different across 
groups despite NHW having a 2% lower PAF. Given the clear disparities between race-ethnic 
groups, understanding how different preventive health behaviors, such as physical activity (PA), 
relate to diabetes-related mortality risk is of critical importance.        
 
 
58 
 
 A recent meta-analysis by Boyer et al. (10) examined the effect modification of race-
ethnicity on the relationship between aerobic PA and incidence of type 2 diabetes. When 
comparing the most active to the least active groups, a significant summary protective effect was 
found for NHW, American Indians, Asians, and Hispanics. No significant reduction in risk was 
found for NHB. Furthermore, when conducting a sensitivity analysis, the significant summary 
effect of PA was eliminated in Hispanics. Knowing the clear link between diabetes incidence and 
risk of diabetes-related mortality, it is hypothesized that the results of Boyer et al. (10) could 
translate to diabetes-related mortality.        
 Currently, only two studies have investigated the relationship between PA and diabetes-
related mortality (11, 12). Using data from the Danish Diet, Cancer, and Health Cohort, 
Andersen et al. (11) found that any participation in sports (Hazard ratio [HR] 0.34, 95% CI 0.21-
0.55), cycling (HR 0.61, 95% CI 0.42-0.89), or gardening (HR 0.42, 95% CI 0.28-0.62) resulted 
in significantly lower HRs for diabetes-related mortality compared to those reporting no 
participation in these activities. In those reporting walking, statistical significance was not 
attained (HR 0.77. 95% CI 0.44-1.33). Due to the relatively homogenous sample of white 
individuals, race-ethnicity was not controlled for. In the second study, Williams et al. (12) 
examined the relationship between daily MET-hours (MET-hrs/d) of self-reported walking and 
diabetes-related mortality using data form the National Walkers’ Health Study. MET-hrs/d of 
walking were categorized into four levels: <1.07 MET-hrs/d (category 1), 1.07-1.8 MET-hrs/d 
(category 2), >1.8-3.5 MET-hrs/d (category 3), and ≥3.6 MET-hrs/d (category 4). Only those in 
category 4 (HR 0.17, 95% CI 0.04-0.80) had a significant reduction in risk for diabetes-related 
mortality. All analyses were adjusted for race-ethnicity; however effect modification was not 
examined. While these two studies reveal an inverse relationship between PA and diabetes-
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related mortality, there currently exists no literature examining this relationship with attention to 
the possible effect modification within race-ethnicity.       
 The NHANES and the available National Data Index (NDI) linked data, provide a 
population based opportunity to examine the extent to which PA protects against diabetes-related 
mortality across several race-ethnic groups. Therefore, the purpose of this study was to examine 
the effect modification of race-ethnicity on the association between PA and diabetes-related 
mortality using data from the NHANES III and the NDI. It is hypothesized that similar doses of 
aerobic PA will not lead to similar risk reductions for diabetes-related mortality when comparing 
NHW to NHB and MA.      
Methods 
Participants 
The present study utilized data from the NHANES III (1988-1994) (98). The NHANES is 
a cross-sectional survey conducted by the National Center for Health Statistics (NCHS) that 
utilizes a complex, multistage sampling design to provide a representative sample of the non-
institutionalized U.S. population. Within the NHANES III, several different assessments and 
measurements were conducted. All NHANES III participants underwent a household interview 
in which demographic characteristics, socioeconomic status, self-reported health behaviors, and 
health issues were self-reported (66). A subsample of participants underwent a detailed health 
examination and laboratory test at a mobile examination center (MEC) in which several 
physiological variables were measured such as glycosylated hemoglobin (HbA1c) (66, 71).   
 For the present study participants met the following inclusion criteria: 1) adults 20-79 
years of age (79 years was chosen as the upper end cutoff for age as previous research has shown 
that the role of diabetes becomes ambiguous in its contribution to mortality at higher ages (32)); 
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2) did not die within the first three years of follow-up to reduce the potential effects of residual 
confounding from other chronic diseases; 3) completed testing at the MEC; 4) had complete data 
for all variables of interest; and 5) if female, were not pregnant or lactating. The total sample for 
the current study was 10,717 participants at baseline.   
Physical activity 
Within the NHANES III, intensity and frequency of 12 possible leisure-time activities 
were reported. Leisure-time PA (LTPA) was assessed via questionnaire inquiring about 
participation in eight specific aerobic activities (walking, running/jogging, cycling, swimming, 
aerobics, calisthenics, swimming, and lawn work/gardening) (68). Furthermore, four open-ended 
PA questions were also asked to assess activity beyond the eight specific activity questions. The 
intensity of each activity, denoted by a specific metabolic equivalent (MET), was defined and 
classified according to the Compendium of Physical Activities (74). One MET is defined as 3.5 
ml/kg/min and equates to the energy cost of rest (75). Participants also self-reported the monthly 
frequency of each activity reported. Duration was not assessed in the NHANES III PA 
component. Furthermore, activity associated with lifting weights was excluded as the study 
purpose was specifically examining aerobic PA.        
 The primary independent variable in this study was a three category, physical activity 
guideline index (PAGI); using the 2007 PA guidelines (76) as the criteria for meeting the 
recommendations (≥ 5 d/wk of moderate-intensity PA or ≥3 d/wk of vigorous-intensity PA). 
Initially, each reported activity was categorized into one of five intensity categories based upon 
the age-specific MET cut-points in the 1996 Surgeon General's Report on Physical Activity and 
Health (77)(appendix 4). Categories were adjusted based on the relative intensities for the 
following age groups: 20-39, 40-59, and 60-79.  The five categories were as follows: very light 
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(level 1), light (level 2), moderate (level 3), hard (level 4), and very hard (level 5). Intensity 
levels 2 and 3 were classified as moderate-intensity activity; intensity levels 4 and 5 were 
classified as vigorous-intensity activity. The weekly frequency for each activity (calculated by 
dividing the monthly frequency by 4.3) was multiplied by its coinciding relative-intensity 
activity level (1-5); creating a physical activity score (PAS) for each individually reported 
activity. The individual PAS were then summed to create an age-adjusted overall total PAS.  
 The three categories for the PAGI are as follows: inactive, insufficiently active, and 
active. Inactive was defined as a total PAS of 0 or those whose PAS only included “very light” 
activity. Across the 12 potential activities reported, only 10 participants reported only “very 
light” activity. Thus, they were categorized as inactive. Insufficiently active was defined as a 
total PAS ranging between >0 and <10. Active was defined as a PA score of ≥10. The cutoff of 
10 was used as it is a proxy cutoff that equates to 5 bouts/wk of moderate-intensity activity (78, 
79). For the purpose of the PAGI, bouts were assumed to be reflective of days/week (d/wk). For 
example: The NHANES III MET value associated with the walking question was 3.5 METs. In 
an adult aged 38, this would categorize them into PA intensity level 2; which would be 
considered a moderate-intensity activity (see appendix 4) for that age-group. If at least 5 d/wk of 
walking are reported, this participant would be classified as active (i.e. PA intensity level 2 x 5 
d/wk = PA score 10).   
Diabetes-related mortality 
The dependent variable of interest was diabetes-related mortality. The NCHS linked 
death records from the National Death Index (NDI) to the NHANES participants’ sequence 
numbers in NHANES via a process outlined elsewhere (72)(Chapter 3). Within those who were 
deceased, cause of death was determined and classified using the International Statistical 
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Classification of Diseases, Injuries, and Causes of Death (ICD)-10 codes. Diabetes-related 
mortality was determined from the public-use mortality data files using the ICD-10 codes E10-
E14 (73). In order to include those who had diabetes as an underlying or non-primary cause, 
diabetes-related mortality was defined as either death from diabetes mellitus or if diabetes was 
flagged on the death certificate with multiple causes of death.  
Covariates 
Several potential confounding measures were used as covariates in this study. The 
demographic covariates included: age (examined continuously), gender (categorized as male or 
female), education (< high school, high school graduate, or some college/college graduate), and 
family history of diabetes (yes or no). Health behavior covariates included: self-reported 
smoking (current smoker, previous smoker, or non-smoker), alcohol consumption (categorized 
as either drinker or non-drinker by responding yes or no to the question “In the past 12 months 
did you have at least 12 drinks of any kind of alcoholic beverage”), and the Healthy Eating Index 
(HEI). The HEI is a quantitative reflection of overall dietary quality and has been validated for 
use in the NHANES (94). The HEI is based upon 10 dietary components that are summed on a 0-
100 scale; the higher the score being indicative of a better dietary quality (95). HEI was 
examined continuously. Metabolic covariates included: glycemic index (a three-category 
variable based on the current American Diabetes Association HbA1c recommendations (13) to 
establish euglycemia (HbA1c <5.7%), those with pre-diabetes (HbA1c 5.7 - <6.5%), and those 
with diabetes (HbA1c ≥6.5%)), and body mass index (BMI) (examined continuously). 
Statistical analysis 
All variable recodes and analyses were conducted using SAS 9.4 (96), which allows for 
the incorporation of the sampling weights to account for the complex survey design, 
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oversampling of certain groups, non-response, and post-stratification inherent to NHANES (97). 
These weights are utilized to ensure the correct representative sample is used in analyses.  
 Weighted prevalence estimates were generated using PROC SURVEYFREQ. PROC 
LIFETEST was used to estimate the survivorship related to diabetes-related mortality via 
weighted Kaplan-Meier curves. Specific Kaplan-Meier curves were created across the PA 
variables specific to each race-ethnic group. PROC SURVEYPHREG was used to test the null 
hypothesis that the individual Cox proportional hazard ratios (HR) are equal to 1 across PA 
measures within each race-ethnic group. This procedure allows for the incorporation of sampling 
weights inherent with the sampling design of NHANES. Two specific analyses were conducted. 
The first examined the relationship between PA and diabetes-related mortality using race-
ethnicity as a controlling covariate. Within this analysis, the interaction between race-ethnicity 
and the PAGI was tested. The second examined the same relationship stratifying by race-
ethnicity. Two models were used across the two specific analyses:  unadjusted and fully adjusted 
using the aforementioned covariates.   
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Results 
 Table 4.1 provides the demographic, health behavior and physical activity characteristics 
of the total study sample and specific to race-ethnicity. Compared to NHW, NHB and MA were 
younger, had a significantly higher prevalence of diabetes and family history of diabetes. 
Regarding PA participation, NHB and MA had a significantly lower median PAS score and had 
a higher prevalence of inactive participants.        
 Table 4.2 provides the diabetes-related mortality characteristics of the total study sample 
and specific to race-ethnicity. Compared to NHW, NHB and MA had a significantly younger 
baseline age when examined at the MEC as well as a significantly younger age in which 
mortality occurred. Compared to NHW, NHB and MA had a higher age-adjusted mortality rate 
per 10,000 person years.          
 Figures 4.1, 4.2, and 4.3 illustrate the weighted, unadjusted Kaplan-Meier survival 
probability curves across the PAGI for each race-ethnic group. Across all race-ethnic groups the 
poorest survival probability was in inactive participants.       
 Table 4.3 illustrates the results of the Cox proportional hazards model examining the 
relationship between the PAGI and diabetes-related mortality in the total sample. In model 2 
(adjusted for age and race-ethnicity), a significant reduction in the hazard for diabetes-related 
mortality was found for those who were categorized as either insufficiently active (HR 0.46, 95% 
CI 0.31-0.67) or active (HR 0.35, 95% CI 0.23-0.53). For model 2, the p-for-interaction between 
race-ethnicity and the PAGI was p=0.44. Following further adjustment for other covariates 
(model 3) results remained significant, but attenuated (insufficiently active [HR 0.54, 95% CI 
0.34-0.86], active [HR 0.58, 95% CI 0.36-0.94)]. For the fully-adjusted model 3, the p-for-
interaction between race-ethnicity and the PAGI was p=0.83.       
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Table 4.4 displays the results of the Cox Proportional HR analyses of the PAGI with diabetes-
related mortality stratified by race-ethnicity. In the unadjusted analysis, NHWs categorized as 
insufficiently active (HR 0.30, 95% CI 0.18-0.48) or active (HR 0.26, 95% CI 0.16-0.43) had 
significantly lower risk for diabetes-related mortality. In the unadjusted analysis for NHBs, 
significantly lower risk for diabetes-related mortality was found for those who were either 
insufficiently active (HR 0.44, 95% CI 0.26-0.75) or active (HR 0.27, 95% CI 0.12-0.58). In the 
unadjusted analysis in MA, only those categorized as active had a significantly lower risk for 
diabetes-related mortality (HR 0.32, 95% CI 0.17-0.60). In the fully-adjusted analysis, only 
insufficiently active (HR 0.51, 95% CI 0.29-0.89) and active (HR 0.57, 95% CI 0.33-0.99) 
NHWs had a significant reduction in risk for diabetes-related mortality. In NHB and MA, no 
significant risk reductions were found for the PAGI and diabetes-related mortality following 
further adjustment for all covariates. Linear trend analysis found only MA having a significant 
inverse trend across categories of the PAGI for diabetes-related mortality (p=0.04).     
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Table 4.1. Demographic, heath, mortality, and physical activity characteristics of the participants: 
NHANES III (N=10,717) 
Variables  Valueb  
  RACE-ETHNICITY  
 Total NHW (N=4563) NHB (N=3057) MA (N=3097) Χ2 
      
Demographics          
Age - ࢞ഥ (SE) 42.7 (0.4) 40.2  (0.5) 37.3  (0.5) * 33.6  (0.5) *,^ p<0.001 
Gender - % (SE)          
        Male 48.3 (0.6) 51.5  (0.7) 49.5  (1.2) 60.5  (1.3) *,^ 
p<0.001 
        Female 51.7 (0.6) 48.5  (0.7) 50.5  (1.2) 39.5  (1.3) *,^ 
Education - % (SE)          
        Less than high school 20.5 (0.9) 17.6  (1.0) 27.7  (1.2) * 54.4  (1.9) *,^ 
p<0.001         High school graduate 34.9 (0.8) 35.1  (0.9) 38.2  (1.4) 25.7 (1.2) *,^ 
        Some college/college graduate 44.6 (1.2) 47.3  (1.4) 34.1  (1.7) * 19.9  (1.5) *,^ 
Family History of Diabetes - % (SE)          
        Yes 22.9 (0.7) 21.7  (0.8) 29.1  (1.0) * 31.0  (1.0) * 
p<0.001 
        No 77.1 (0.7) 78.3  (0.8) 70.9  (1.0) * 69.0  (1.0) * 
Metabolic Markers          
Body Mass Index (kg/m2) -  ࢞ഥ (SE) 26.5  (0.1) 25.3  (0.1) 26.6  (0.1) * 26.6  (0.1) * p<0.001 
Glycemic Status - % (SE)          
        Diabetes (A1c ≥ 6.5%) 4.4 (0.3) 3.8 (0.3) 8.1  (0.5) * 6.1  (0.4) *,^ 
p<0.001         Pre-diabetes (A1c 5.7-6.5%) 13.2 (0.8) 11.3 (0.9) 27.7  (1.0) * 16.0 (1.1) *,^ 
        Euglycemic (A1c < 5.7%) 82.4  (0.9) 84.9  (1.0) 64.2  (1.1) * 77.9  (1.2) *,^ 
Health Behaviors          
Healthy Eating Index (0-100) - ࢞ഥ (SE) 63.2  (0.3) 63.5  (0.5) 58.8  (0.5) * 64.0  (0.5) ^ p<0.001 
Smoking Status - % (SE)          
        Current smoker 39.7  (0.9) 38.6  (1.1) 43.6  (1.2) * 50.9  (1.0) *,^ 
p<0.001         Former 27.9 (0.7) 29.3  (0.8) 18.2  (1.0) * 23.0  (0.8) *,^ 
        Non-smoker 32.4 (1.2) 32.1  (1.2) 38.2  (1.2) * 26.1 (1.1) *,^ 
Alcohol consumption - % (SE)          
        Drinker (≥12 dks/yr) 35.9 (1.3) 34.7 (1.5) 42.8 (1.2) * 37.5 (0.9) ^ 
p<0.001 
        Non-drinker (<12 dks/yr) 64.1 (1.3) 65.0 (1.5) 57.2 (1.2) * 62.5 (0.9) ^ 
Physical Activity          
Physical Activity Score – median (IQR) 12.3 (3.5-28.9) 13.3  (3.7-29.6) 9.0   (1.4-26.0) * 5.4   (0.3-21.1) *,^ p<0.001 
Physical Activity Guideline Index - % (SE)          
        Inactivea 11.9 (0.7) 10.2  (0.7) 18.7  (1.0) * 24.5  (1.4) *,^ 
p<0.001         Insufficiently Active (PAS ≥0-<10) 44.4 (1.1) 44.3  (1.2) 45.5  (1.1)  44.5  (1.6)  
        Active (PAS ≥10) 43.7 (1.3) 45.5  (1.5) 35.8  (1.4) * 31.0  (1.3) * 
 
SE = Standard Error; PAS: Physical Activity Score; A1c: glycosylated hemoglobin; dks: drinks; yr: year; IQR: Interquartile Range. NHW: non-
Hispanic white; NHB: non-Hispanic black; MA: Mexican American. 
aZero activity reported. 
bMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as weighted percentage 
(SE).  
*significantly different (p<0.05) from NHW; ^significantly different (p<0.05) from NHB. 
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Table 4.2. Diabetes-related mortality rates by race-ethnic group: NHANES III 
RACE-
ETHNICITY  N 
Death 
events 
Baseline* ܠത age 
(SE) 
ܠത age of death 
(SE) 
Total  
person-years 
Crude mortality rate  
(per 10,000 person-
years) 
Age-standardized mortality 
rate  
(per 10,000 person-years) 
Non-Hispanic White 4563 127 62.1 (0.8) 75.1 (1.2) 81,008.3 15.7 12.3 
Non-Hispanic Black 3057 88 58.0 (1.0) 69.7 (1.0) 54,841.5 16.0 18.1 
Mexican American 3097 116 54.6 (1.3) 68.3 (1.3) 58,086.1 19.9 26.6 
*When examined at the Mobile Examination Center 
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Table 4.3. Diabetes-related mortality risk and the Physical Activity Guideline Index: NHANES III 
(N=10,717) 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Model 1 Model 2# Model 3^  
Physical Activity    
Physical Activity Guideline Index    
        Inactive 1.00 1.00 1.00 
        Insufficiently Active (PAS ≥0-<10) 0.34 (0.25-0.48)* 0.46 (0.31-0.67)* 0.54 (0.34-0.86)* 
        Active (PAS ≥10) 0.29 (0.20-0.42)* 0.35 (0.23-0.53)* 0.58 (0.36-0.94)* 
Demographics    
Age (years)  1.11 (1.09-1.12)* 1.10 (1.08-1.12)* 
Race-ethnicity    
        NHW  1.00 1.00 
        NHB  1.42 (0.97-2.07) 0.76 (0.53-1.09) 
        MA  1.61 (1.13-2.32)* 1.00 (0.67-1.52) 
Gender    
        Male   1.00 
        Female   0.80 (0.52-1.24) 
Education    
        Less than high school   1.00 
        High school graduate   1.05 (0.70-1.56) 
        Some college/college graduate   0.74 (0.40-1.35) 
Family History of Diabetes    
        Yes   1.00 
        No   0.77 (0.55-1.08) 
Metabolic Markers    
Body Mass Index (kg/m2)   1.05 (0.99-1.08) 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.17 (0.10-0.26)* 
        Euglycemic (A1c < 5.7%)   0.07 (0.04-0.12)* 
Health Behaviors    
Healthy Eating Index (0-100)   1.00 (0.99-1.02) 
Smoking Status    
        Current smoker   1.00 
        Former   0.42 (0.29-1.62) 
        Non-smoker   0.43 (0.28-0.66)* 
Alcohol consumption    
        Drinker (≥12 dks/yr)   1.00 
        Non-drinker (<12 dks/yr)   0.72 (0.49-1.08) 
    
P-for-interaction    
       Race-ethnicity x PAGI  0.44 0.83 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. *p<0.05 
#Adjusted for physical activity, age and race-ethnicity  
^Adjusted for physical activity, age, race-ethnicity, gender, education, family history of diabetes, body mass index, glycemic 
status, healthy eating index, smoking status, and alcohol consumption  
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Figure 4.1. Non-Hispanic White Kaplan-Meier Survival Curve: Physical Activity Guideline Index (PAGI) and diabetes-realted 
mortality  
PAGI 1: Inactive; PAGI 2: Insufficiently Active; PAGI 3: Active 
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Figure 4.2. Non-Hispanic Black Kaplan-Meier Survival Curve: PAGI and diabetes-realted mortality  
PAGI 1: Inactive; PAGI 2: Insufficiently Active; PAGI 3: Active 
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Figure 4.3. Mexican American Kaplan-Meier Survival Curve: PAGI and diabetes-realted mortality  
PAGI 1: Inactive; PAGI 2: Insufficiently Active; PAGI 3: Active 
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Table 4.4. Diabetes-related mortality risk and the Physical Activity Guideline Index stratified by race-ethnicity: NHANES III 
 
 Physical Activity Guideline Index  
 Inactive Insufficiently Active Active p-for-trend 
Physical Activity Score 0 >0-<10 ≥10  
     
Total     
        N 1946 4829 3942  
        No. of deaths 102 151 78  
        Person-years 33527.8 88132.0 72276.1  
        Unadjusted HR 1.00   0.34 (0.25-0.48)*   0.29 (0.20-0.42)* p<0.001 
        Adjusted HRa 1.00   0.54 (0.34-0.86)*   0.58 (0.36-0.94)* p=0.08 
     
Non-Hispanic White     
        N 552 1991 2020  
        No. of deaths 32  50  45  
        Person-years 8837.8 35847.4 36323.1  
        Unadjusted HR 1.00   0.30 (0.18-0.48)*   0.26 (0.16-0.43)* p<0.001 
        Adjusted HRa 1.00   0.51 (0.29-0.89)*   0.57 (0.33-1.00)^ p=0.14 
     
Non-Hispanic Black     
        N 590 1432 1035  
        No. of deaths 32  40  16  
        Person-years 997.2 25706.1 19218.3  
        Unadjusted HR 1.00   0.44 (0.26-0.75)*   0.27 (0.12-0.58)* p=0.002 
        Adjusted HRa 1.00 0.62 (0.34-1.15) 0.56 (0.27-1.19) p=0.14 
     
Mexican American     
        N 804 1406 887  
        No. of deaths 38 61  17  
        Person-years 14712.8 26638.5 16734.8  
        Unadjusted HR 1.00 0.76 (0.52-1.12)   0.32 (0.17-0.60)* p<0.001 
        Adjusted HRa 1.00 0.84 (0.59-1.19) 0.50 (0.23-1.09) p=0.04 
aAdjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol 
consumption. HR: Hazard Ratio. *p<0.05. ^p=0.048 
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Discussion 
The current study is the first to examine the potential effect modification of race-ethnicity on the 
relationship between aerobic PA and diabetes-related mortality. In the non-stratified analysis, the 
results indicate that accumulation of any volume of PA is sufficient to reduce risk for diabetes-
related mortality. Furthermore, no significant trend was evident. In the race-ethnicity specific 
analysis, the results allude to possible effect modification by race-ethnicity in that only NHW 
had a statistically significant reduction in risk for diabetes-related mortality whether 
insufficiently active or active. Moreover, a significant dose-response was found only for MA 
9illusrtaed by the significant p-for-trend). However, there was no statistically significant 
interaction between race-ethnicity and PA in the age-adjusted or fully-adjusted analyses which 
suggests no effect modification.         
 The results of the current study found no significant trends in the fully adjusted analyses 
for either NHW or NHB suggesting that any volume of activity may be sufficient to reduce 
diabetes-related mortality risk and accruing more activity does not lead to more favorable risk 
reductions. The magnitude of the hazard ratio estimates were similar between NHW and NHB, 
especially in those who were active. However, the results also indicate that in the fully adjusted 
models, the risk reductions among insufficiently active and active NHB were not statistically 
significant. It is important to note that the total number of deaths as well as the sample size was 
lower among insufficiently active and active NHB compared to NHW. These factors could have 
very well influenced the results as the lack of power could have driven the large confidence 
intervals, thus the lack of statistical significance. Given that previous analyses (99-103) 
examining effect modification by race-ethnicity on PA and all-cause mortality have consistently 
shown no differences between NHB and NHW, it is possible that no effect modification exists 
between NHW and NHB for PA and diabetes-related mortality.  It is hypothesized that given 
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additional time for follow-up in the NHANES III cohort, the magnitude of mortality events 
among NHB will increase allowing for more precise estimates of risk and, potentially, attainment 
of statistical significance for the PA and race-ethnicity interaction.     
 MA were the only race-ethnic group to present statistical evidence for a dose-response 
relationship (evidenced by a statistically significant p-for-trend) associated with PA and 
diabetes-related mortality. Furthermore, MA were the only group who had no statistically 
significant reduction in the insufficiently active group in the unadjusted analysis; indicating a 
potential difference in the minimum volume of PA needed to reduce risk for diabetes-related 
mortality when compared to NHW and NHB. Despite attempting to adjust for confounders, it is 
possible other variables play a role in mediating the effect of PA on diabetes-related mortality 
including occupational PA (OPA), increased allostatic load (30, 104), and issues related to 
diminished access to healthcare (103, 105). Further research is warranted specifically in those 
identifying as MA to further quantify the dose-response relationship between LTPA and 
diabetes-related mortality. More specifically, examination of potential physiological mechanisms 
that may explain the current findings as well as the potential interaction between PA other 
measures, such as allostatic load, is needed within the scope of race-ethnicity and diabetes-
related mortality.           
 There are several strengths to the current study. First, the large, population-based sample 
allows for a generalization of the results to the population of the U.S. Second, the methodology 
behind the NDI mortality linkage has been previously validated (72, 106). Third, this is the first 
study to examine the possible effect modification of race-ethnicity on the relationship between 
PA and diabetes-related mortality. Only two previous studies have investigated this relationship 
(11, 12), both of which found an inverse relationship between PA and diabetes-related mortality 
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risk. However, both studies failed to examine effect modification by race-ethnicity. This study 
also adds to the two previous studies (10, 62) that have examined the effect modification of race-
ethnicity on aspects of the diabetes life experience. Briefly, a meta-analysis by Boyer et al. (10) 
found effect modification by race-ethnicity on the relationship between PA and type 2 diabetes 
risk. Specifically, when comparing the most active to least active, NHB and Hispanics had no 
significant reduction in risk for type 2 diabetes. An analysis by Glenn et al. (62) found similar 
risk reductions for all-cause mortality across quartiles of PA in NHW and NHB. Finally, this 
study also addresses the recommendations outlined by the 2008 Physical Activity Guidelines 
Committee report (33) which state that there is a need to examine the interaction between race-
ethnicity and PA on a number of health-related outcomes including mortality. It is evident that 
more research is needed to fully understand how PA may be associated with differential 
diabetes-related mortality across race-ethnic groups.       
 This study is not without limitations. The first is the inability to track potential changes in 
PA measures over the course of follow-up. Moreover, there is always the possibility of residual 
confounding, particularly from constructs such as allostatic load, markers of socioeconomic 
status not included in this analysis, and diabetes medication use. A second limitation is that 
duration of PA bouts was not measured as part of the NHANES III PA interview. Thus, a true 
measure of total LTPA volume was unable to be quantified. Furthermore, due to the nature of 
self-report data, the PA data is subject to both recall bias as well as the social desirability effect. 
Next, previous studies have shown low sensitivity and specificity in how diabetes is classified as 
a cause/contributing cause of death (32). Thus, the under-reporting of deaths attributable to 
diabetes could be a factor in the overall large confidence intervals and HR estimates across 
categories of the PAGI. A final limitation is that the public-use mortality data file limits the 
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ability to examine mortality specific to diabetes “type”.  While the vast majority of diabetes 
deaths are related to type 2 diabetes (1), some deaths may have come from type 1 or others 
(excluding gestational diabetes). Thus, a sensitivity analysis isolating death from type 2 diabetes 
is warranted in future research.         
 In conclusion, the results of this study indicate that accumulation of any volume of PA is 
associated with a significantly lowered risk for diabetes-related mortality. In the race-ethnicity 
specific analyses, estimates for the reduction in risk among NHW and NHB were similar in 
magnitude and additionally suggested that any volume of PA is associated with a significantly 
lowered risk for diabetes-related mortality; although there was no attainment of statistical 
significance in NHB. Moreover, there was evidence of a dose-response relationship only among 
MA illustrated by the significant trend. Nevertheless, no statistical significance was achieved 
across any level of the PAGI for MA. These results allude to potential effect modification by 
race-ethnicity in that NHW were the only group that had a statistically significant reduction in 
risk for diabetes-related mortality across categories of the PAGI. However, there was no 
statistically significant interaction between race-ethnicity and PA. Thus, the results advocate that 
until more data are available within the NHANES III cohort, there is an inability to truly 
determine, statistically, the extent in which effect modification does or does not exist across race-
ethnicity.           
 Future studies should investigate these relationships using more robust measures of PA; 
either more detailed questionnaires including duration or via objective monitors such as 
accelerometers. The continuous NHANES has a more robust PA interview questionnaire (1999-
2004) that includes duration of PA, as well as accelerometer-derived PA measures (2003-2006), 
and could be used to further study the effect modification of race-ethnicity on the relationship 
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between PA and diabetes-related mortality. As stated before, with the continued follow-up time 
of the NHANES III cohort and as more data becomes available from the NDI, the ability to 
estimate more accurate risk reductions will become plausible.     
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The following tables provide a visual representation of the International Statistical Classification 
of Diseases, Injuries, and Causes of Death codes used to (a) classify death from diabetes mellitus 
(Table A1.1) and (b) provide a frame of reference for the recoding of all deaths to match the 
ICD-10 code for cause of death (Table A1.2) 
The following tables provide a visual representation of the International Statistical Classification 
of Diseases, Injuries, and Causes of Death codes used to (a) classify death from diabetes mellitus 
(Table 1) and (b) define the ICD-10 codes used to categorize diabetes mortality (Table 2) 
Table A1.1. Mortality codes used to classify death from type 2 diabetes 
UCOD_LEADING 
RECODE 
113 Recode Cause Title and ICD-10 
Codes 
007 046 Diabetes mellitus (E10-E14) 
*Adapted from Appendix 4. Tenth Revision 113 Selected Causes of Death (UCOD_113) (1)  
 
Table A1.2. ICD-10 codes 
ICD-10 Code Cause description 
E10 Insulin-dependent diabetes mellitus 
E11 Non-insulin-dependent diabetes mellitus   
E12 Malnutrition-related diabetes mellitus 
E13 Other specified diabetes mellitus 
E14 Unspecified diabetes mellitus 
*Adapted from LIST OF ALL VALID ICD-10 CODES, 1999-2011 
Table 2: Modified version of the “List of all valid ICD-10 codes, 1999-2011” illustrating the 
cause descriptions associated with death from diabetes mellitus 
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Abstract 
Background: It is well known physical activity (PA) plays a role in the prevention of type 2 
diabetes (T2D). However, the extent to which PA may impact T2D risk among different race-
ethnic groups is unknown. Therefore, the purpose of this study was to systematically examine the 
effect modification of race-ethnicity on PA and T2D. Methods: PubMed and Embase databases 
were systematically searched through June 2016. Study assessment for inclusion was conducted 
in three phases: 1) title review (N= 13,022), 2) abstract review (N=2,200), and 3) full text review 
(N=265). A total of 27 studies met the inclusion criteria and were used in the analysis. Relative 
risks (RRs) and 95% confidence intervals (CIs) were extracted and analyzed using the 
Comprehensive Meta-Analysis software. All analyses used a random-effects model. Results: A 
significant protective summary RR, comparing the most active group to the least active PA 
group, was found for non-Hispanic White (RR 0.71, 95% CI 0.60-0.85), Asians (RR 0.76, 95% 
CI 0.67-0.85), Hispanics (RR 0.75, 95% CI 0.64-0.89), and American Indians (RR 0.73, 95% CI 
0.60-0.88). The summary effect for non-Hispanic Blacks (RR 0.91, 95% CI 0.76-1.08) was non-
significant. Conclusions: The results of this study indicate that PA (comparing most to least 
active groups) provides significant protection from T2D with the exception of non-Hispanic 
Blacks. The results also indicate a need for race-ethnicity specific reporting of RRs in 
prospective cohort studies that incorporate multi-ethnic samples.   
Highlights: There is a significant and similar risk reduction associated with physical activity 
across race-ethnicity with the exception of non-Hispanic blacks 
There are several physiological mechanisms that may explain this finding that are in need of 
further exploration in the context of physical activity 
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INTRODUCTION 
The prevalence of type 2 diabetes among adults in the United States (U.S.) is estimated to 
be anywhere from 9.3-14.5%, depending upon the dataset and diagnostic criteria (1, 2). 
Furthermore, by the year 2050, the type 2 diabetes prevalence in the U.S. is projected to reach 
upwards of 21-33% (3). However, substantial race-ethnic disparities exist in the prevalence of 
type 2 diabetes. At 15.9%, American Indian/Alaskan Natives have the highest estimated 
prevalence of type 2 diabetes (1). The next highest prevalence rates are found among Non-
Hispanic Blacks (NHB, 13.2%), Hispanics (12.8%), Asians (9.0%) and those who are non-
Hispanic White (NHW, 7.6%)  (1). Race-ethnic disparities in the prevalence of type 2 diabetes 
are expected to persist4: the projected 50 year increase in prevalence of type 2 diabetes will be 
highest among NHBs, followed by Hispanics and other ethnicities compared to NHW.  
 Physical activity (PA) is an important component of type 2 diabetes prevention 
initiatives5 and has been shown to reduce the risk of type 2 diabetes (6). However, the extent of 
type 2 diabetes protection associated with PA has yet to be fully examined in regards to effect 
modification by race-ethnicity. A narrative review by Gill et al. (7) suggested varying thresholds 
of PA protection against type 2 diabetes may across race-ethnic groups. Moreover, the authors 
also suggested that the current U.S. Department of Health and Human Services (DHHS) uniform 
guideline of 150 min moderate-intensity aerobic PA per wk 8 may not provide equal protection 
against developing type 2 diabetes across race-ethnic groups.     
 The 2008 Physical Activity Guidelines Committee Report (9), indicates significant need 
to further understand the effects of PA on diabetes risk among ethnically-diverse populations. 
While meta-analyses have examined and established a clear inverse relationship between PA and 
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type 2 diabetes risk (6, 10), to our knowledge, no meta-analysis has assessed effect modification 
of this relationship by race-ethnicity. Therefore, the purpose of this systematic review and meta-
analysis was to compile the evidence from prospective cohort studies on potential effect 
modification of the aerobic PA and type 2 diabetes risk relationship by race-ethnic groups. 
METHODS 
Data sources and searches 
Systematic searches of the literature were independently conducted in PubMed and 
Embase by two authors (W.R.B. and E.C.F.). A modified version of the search criteria employed 
by Aune et al. (6) was used: (physical activity OR exercise OR sports OR walking OR biking OR 
running OR fitness OR exercise test OR inactivity OR sedentary activity) AND diabetes AND 
(case–control OR retrospective OR cohort OR cohorts OR prospective OR longitudinal OR 
follow-up OR cross-sectional OR trial) AND (ethnic OR ethnic group OR race OR racial group). 
Furthermore studies included in another meta-analysis we screened as well (6). Standard 
guidelines for conducting and reporting meta-analyses were followed (11). 
Study Selection 
Research articles were examined for the following eligibility criteria: human participants 
who were without type 2 diabetes at the start of the studies and were adults (≥18 years) at the 
time of follow-up; assessed aerobic-based PA; published or available in English; were 
prospective cohort studies; assessed and reported the race-ethnicity specific relative risks (RR) 
for type 2 diabetes; adjusted risk estimates for age; and allowed for the determination of a most 
versus least physically active group. The article screening process is presented in Figure A1.1. A 
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total of 27 individual articles met the full eligibility criteria (12-38). Race-ethnic groups 
identified and used in the analyses were NHW, NHB, Asian, Hispanic, and American Indian.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.1. PRISMA Flow Chart 
Relevant studies identified by using 
multiple key words 
(n=13,022) 
Relevant studies after duplicate 
removal and title screening 
(n=2200) 
Relevant articles after abstract reading 
(n=265) 
Relevant studies following full article 
reading 
(n=27) 
Studies removed 
(n=10,822) 
Studies removed 
(n=1,935) 
Studies removed 
(n=238) 
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Data Extraction and Quality Assessment 
Relative risks and 95% confidence intervals (CIs) for diabetes were extracted and entered 
into Comprehensive Meta-Analysis (CMA) software version 3.0 (Biostat, Englewood, NJ, USA, 
2014). Random-effects models were used for all analyses, given that true effects are likely to 
vary across studies (rather than a fixed-model, which assumes the same value or true effect for 
all studies) (39). In all studies, the RR estimates extracted were those comparing the highest to 
the lowest level of PA. A second analysis was conducted among studies (17, 21, 28, 37, 38) that 
used the current DHHS moderate-intensity aerobic PA guideline of at least 150 min/wk as their 
demarcation point for PA (8) (i.e., comparing those who met the recommendations to those who 
did not). Race-ethnic groups utilized in the secondary analysis included all identified previously 
except American Indians.         
 Quality assessment was performed using the Quality Assessment Tool for Observational 
Cohort and Cross-Sectional Studies (40) which uses a 14 question scale (higher score 
corresponding to higher quality) to assess quality. All studies were independently rated by two 
researchers (W.B. and E.F.); all studies were rated as ‘good’ (average Quality Assessment score= 
10.9, range 10-11). Since the studies were all of good quality, analyses examining the potential 
impact of differential study quality on the main RR effects were not conducted.    
Data Synthesis and Analysis 
Data analysis was conducted using CMA software version 3.0. Heterogeneity was 
quantified using I2; a descriptive index that estimates the ratio of true variation (heterogeneity) to 
total variation across the observed effect sizes (39). An overall main effect of PA on type 2 
diabetes was calculated for each race-ethnic group. A second analysis was conducted to assess 
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the overall effect of meeting the 2008 DHHS moderate-intensity aerobic PA recommendation on 
type 2 diabetes risk (8). Significance for the main effects was set at 0.05. Potential publication 
bias was examined using a funnel plot.  
RESULTS 
A total of 1,150,574 participants were identified across all studies meeting the inclusion 
criteria. Table A2.1 illustrates the characteristics of the individual studies (N=27). Duration of 
follow-up ranged from two (30) to twenty-eight years (35). Studies were conducted in the U.S. 
(n=9) and internationally (n=17), with one study conducted in both the U.S. and Canada (30). 
The method for identifying cases of type 2 diabetes varied by study and included ascertainment 
by medical records; report of insulin or medication use; 2 hr oral glucose tolerance tests; fasting 
plasma glucose, or self-report of a physician diagnosis. Potential publication bias was not 
detected in the funnel plot (supplemental figure 1 [supp. 1.]).      
 Figures 2-6 show the results comparing the most active to the least active groups among 
the race-ethnic groups examined (Figure 2: NHW, Figure 3: Asian, Figure 4: Hispanic, Figure 5: 
American Indian, Figure 6: NHB). Significant, and similar, summary RRs for PA and type 2 
diabetes were found for NHWs (RR 0.71, 95% CI 0.60-0.85), Asians (RR 0.76, 95% CI 0.67-
0.85), Hispanics (RR 0.74, 95% CI 0.64-0.84), and American Indians (RR 0.73, 95% CI 0.60-
0.88). The summary effect for NHBs (RR 0.91, 95% CI 0.76-1.08) did not attain statistical 
significance.           
 In analyses examining the 2008 DHHS moderate-intensity aerobic PA recommendation 
and diabetes risk by race-ethnicity (data not shown), a suggestion of a significant trend was 
observed for NHWs (RR 0.75. 95% CI 0.55-1.01, p=0.06) and Asians (RR 0.80, 95% CI 0.64-
1.01, p=0.06), but the estimates did not attain statistical significance. The summary effects for 
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meeting the 2008 DHHS moderate-intensity aerobic PA recommendation and diabetes risk 
among NHBs (RR 1.26, 95% CI 0.84-1.90) and Hispanics (RR 0.95, 95% CI 0.66-1.65) did not 
attain statistical significance.          
 Sensitivity analyses were conducted to examine the effect of removing a single study on 
the overall summary effects by race-ethnic group (data not shown). No significant changes were 
found to the race-ethnic specific summary RRs with the exception of Hispanics. When removing 
Hsia et al. (18) from the Hispanic analysis, statistical significance was lost (RR 0.79, 95% CI 
0.60-1.03, p=0.09). Furthermore, when removing Ma et al. (25) from the analysis, similar results 
were found (RR 0.89, 95% CI 0.65-1.22, p=0.46).  
 
 
 
 
 
 
 
 
 
 104 
 
Table A2.1. Study characteristics 
Author, 
year 
Race-Ethnicity Country Gender Age 
(years) 
N Physical 
activity 
measure 
Follow-
up 
(years) 
Adjustments 
Burchfield, 
1995 
Asian U.S. M 45 - 68 6,815 hrs x estimated 
O2 consumption 
6 age, BMI, subscapular/triceps skinfold ratio, systolic 
blood pressure, triglycerides, glucose, hematocrit, 
parental history of diabetes 
Burke, 2007 NHW Australia M/F 15 - 88 514  d/wk 14 sex, age, BMI, location 
Fan, 2015 Asian China M/F 35 - 74 6,348 MET-hrs 7.9 age, sex, geographic region (north or south), 
educational level (0–6, 7–9, or ≥10 yr), cigarette 
smoking (never, ever, or current), alcohol 
consumption (yes or no), BMI, waist circumference 
Fretts, 2009 American 
Indians 
U.S. M/F 45 - 74 1,651 MET-hrs/wk 10 age, study site, sex, education (less than high school, 
high school, post-high school), 
cigarette smoking (never, ever, current), alcohol use 
(never, ever, current), FH of diabetes 
Fretts, 2014 American 
Indians 
U.S. M/F 18 - 74 1,639 Steps/d 8 age, sex, site, 
education (years), FH of diabetes 
Honda, 
2015 
Asian Japan M/F 30 – 64 26,628 MET-hrs 5.2 age, sex, shift work, sleep duration, alcohol 
consumption, smoking, 
hypertension, a family history of diabetes, 
occupational activity, and walking for commuting to 
and from work 
Hsia, 2005 NHW, Asian, 
Non-Hispanic 
Black, Hispanic, 
American Indian 
U.S. F No range 
presented 
Total: 86,708 
NHW: 74,240 
NHB: 6,465 
Asian: 2,445 
Hispanic: 
3,231 
American 
Indian: 327 
MET-hrs/wk 4 - 8 alcohol (past/never vs current drinker), education, 
smoking, hypertension, hypercholesterolemia, dietary 
fiber (g), 
percent energy from carbohydrate 
Hu, 2004 NHW Finland M/F 45 - 64 4,369 min 9.4 age, sex, study year, systolic blood pressure, smoking 
status, education, BMI 
James, 1998 Non-Hispanic 
Black 
U.S. M/F 30 – 55 916 Categorized by 
min into 
inactive, 
moderate or 
strenuous 
5 age, sex, education, BMI, WHR 
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Table A2.1 continued 
Author, year Race-Ethnicity Country Gender Age 
(years) 
N Physical 
activity 
measure 
Follow-
up 
(years) 
Adjustments 
Joseph, 2016 NHW, Asian, 
Non-Hispanic 
Black, Hispanic 
U.S. M/F 45 - 84 Total: 5,348 
NHW: 2,277 
Non-Hispanic 
Black: 1,293 
Asian: 676 
Hispanic: 
1,102 
MET-min/wk 11.1 age, education, sex, study site, race/ethnicity, 
occupational status, alcohol use, estimated 
glomerular filtration rate, other 
cardiovascular 
health components 
Koloverou, 2014 NHW Greece M/F 32 - 59 1,485 Total min 10 age 
Kriska, 2003 American Indian U.S. M/F 15 - 59 1,728 MET-hrs/wk 6 age, BMI 
Lee, 2012 Asian Korea M ≥18 675,496 min/wk 7.5 age, smoking status, alcohol intake, 
hypertension, parental diabetes, baseline 
glucose, BMI 
Ma, 2012 NHW, Asian, 
Non-Hispanic 
Black, Hispanic 
U.S. F 50 - 79 Total: 158,833  
NHW: 
133,541 
Non-Hispanic 
Black: 14,618 
Asian: 4,190 
Hispanic: 
6,484 
MET-hrs/wk 10.4 age, FH of diabetes, hormone therapy use, 
study arm, each lifestyle risk factor 
Nakanishi, 2004 Asian Japan M 35 - 59 2,924 Daily energy 
expenditure 
(kcals) 
7 age, FH of diabetes, alcohol consumption, 
cigarette smoking, BMI, weekly energy 
expenditure on physical exercise, systolic 
blood pressure, HDL cholesterol, 
triglycerides 
Okada, 2000 Asian Japan M 35 - 60 6,013 d/wk 59,966 
person-
years 
age, BMI, alcohol consumption, smoking 
habits, blood pressure, parental history of 
Type 2 diabetes 
Panagiotakos, 2008 NHW Greece M/F >18 1,806 MET-min/wk 5 age 
Shi, 2013 Asian China M 40 - 74 51,464 METS 5.4 age, energy intake, smoking, alcohol 
consumption, education level, occupation, 
income FH of 
diabetes 
Tonstad, 2013 
(subsample of Non-
Hispanic Blacks) 
Non-Hispanic 
Black 
U.S. and 
Canada 
M/F ≥30 7,160 d/wk 2 age 
Tsai, 2015 Asian Taiwan M/F ≥53 2,995 d/wk 14 age 
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Table A2.1 continued 
Author, 
year 
Race-
Ethnicity 
Country Gender Age 
(years) 
N Physical 
activity 
measure 
Follow-up 
(years) 
Adjustments 
Villegas, 
2006 
Asian China F 40 - 70 70,658 METS 4.6 age, kcal/d, education level, income level, occupation, 
smoking, alcohol, hypertension, chronic diseases 
Villegas, 
2009 
Asian China F 40 - 70 62,227 METs/d 4.6 age, WHR, BMI, kcal/d, alcohol consumption, smoking, 
education level, income level, occupation, hypertension 
Waki, 
2005 
Asian Japan M/F 40 - 59 28,896 times/wk 
engaged in 
activity 
10 age 
Waller, 
2010 
NHW Finland M/F ≥18 20,487 MET-hrs/d 28 age, BMI 
Wang. 
2010 
American 
Indians 
U.S. M/F 45 - 74 1,677 MET-hrs/wk 7.8 age, sex 
Xu, 2012 Asian China M/F ≥35 3,031 min/wk 3 age, sex, residence area, educational attainment, BMI 
category, 
cigarette smoking, alcohol drinking, TV viewing, 
vegetables intake, meat intake, diagnosed hypertension 
Xu, 2015 Asian China M/F ≥35 4,550 min/wk 3 age, gender, educational attainment, FH/PA, 
body weight status, cigarette smoking, alcohol drinking, 
TV viewing, vegetables intake, meat intake, diagnosed 
hypertension 
 
U.S. = United States, M = Male, F = Female, MET = Metabolic Equivalent, hr = Hour, BMI = Body Mass Index, WHR = Waist-to-hip ratio, kcal 
= Kilocalorie, FH = Family History, TV = Television, HDL = High-density lipoprotein cholesterol  
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Figure A2.2. Relative risks for diabetes by aerobic physical activity (most vs. least): NHW adults. 
N = 238,719. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight 
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Figure A2.3. Relative risks for diabetes by aerobic physical activity (most vs. least): Asian adults. 
N = 928,319. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight 
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Figure A2.4. Relative risks for diabetes by aerobic physical activity (most vs. least): Hispanic adults. 
N = 10,817. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight 
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Figure A2.5. Relative risks for diabetes by aerobic physical activity (most vs. least): American Indian adults. 
N = 7,022. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight 
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Figure A2.6. Relative risks for diabetes by aerobic physical activity (most vs. least): Non-Hispanic Black adults 
N = 30,452. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight 
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Figure A2.7. Funnel plot assessing publication bias within prospective cohort studies examining PA and type 2 diabetes risk.
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DISCUSSION 
This systematic review and meta-analysis provides insight into race-ethnic differences in 
the effect of aerobic PA on type 2 diabetes risk. With the exception of NHBs, a similar 
magnitude of protection was found comparing the most active to the least active groups, ranging 
from 24% (among Asians) to 29% (among NHWs). The summary estimate for NHBs, though 
protective, did not attain statistical significance. The results of this analysis add to the existing 
literature on PA and type 2 diabetes (6, 10) by demonstrating effect modification by race-
ethnicity.   
Previous work (7, 41-43) has also found that there may be race-ethnicity specific 
differences in the volume of aerobic PA necessary to elicit protection against type 2 diabetes. 
Celis-Morales et al. (41) found that Asian men needed 266 min/wk of moderate aerobic PA in 
order to achieve similar cardiometabolic profiles (inclusive of fasting glucose and fasting insulin) 
as NHW men participating in 150 min/wk of moderate aerobic PA. Steinbrecher et al. (42), in a 
study contrasting race-ethnic specific differences of type 2 diabetes risk with PA, found that 
moderate intensity PA was associated with lower risk for type 2 diabetes only among NHW 
males and females. In the same study, Native Hawaiians and Japanese Americans were found to 
receive no protection from moderate intensity PA. However, vigorous intensity sport activity was 
associated with lower risk for type 2 diabetes across all race-ethnic groups independent of 
gender. These results indicate that higher volumes, as well as a higher intensity, may be needed 
to provide similar protection from type 2 diabetes across various race-ethnic groups.  
 Among the studies included the current analysis, five studies directly reported the race-
specific RRs based upon meeting versus not meeting the current DHHS moderate-intensity 
aerobic PA recommendation and type 2 diabetes risk. The summary results of these studies 
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suggest a trend towards significant protection against type 2 diabetes for Asians and NHWs, but 
not NHBs or Hispanics. While these results need to be interpreted with caution, this illustrates a 
lack of studies specifically examining how meeting the current moderate-intensity aerobic PA 
guideline relates to type 2 diabetes risk. Previous work in the Diabetes Prevention Program  (5) 
(designed to examine how lifestyle change inclusive of PA, dietary change and weight loss 
impacts type 2 diabetes risk) indicated that lifestyle intervention, inclusive of 150 min/wk of 
moderate aerobic PA, significantly reduced the incidence of type 2 diabetes in NHWs, NHBs, 
Asians, Hispanics and American Indians. It is possible that meeting the recommendations may 
not have a significant impact on diabetes risk reduction among NHBs without the addition of 
weight loss and dietary intervention; however more research is needed.    
 The discussion above, in addition to the results of the current meta-analysis, prompted the 
current authors to examine/review possible underlying physiological mechanisms that explain 
the race-ethnic differences in the protective role of PA. Further, the current results warranted 
specific focus on these mechanisms in NHBs. 
Mechanisms proposed          
 There are several physiological mechanisms proposed that could explain the lack of 
significance found for NHBs in the current analysis. These include: 1) genetic predisposition, 2) 
compromised hepatic suppression of endogenous glucose production (EGP) in response to 
insulin, 3) lower insulin sensitivity (Si) in the peripheral tissues (specifically skeletal muscle) 
despite similar volumes of aerobic PA, 4) a down regulation of insulin receptors driven by 
hyperinsulinemia and decreased hepatic insulin clearance, 5) increases in intramuscular adipose 
tissue (IMAT) and intra-myocellular lipid content (IMCL) deposits, and 6) skeletal muscle fiber 
type differences.           
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 It is well known that decreases in Si are related to an increased risk for type 2 diabetes 
(44, 45). Lakoski and colleagues (46), when comparing NHBs to NHWs, found similar changes 
in the homeostatic model assessment of insulin resistance (HOMA-IR) for every 10 minute 
increase in MVPA, moderate PA, or vigorous PA. Among NHB and NHW women, Irwin and 
colleagues (47) reported similar decreases in fasting insulin levels for every 90 MET-min/d 
change.  Another study conducted by Hasson et al. (48) found no differences in the acute 
improvements in whole-body Si comparing NHBs to NHWs following a single 75 minute bout of 
exercise at 75% VO2 max. The results of these studies indicate that NHBs and NHW have 
similar physiological responses in the change in Si from PA. However, similar levels of Si among 
NHWs and NHBs may not be indicative of similar risk profiles for type 2 diabetes as other 
factors may contribute.  
1. Genetic predisposition 
Despite the similar changes in Si in response to PA, NHBs tend to have lower initial Si 
compared to NHWs (49-51); which may contribute to the lack of significance found in the 
current study. Further explanation of this potential increased susceptibility to diabetes is 
associated with the relationship between whole-body Si and insulin response in NHBs compared 
to NHW and Asians. In a recent systematic review, Kodama et al. (50) calculated and illustrated 
the relationship between whole-body Si and the acute-insulin response to glucose (AIRg). 
Specifically in NHBs with normal glucose tolerance (NGT), the authors concluded that due to 
the relationship found between Si and AIRg, even the slightest decrease in Si results in large 
nonlinear increases in AIRg which plays a role in the progression towards type 2 diabetes. In 
contrast, these changes in Si among NHWs and Asians result in a vastly lower magnitude of 
changes in AIRg. In other words, among NHBs, the slightest decrease in Si results in a large 
 116 
 
increase in the volume of insulin needed to maintain normal blood glucose. Furthermore, NHBs 
with similar Si values had significantly higher AIRg compared to NHWs. This relationship was 
further confirmed in a study by Albu et al. (52) which found higher AIRg in NHBs during an 
intravenous-glucose-tolerance test independent of Si, visceral adipose tissue, intramuscular 
adipose tissue (IMAT), subcutaneous adipose tissue, and skeletal muscle mass. Thus Kodama et 
al. (50) and Albu et al. (52) conclude there is underlying genetic phenotype in NHBs that may 
predispose them to increased risk to type 2 diabetes reflected by this relationship.  
2.  Hepatic influence          
 Previous research examining the potential mechanism behind why NHBs are at a higher 
risk for type 2 diabetes has focused on the contributions of hepatic glycemic function. Insulin 
acts primarily on the peripheral tissues but also has inhibitory effects on hepatic endogenous 
glucose production (EGP) (53, 54). EGP has been shown to be the primary determinant of 
glucose tolerance (55) as well as a contributor to the development of type 2 diabetes (56). The 
aforementioned mechanisms may contribute to the lack of significant findings for NHBs in the 
current meta-analysis. While still controversial, a review by Gaillard et al. (57) suggested that 
impaired EGP may be a contributing factor to the increased susceptibility of NHBs to type 2 
diabetes compared to NHWs. Moreover, in studies that showed similar EGP between NHBs and 
NHWs, AIRg tended to be higher in NHBs which is indicative of the increased compensation of 
the pancreatic β-cells to secrete more insulin. Thus, while EGP is linked to increased risk for 
type 2 diabetes, this proposed mechanism may not be a driving factor as results are equivocal. 
3.  Peripheral Si           
 A review by Gaillard et al. (57) showed that while hepatic Si differences between NHBs 
and NHWs remains uncertain, peripheral Si tends to be lower among NHBs. With the established 
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association between type 2 diabetes risk and peripheral Si; another mechanism to describe the 
findings of the current study is a diminished response of the skeletal muscle to changes in 
peripheral Si. Delany et al. (43) revealed that participation in similar volumes of objectively 
measured PA (via upper extremity activity monitors), peripheral Si (calculated by dividing the 
rate of glucose disposal by the plasma insulin concentration) was 26% lower in NHBs compared 
to NHWs in the absence of obesity. Furthermore, hepatic Si as well as EGP was similar between 
groups. Haffner et al. (58) found lower peripheral Si (quantified by insulin-mediated glucose-
disposal) independent of aerobic PA. The results of these studies indicate that aerobic PA may 
not affect peripheral Si in the same manner that it affects hepatic Si, especially in NHBs, which 
could explain the lack of significance found in the current analysis. However, more research is 
warranted to confirm.        
4.  Hepatic Insulin Clearance         
 The consistent findings (50, 57) that show NHBs have higher AIRg compared to NHWs 
even with similar values of Si could also explain the differences seen in peripheral Si. Higher 
AIRg is related to decreases in hepatic insulin clearance (50, 59). Gaillard et al. (57) suggested 
that the compensatory hyperinsulinemic response to a diminished hepatic insulin clearance may 
contribute to the down-regulation of the skeletal muscle insulin receptors. This would directly 
lead to decreases in peripheral Si. It can also be postulated that this mechanism would manifest 
independent of aerobic PA as aerobic PA does not seem to impact AIRg in the same way as is 
does hepatic Si. However, as stated by Gaillard et al. (57) this needs further exploration. 
5.  Skeletal muscle adiposity        
 One mechanism that may influence the decreased peripheral Si in NHBs is IMAT and 
intra-myocellular lipid content (IMCL). IMAT, defined as the adipose tissue found within the 
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muscle fascia, has been linked to a decrease in Si through inhibition of the insulin signaling 
pathway (60) leading to compromised insulin-stimulated glucose uptake and decreased Si. A 
recent study by Goedecke et al. (61) showed that, in NHB women, increased IMCL defined as 
the accumulation of lipid particles within the muscle cell, and muscle fat % (IMAT) in the soleus 
were significantly correlated with lower Si. NHW women had no relationship between IMCL 
and Si. It is important to note that dietary habits and PA volume were similar between groups. 
Albu et al. (52) showed that despite similar overall associations, NHB women had significantly 
lower Si across volumes of IMAT compared to NHWs. Furthermore, the study participants had 
similar PA volumes. The results of these studies indicate that independent of PA, the increase in 
skeletal muscle lipid content may play a role in the decreased peripheral Si observed in NHBs. 
However, Ingram et al. (62) found conflicting evidence in NHB participants who had no 
significant correlation between IMCL and decreased peripheral Si; but NHWs did. Study 
participants were sedentary and no differences were found in regards to PA between groups.  
While this mechanism may explain differences in peripheral Si and perhaps the lack of 
significance in the current study, more research is needed to isolate the true effects of skeletal 
muscle lipid accumulation on Si and type 2 diabetes risk.       
6.  Skeletal muscle fiber type            
 Another mechanism that could contribute to lower Si and compromised glucose control 
(63), is a higher percentage of type II skeletal muscle fibers that can be found among NHBs 
compared to NHWs. Previous research contrasting race-ethnic groups has suggested a potential 
predisposition to an increased risk for type 2 diabetes with higher percentages of type II fibers 
(63, 64). More specfically, among lean, obese or particpants with type 2 diabetes, type I fibers 
have been shown to have a higher expression of GLUT4, a greater insulin-stimulated glucose 
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disposal rate, higher glucose oxidation rates and higher nonoxidative glucose metabolism 
compared to type II fibers (65). Interestingly, the expression of proteins specifc to the effects of 
insulin were similar across fiber types i.e. phosphoregulation. However, the study suggests that 
there needs to be more research to examine how phosphoregulation itself relates to glucose 
uptake and similar phosphoregulation might not mediate Si differences between fiber types. 
These results were futher confirmed by Daugaard et al. (66) who showed that only type I fibers 
had a significant increase in the expression of GLUT4 compared to both IIa and IIx fibers 
following two weeks of one-leg knee extensor training at 65% of maximum workload. The 
authors also conclude that increasing the intensity of the activity could have led to different 
findings i.e. changes in GLUT4 expression among Type II fibers. Thus, PA at higher intensities 
may be necessary to elicit the same benefits as those with higher percentages of type I fibers 
(64). However, more research is needed to confirm this hypothesis especially among NHBs. 
Nevertheless, among NHBs there is evidence to suggest that the biochemical differences 
between type I and type II fibers coupled with a higher percentage of type II fibers may help 
partially explain the findings of the current study.  
Limitations           
 This study is not without limitations. First, all meta-analyses are subject to potential 
publication bias (39). We attempted to examine potential bias using a funnel plot procedure, 
which revealed no issues in regards to potential publication bias. Nonetheless, this issue is 
inherent to the systematic review process. Another limitation is that PA was self-reported in the 
studies used with the exception of one which used pedometers. Previous literature has shown 
limitations to using self-reported PA measures which may overestimate time spent in MVPA as 
well as failure to capture other intensities or sporadic activity (67, 68). Also, the lack of studies 
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specifically examining the relationship between PA and type 2 diabetes using the current DHHS 
aerobic PA recommendation does not provide enough evidence to clearly draw conclusions. The 
final limitation relates to inherent issues regarding the definitions of race-ethnicity (69). More 
specifically, only four of the definitions we used are considered to be race (NHB, NHW, Asian, 
and American Indian) and one is considered to be ethnicity (Hispanic) (70). Furthermore, there 
were semi-heterogeneous definitions of “race” and “ethnicity” used across the studies in this 
analysis. The authors of the current study elected to group study participants into five common 
race-ethnic groups found in the literature to provide the best insight into the race-ethnic specific 
relationship between aerobic PA and type 2 diabetes risk.  
Future Directions  
In the current meta-analysis, there was an evident paucity of prospective cohort studies 
reporting race-ethnic specific RRs, specifically in NHBs (N=5), Hispanics (N=3), and American 
Indians (N=5). Sensitivity analyses revealed a complete loss of statistical significance when Hsia 
et al. (18) or Ma et al. (25) were removed from the model; thus the interpretability of the 
summary RR for Hispanics is drastically limited by the available literature.  Therefore, priorities 
for future research in this area should include prospective cohort studies examining PA and type 
2 diabetes among multi-ethnic cohorts to examine and report risk across race-ethnic groups 
(rather than using race-ethnicity as a confounding variable). Furthermore, due to the mechanisms 
discussed previously, it is also evident that specific intensities should be examined as intensity 
may play a role in reducing risk for type 2 diabetes in NHBs.    
Conclusion           
 In conclusion, with the exception of NHBs, PA plays a significant role in reducing the 
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risk for type 2 diabetes across race-ethnic groups. Furthermore, the current study illustrates the 
need to continue investigating effect modification of relationship by race-ethnicity, as well as the 
need to examine the effect modification between the current aerobic PA guideline and type 2 
diabetes risk by race-ethnicity. There are several complex, physiological mechanisms that may 
explain the findings of the current study, which suggest there may be different race-specific 
thresholds in regards to the minimum aerobic PA needed to significantly reduce the risk for type 
2 diabetes. Future studies may lead to a re-examination of the current aerobic PA guideline for 
potential changes specific to race-ethnicity.  
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Appendix 3 
Yearly trends in diabetes-related mortality across NHW and NHB 
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The following table is adapted from the Centers for Disease Control and Prevention webpage: 
Age-Adjusted Death Rates for Hyperglycemic Crises as Underlying Cause per 100,000 Diabetic 
Population, by Race and Sex, United States, 1980–2009.  
Table A3.1. Age-Adjusted Death Rates for Hyperglycemic Crises as Underlying Cause per 
100,000 Diabetic Population, by Race and Sex, United States, 1980–2009 
Year 
White Black 
Males Females Males Females 
Rate SE Rate SE Rate SE Rate SE 
1980 50.4 3.3 36.2 1.7 97.4 14.2 64.9 7.1 
1981 46.5 3.3 35.8 1.7 111.1 18.0 66.3 7.7 
1982 44.7 3.2 34.7 2.4 108.7 20.6 67.9 10.4 
1983 41.1 3.2 41.2 3.1 175.7 54.8 55.1 8.4 
1984 44.6 3.4 33.1 2.0 133.2 33.1 53.7 8.0 
1985 44.2 4.8 32.2 2.4 102.6 25.9 61.2 10.4 
1986 39.9 4.1 34.8 2.6 97.9 20.9 61.2 14.9 
1987 44.2 4.2 31.1 2.3 73.5 12.8 42.5 6.6 
1988 46.6 3.7 35.3 2.1 116.4 18.8 52.3 6.3 
1989 50.1 3.9 34.5 2.0 128.6 23.2 48.7 5.0 
1990 42.2 3.6 28.9 1.6 137.3 40.8 53.4 5.7 
1991 40.7 3.3 29.0 1.7 142.3 40.2 52.1 7.0 
1992 39.6 3.0 23.0 1.3 103.3 24.1 43.2 6.4 
1993 36.2 2.7 25.4 1.6 96.8 17.1 36.9 4.4 
1994 41.1 3.4 25.0 1.6 81.4 13.7 45.1 6.0 
1995 46.5 4.7 24.0 1.5 96.4 21.1 45.8 6.2 
1996 46.1 4.2 21.2 1.2 78.5 14.2 40.5 5.1 
1997 35.5 2.6 21.7 1.2 79.8 12.2 37.9 4.0 
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Table A3.1 continued 
 
SE = Standard Error 
 
 
 
 
 
Year 
White Black 
Males Females Males Females 
Rate SE Rate SE Rate SE Rate SE 
1998 32.1 2.0 20.0 0.9 85.0 11.2 32.9 2.8 
1999 33.5 2.1 18.7 0.8 70.7 9.7 31.6 2.5 
2000 30.4 1.8 17.0 0.7 67.1 7.8 27.1 1.9 
2001 25.8 1.5 18.0 0.7 63.1 6.3 26.3 1.9 
2002 32.9 1.9 16.4 0.6 61.7 6.3 25.9 1.9 
2003 33.7 2.1 16.6 0.7 54.4 5.5 28.5 2.4 
2004 27.5 1.6 14.1 0.7 55.4 5.9 27.9 2.0 
2005 25.7 1.4 13.7 0.6 45.8 4.2 19.5 1.6 
2006 22.8 1.5 13.4 0.7 53.8 5.6 20.3 1.6 
2007 24.0 1.7 13.2 0.7 44.6 5.1 22.9 2.0 
2008 21.2 1.4 14.1 0.7 47.5 6.4 19.6 1.6 
2009 19.5 1.5 11.7 0.6 42.6 7.0 16.0 1.5 
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Appendix 4 
Age-specific MET cut-points in the 1996 Surgeon General's report on physical activity 
and health 
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 Table A4.1. 1996 Surgeon General's Report on Physical Activity and Health 
 
 
 Intensity (METs) in healthy adults 
 Young (20-39) 
Middle aged 
(40-64) 
Old 
(65-79) 
Very old 
(80+) 
Very light <3.0 <2.5 <2.0 <1.25 
Light 3.0-4.7 2.5-4.4 2.0-3.5 1.26-2.2 
Moderate 4.8-7.1 4.5-5.9 3.6-4.7 2.3-2.95 
Hard 7.2-10.1 6.0-8.4 4.8-6.7 3.0-4.25 
Very Hard ≥10.2 ≥8.5 ≥6.8 ≥4.25 
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Appendix 5 
Supplementary tables for Part 4: 
Effect modification of the association between leisure-time aerobic physical activity and 
diabetes-related mortality by race-ethnicity: a population-based prospective study using 
NHANES III 
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Table A5.1. Demographic, Heath and Physical Activity characteristics of participants stratified by 
diabetes-related mortality status: NHANES III (N=10,717) 
Variables Valuec  
   
 
Alive or non-diabetes-
related mortality 
(n=10,386) 
Diabetes-related mortality  
 (n=331)       Χ
2 
Demographics      
Age (mean) 42.4  (0.4) 61.2  (0.7) *             p<0.001 
Gender (%)      
        Male 48.3  (0.6) 50.4  (4.7) 
            p<0.001 
        Female 51.7  (0.6) 49.6  (4.7) 
Education (%)      
        Less than high school 20.2 (0.9) 40.4  (4.2) * 
            p<0.001         High school graduate 34.8  (0.8) 38.4  (4.9) 
        Some college/college graduate 45.0  (1.3) 21.2  (4.6) * 
Family History of Diabetes (%)      
        Yes 22.5  (0.7) 43.8  (4.3) * 
            p<0.001 
        No 77.5  (0.7) 56.2  (4.3) * 
Metabolic Markers      
Body Mass Index (kg/m2)(mean) 26.5  (0.1) 30.6  (0.6) *             p<0.001 
Glycemic Status (%)      
        Diabetes (A1c ≥ 6.5%) 3.5 (0.3) 48.9  (3.5) *  
        Pre-diabetes (A1c 5.7-6.5%) 13.0 (0.8) 23.6  (3.8)             p<0.001 
        Euglycemic (A1c < 5.7%) 83.5  (1.0) 27.5  (4.0) *  
Health Behaviors      
Healthy Eating Index (0-100)(mean) 63.1  (0.3) 65.1  (1.0)              p=0.09 
Smoking Status (%)      
        Current smoker 39.9  (0.9) 30.9  (3.7)  
        Former 27.6  (0.7) 39.0  (3.9) *             p<0.01 
        Non-smoker 32.5  (1.0) 30.1  (3.7)  
Alcohol consumption (%)      
        Drinker (≥12 dks/yr) 35.3  (1.3) 64.6  (4.4) * 
            p<0.001 
        Non-drinker (<12 dks/yr) 64.7  (1.3) 35.4  (4.4) * 
Physical Activity      
Physical Activity Score (median) 12.6  (3.6-29.2) 5.4   (0.5-3.4)*             p<0.001 
Physical Activity Guideline Index (%)      
        Inactiveb 11.5  (0.7) 27.5  (3.9) * 
            p<0.001         Insufficiently Active (PAS ≥0-<10) 44.5  (1.1) 39.3  (4.4) 
        Active (PAS ≥10) 44.0  (1.4) 33.2  (4.2) 
Physical Activity Index (%)   
        Inactivea 11.5  (0.7) 26.4  (3.8) * 
            p<0.001 
        Quartile 1 21.6  (1.0) 25.9  (3.8) 
        Quartile 2 22.6  (0.6) 14.3 (2.3) * 
        Quartile 3 22.1  (0.8) 23.3  (4.3) 
        Quartile 4 22.2  (1.0) 10.1  (2.3) * 
 
SE = Standard Error; PAS: Physical Activity Score; A1c: glycosylated hemoglobin; dks: drinks; yr: year 
aZero activity reported.  
bZero activity or only very light activity reported. 
cMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as weighted percentage 
(SE).  
*significantly different (p<0.05) from “Alive or non-diabetes-related mortality” 
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Table A5.2. Diabetes-related mortality risk and the Physical Activity Guideline Index stratified by race-
ethnicity: NHANES III (N=10,717) 
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW                                  NHB                            MA 
 Fully-adjusted Fully-adjusted Fully-adjusted 
Physical Activity    
Physical Activity Guideline Index    
        Inactive 1.00 1.00 1.00 
        Insufficiently Active (PAS ≥0-10)                       0.51 (0.29-0.89)* 0.62 (0.34-1.15) 0.84 (0.59-1.19) 
        Active (PAS ≥10) 0.57 (0.33-0.99)* 0.56 (0.27-1.19) 0.50 (0.23-1.09) 
Age 1.10 (1.18-1.13)* 1.08 (1.06-1.11)* 1.09 (1.06-1.11)* 
Gender    
        Male 1.00 1.00 1.00 
        Female 0.86 (0.52-1.41) 0.63 (0.33-1.21) 0.65 (0.38-1.10) 
Education    
        Less than high school 1.00 1.00 1.00 
        High school graduate 1.03 (0.65-1.66) 1.14 (0.66-1.97) 0.70 (0.36-1.39) 
        Some college/college graduate 0.73 (0.35-1.52) 0.80 (0.41-1.55) 1.36 (0.66-2.79) 
Family History of Diabetes    
        Yes 1.00 1.00 1.00 
        No 0.73 (0.49-1.13) 0.91 (0.60-1.41) 0.95 (0.57-1.57) 
Metabolic Markers    
Body Mass Index (kg/m2) 1.05 (1.02-1.09) 1.03 (0.99-1.08) 1.04 (0.99-1.10) 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%) 1.00 1.00 1.00 
        Pre-diabetes (A1c 5.7-6.5%) 0.16 (0.09-0.28)* 0.14 (0.07-0.31)* 0.19 (0.10-0.35)* 
        Euglycemic (A1c < 5.7%) 0.06 (0.03-0.11)* 0.14 (0.06-0.30)* 0.10 (0.07-0.17)* 
Health Behaviors    
Healthy Eating Index (0-100) 1.00 (0.98-1.02) 1.00 (0.99-1.03) 1.01 (0.99-1.02) 
Smoking Status    
        Current smoker 1.00 1.00 1.00 
        Former 0.40 (0.25-0.64)* 0.55 (0.25-1.18) 0.50 (0.27-0.93)* 
        Non-smoker 0.45 (0.27-0.74)* 0.35 (0.16-0.77)* 0.23 (0.13-0.42)* 
Alcohol consumption    
        Drinker (≥12 dks/yr) 1.00 1.00 1.00 
        Non-drinker (<12 dks/yr) 0.74 (0.45-1.20) 0.62 (0.36-1.08) 1.05 (0.58-1.91) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. *p<0.05 
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Appendix 6 
Research question 1, part 2: 
Is there a dose-response relationship between self-reported quartiles of PA and diabetes-
related mortality across race-ethnic groups? 
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Using the data from the NHANES III, a dose-response analysis was conducted using 
quartiles of PA. Using the methodology outlined in chapter 3, the physical activity scores (PAS) 
were then recoded into quartiles using the following methods:    
 Creation of five-level PA Index (PAI). The PAI was created to examine the dose-
response relationship with diabetes-related mortality in NHANES III. Participants with a PAS of 
zero served as the referent group. The other four categories within the PAI were categorized 
using PAS quartiles. More specifically, the PAS quartiles were generated by excluding those 
with a “zero” PAS to find the PAS cut-points at the 25th, 50th and 75th percentiles. The cut-points 
for the PAI are as follows: Category 1 (PAS: 0), Category 2 (PAS: >0-5.46), Category 3 (PAS: 
5.47-14.41), Category 4 (PAS: 14.42-31.32), and Category 5 (PAS: ≥31.33).     
 Table A6.4 displays the results of the analysis examining relationship between PA 
quartiles and the risk of diabetes-related mortality using race-ethnicity as a covariate. In the 
unadjusted analysis, significantly lower risk for diabetes-related mortality was found for all 
quartiles. Following adjustment for age and race-ethnicity, significance remained for quartiles 2 
(HR 0.30, 95% CI 0.18-0.50), 3 (HR 0.54, 95% CI 0.33-0.91), and 4 (HR 0.23, 95% CI 0.13-
0.40. Following further adjustment for all covariates, results remained significant for quartiles 2 
(HR 0.41, 95% CI 0.24-0.68) and 4 (HR 0.38, 95% CI 0.22-0.64).      
 Tables A6.5 and A6.6 display the results of the analysis examining the effect 
modification of race-ethnicity on the relationship between PA quartiles and the risk of diabetes-
related mortality. In the unadjusted analyses significantly lower risk for diabetes-related 
mortality was found across all quartiles in NHW and NHB. Significance was only found in the 
fourth quartile in MA. Following adjustment for covariates, NHW in quartiles 2 (HR 0.38, 95% 
CI 0.20-0.71) and 4 (HR0.35, 95% CI 0.20-0.34) had significantly lower risk for diabetes-related 
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mortality. Only NHB in the first quartile (HR 0.44, 95% CI 0.24-0.81) retained significance 
following further adjustment for covariates. In MA, significance remained in the fourth quartile 
(HR 0.36, 95% CI 0.16-0.81). A significant trend was found only for NHW.   
 The results of this analysis must be interpreted with caution for two reasons. First, the 
results of the Kaplan-Meier survival curves (not shown) indicated that the use of quartiles 
violated the proportional hazards assumption of the models. Second, due to the few deaths 
spaced across the quartiles of activity, the confidence intervals associated with each HR are 
large. It can be postulated that as more data becomes available from the NDI, the use of a more 
detailed dose-response (such as the quartiles) examination will become possible. Because of 
these two reasons, drawing conclusions from this analysis is not recommended.     
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Physical Activity Quintile Characteristics 
Table A6.1. Physical Activity characteristics of the participants: NHANES III (N=10,717) 
Variables Valueb 
 
Physical Activity Quartiles   
Physical Activity Index (%) 
        Inactivea 11.8 (0.7) 
        Quartile 1 21.7 (1.0) 
        Quartile 2 22.4 (0.6) 
        Quartile 3 22.1 (0.8) 
        Quartile 4 22.0 (1.0) 
 
SE = Standard Error. 
aZero activity reported.  
bWeighted percentage (SE).  
 
Table A6.2 Physical Activity characteristics of participants stratified by diabetes-related mortality status: 
NHANES III (N=10,717) 
Variables Valueb  
   
 
Alive or non-diabetes-
related mortality 
(n=10,386) 
Diabetes-related mortality  
 (n=331)       Χ
2 
Physical Activity Index (%)      
        Inactivea 11.5  (0.7) 26.4  (3.8) * 
            p<0.001 
        Quartile 1 21.6  (1.0) 25.9  (3.8) 
        Quartile 2 22.6  (0.6) 14.3 (2.3) * 
        Quartile 3 22.1  (0.8) 23.3  (4.3) 
        Quartile 4 22.2  (1.0) 10.1  (2.3) * 
 
SE = Standard Error. 
aZero activity reported.  
bWeighted percentage (SE).  
*significantly different (p<0.05) from “Alive or non-diabetes-related mortal
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Table A6.3. Physical Activity characteristics of participants stratified by race-ethnicity: NHANES III 
(N=10,717) 
Variables Valueb  
    
 NHW NHB  MA Χ2 
Physical Activity Index (%)        
        Inactivea 10.2  (0.7) 18.6  (1.0) * 24.4  (1.4) *,^ 
p<0.001 
        Quartile 1 21.1  (1.1) 18.6  (0.8)  17.2  (1.0)  
        Quartile 2 23.1  (0.7) 20.3  (0.7)  19.5  (1.1) *,^ 
        Quartile 3 22.0  (0.9) 21.4  (0.9) * 18.8  (1.0) * 
        Quartile 4 22.6  (1.1) 21.1  (1.2)  20.1  (1.1) * 
 
SE = Standard Error. 
aZero activity reported.  
bWeighted percentage (SE).  
*significantly different (p<0.05) from NHW; ^significantly different from NHB. 
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Table A6.4. Diabetes-related mortality risk and the Physical Activity Index: NHANES III (N=10,717) 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Unadjusted Age and race-ethnicity adjusted Fully-adjusted 
 
Physical Activity    
Physical Activity Index    
        Inactive 1.00 1.00 1.00 
        Q1 0.49 (0.31-0.76)* 0.66 (0.43-1.02) 0.65 (0.41-1.05) 
        Q2 0.22 (0.13-0.36)* 0.30 (0.18-0.50)* 0.41 (0.24-0.68)* 
        Q3 0.46 (0.27-0.77)* 0.54 (0.33-0.91)* 0.88 (0.52-1.50) 
        Q4 0.18 (0.11-0.30)* 0.23 (0.13-0.40)* 0.38 (0.22-0.64)* 
Demographics    
Age (years)  1.11 (1.09-1.12)* 1.10 (1.08-1.12)* 
Race-ethnicity    
        non-Hispanic white  1.00 1.00 
        non-Hispanic black  1.47 (0.99-2.16) 0.74 (0.51-1.06) 
        Mexican American  1.72 (1.21-2.47)* 1.04 (0.69-1.55) 
Gender    
        Male   1.00 
        Female   0.78 (0.50-1.21) 
Education    
        Less than high school   1.00 
        High school graduate   1.33 (0.74-2.41) 
        Some college/college graduate   1.46 (0.77-2.77) 
Family History    
Family History of Diabetes    
        Yes   1.00 
        No   0.76 (0.54-1.06) 
Metabolic Markers    
Body Mass Index (kg/m2)   1.05 (1.02-1.08)* 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.17 (0.11-0.26)* 
        Euglycemic (A1c < 5.7%)   0.07 (0.04-0.12)* 
Health Behaviors    
Healthy Eating Index (0-100)   1.00 (0.99-1.02) 
Smoking Status    
        Current smoker   1.00 
        Former   0.42 (0.30-0.60)* 
        Non-smoker   0.42 (0.28-0.64)* 
Alcohol consumption    
        Drinker (≥12 dks/yr)   1.00 
        Non-drinker (<12 dks/yr)   0.73 (0.50-1.07) 
 
           Q: Quartile. *p<0.05 
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Table A6.5. Diabetes-related mortality risk and the Physical Activity Index stratified by race-ethnicity: 
NHANES III (N=10,717) 
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW NHB MA 
 Fully-adjusted Fully-adjusted Fully-adjusted 
Physical Activity    
Physical Activity Index    
        Inactive 1.00 1.00 1.00 
        Q1 0.67 (0.38-1.15) 0.44 (0.24-0.81)* 0.74 (0.48-1.15) 
        Q2 0.38 (0.20-0.71)* 0.63 (0.25-1.62) 0.64 (0.32-1.28) 
        Q3 0.90 (0.46-1.76) 0.75 (0.36-1.57) 1.38 (0.78-2.41) 
        Q4 0.35 (0.20-0.34)* 0.62 (0.24-1.57) 0.36 (0.16-0.81)* 
Age 1.11 (1.08-1.13)* 1.09 (1.06-1.11)* 1.09 (1.07-1.11)* 
Gender    
        Male 1.00 1.00 1.00 
        Female 0.82 (0.50-1.37) 0.63 (0.33-1.20) 0.62 (0.35-1.09) 
Education    
        Less than high school 1.00 1.00 1.00 
        High school graduate 1.10 (0.72-1.69) 1.12 (0.67-1.87) 0.71 (0.37-1.38) 
        Some college/college graduate 0.75 (0.37-1.53) 0.77 (0.39-1.51) 1.19 (0.58-2.43) 
Family History    
Family History of Diabetes    
        Yes 1.00 1.00 1.00 
        No 0.73 (0.48-1.11) 0.90 (0.58-1.37) 0.92 (0.56-1.53) 
Metabolic Markers    
Body Mass Index (kg/m2) 1.06 (1.02-1.09)* 1.03 (0.99-1.07) 1.05 (0.99-1.11) 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%) 1.00 1.00 1.00 
        Pre-diabetes (A1c 5.7-6.5%) 0.16 (0.10-0.28)* 0.14 (0.07-0.30)* 0.18 (0.09-0.34)* 
        Euglycemic (A1c < 5.7%) 0.06 (0.03-0.11)* 0.14 (0.06-0.30)* 0.10 (0.06-0.16)* 
Health Behaviors    
Healthy Eating Index (0-100) 1.00 (0.98-1.02) 1.00 (0.99-1.03) 1.01 (0.99-1.02) 
Smoking Status    
        Current smoker 1.00 1.00 1.00 
        Former 0.40 (0.26-0.60)* 0.53 (0.39-1.15) 0.47 (0.25-0.88)* 
        Non-smoker 0.44 (0.27-0.70)* 0.35 (0.16-0.78)* 0.22 (0.13-0.40)* 
Alcohol consumption    
        Drinker (≥12 dks/yr) 1.00 1.00 1.00 
        Non-drinker (<12 dks/yr) 0.75 (0.48-1.19) 0.60 (0.35-1.04) 1.03 (0.57-1.84) 
 
Q: Quartile. *p<0.05 
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Table A6.6. The relationship between the physical activity index and diabetes-related mortality: NHANES III 
 Physical Activity Index  
 Inactive Q1 Q2 Q3 Q4 p-for-trend 
Total       
        Physical Activity Score 0 >0-<5.88 ≥5.88-<14.93 ≥14.93-<31.63 ≥31.63  
        N 1938 2131 2239 2266 2143  
        No. of deaths 101 67 57 71 35  
        Person-years 8809.83 17462.25 18397.42 18868.50 17470.33  
        Unadjusted HR 1.00 0.49 (0.31-0.76) 0.22 (0.13-0.36) 0.46 (0.27-0.77) 0.18 (0.11-0.30) p<0.001 
        Adjusted HRa 1.00 0.65 (0.41-1.05) 0.41 (0.24-0.68) 0.88 (0.52-1.50) 0.38 (0.22-0.64) p=0.03 
       
Non-Hispanic White       
        Physical Activity Score 0 >0-<5.95 ≥5.95-<15.29 ≥15.29-<31.86 ≥31.86  
        N 550 971 1016 1061 965  
        No. of deaths 31 31 20 29 16  
        Person-years 8809.83 17462.25 18397.42 18868.50 17470.33  
        Unadjusted HR 1.00 0.47 (0.28-0.80) 0.19 (0.10-0.34) 0.42 (0.22-0.80) 0.17 (0.09-0.30) p<0.001 
        Adjusted HRa 1.00 0.67 (0.38-1.15) 0.38 (0.20-0.71) 0.90 (0.46-1.76) 0.35 (0.20-0.34) p=0.05 
       
Non-Hispanic Black       
        Physical Activity Score 0 >0-<4.13 ≥4.13-<13.80 ≥13.80-<29.67 ≥29.67  
        N 586 610 616 644 601  
        No. of deaths 32 15 12 21 8  
        Person-years 9902.33 10854.75 11318.92 11588.42 11237.08  
        Unadjusted HR 1.00 0.37 (0.21-0.67) 0.36 (0.15-0.86) 0.49 (0.24-0.99) 0.22 (0.08-0.60) p=0.01 
        Adjusted HRa 1.00 0.44 (0.24-0.81) 0.63 (0.25-1.62) 0.75 (0.36-1.57) 0.62 (0.24-1.57) p=0.52 
       
Mexican American       
        Physical Activity Score 0 >0-<3.54 ≥3.54-<11.04 ≥11.04-<27.69 ≥27.69  
        N 802 550 607 561 577  
        No. of deaths 38 21 25 21 11  
        Person-years 14672.58 10609.17 11440.50 10526.92 10836.92  
        Unadjusted HR 1.00 0.71 (0.35-1.42) 0.54 (0.29-1.00) 0.86 (0.50-1.50) 0.24 (0.11-0.51) p<0.001 
        Adjusted HRa 1.00 0.74 (0.48-1.15) 0.64 (0.32-1.28) 1.38 (0.78-2.41) 0.36 (0.16-0.81) p=0.15 
 
aAdjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol 
consumption. HR: Hazard Ratio. Q: Quartile 
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Appendix 7 
Demographic charateristics of the 1999-2004 NHANES 
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Table A7.1. Baseline demographic, Heath and Physical Activity characteristics of the participants: 1999-
2004 NHANES (N=3,327) 
Variables Valueb 
   
Physical Activity   
Met-min/wk (median) 688.2 (161.2-1700.0) 
Physical Activity Guideline 3 (%)   
        Inactivea 16.1 (1.19) 
        Insufficiently Active 24.7 (0.84) 
        Active 59.2 (1.40) 
Physical Activity Guideline 4 (%)   
        Inactivea 16.1 (1.19) 
        Insufficiently Active 24.7 (0.84) 
        Active 18.9 (0.77) 
        High Active 40.3 (1.44) 
Physical Activity Quintiles (%) 
        Inactivea 16.1 (1.19) 
        Quintile 1 16.4 (0.78) 
        Quintile 2 17.1 (0.81) 
        Quintile 3 16.9 (0.85) 
        Quintile 4 16.4 (0.82) 
        Quintile 5 17.3 (0.85) 
Demographics   
Age (mean) 55.6 (0.24) 
Gender (%)   
        Male 49.4 (0.90) 
        Female 50.6 (0.90) 
Education (%)   
        Less than high school 17.3 (1.15) 
        High school graduate 26.7 (1.18) 
        Some college 28.3 (1.07) 
        College graduate 27.7 (1.46) 
Family History   
Family History of Diabetes (%)   
        Yes 25.0 (1.27) 
         No 75.0 (1.27) 
Metabolic Markers   
Body Mass Index (kg/m2)(mean) 28.6  (0.18) 
Glycemic Status (%)   
        Diabetes (A1c ≥ 6.5%) 6.7 (0.46) 
        Pre-diabetes (A1c 5.7-6.5%) 16.4 (1.06) 
        Euglycemic (A1c < 5.7%) 76.9  (1.21) 
Health Behaviors   
Healthy Eating Index (0-100)(mean) 53.2  (0.54) 
Smoking Status (%)   
         Current smoker 20.6  (0.96) 
         Former 35.0 (0.98) 
         Non-smoker 44.4 (1.17) 
Alcohol consumption (%)   
         Non-Drinker 32.2  (2.01) 
         Moderate 58.8  (1.77) 
         Above Moderate 9.0 (0.77) 
 
SE = Standard Error. 
aZero activity reported.  
bMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).  
Alcohol consumption:  Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day)  
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: ≥500 MET-min/wk.  
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: 500-999 MET-min/wk; High 
Active: ≥1000 MET-min/wk. 
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Table A7.2. Demographic, Heath and Physical Activity characteristics of participants stratified by 
diabetes-related mortality status: 1999-2004 NHANES (N=3,327) 
 
Variables Valueb 
  
 Alive or non-diabetes-related mortality (n=3,265) 
Diabetes-related mortality  
(n=62) 
Physical Activity     
Met-min/wk (median) 695.9  (168.8-1708.5) 41.9   (0-378.4)* 
Physical Activity Guideline 3 (%)     
        Inactivea 15.8  (1.15) 43.2  (4.37) * 
        Insufficiently Active 24.6  (0.82) 32.6  (5.42) 
        Active 59.7  (1.37) 24.2  (2.11) * 
Physical Activity Guideline 4 (%)   
        Inactivea 15.7  (1.15) 43.2  (4.37) * 
        Insufficiently Active 24.6  (0.82) 32.6  (5.42) 
        Active 19.1  (0.78) 8.9 (2.76) * 
        High Active 40.6  (1.41) 15.3  (2.31) * 
Physical Activity Quintiles (%)     
        Inactivea 15.8  (1.15) 43.2  (4.37) * 
        Quintile 1 16.0  (0.77) 21.9  (5.31) 
        Quintile 2 17.2  (0.80) 11.4 (3.03) 
        Quintile 3 17.0  (0.85) 10.8  (2.98)  
        Quintile 4 16.5  (0.82) 6.2  (1.41) * 
        Quintile 5 17.5  (0.84) 6.4 (2.28) * 
Demographics     
Age (mean) 55.5  (0.23) 63.8  (1.53) * 
Gender (%)     
        Male 50.6  (0.93) 53.8  (5.24) 
        Female 49.4  (0.93) 46.2  (5.24) 
Education (%)     
        Less than high school 16.0 (1.14) 42.1  (6.59) * 
        High school graduate 26.7  (1.19) 27.0  (4.29) 
        Some college 28.3  (1.08) 27.1  (5.09) 
        College graduate 28.0 (1.47) 3.8 (1.30) * 
Family History     
Family History of Diabetes (%)     
        Yes 24.6  (1.23) 42.3  (4.10) * 
         No 75.4  (1.23) 57.3  (4.10) * 
Metabolic Markers     
Body Mass Index (kg/m2)(mean) 28.5  (0.18) 31.0  (1.42) 
Glycemic Status (%)     
        Diabetes (A1c ≥ 6.5%) 6.0 (0.35) 14.5  (3.19) * 
        Pre-diabetes (A1c 5.7-6.5%) 16.4 (1.07) 22.8  (4.53) 
        Euglycemic (A1c < 5.7%) 77.6  (1.19) 62.7  (3.83) * 
Health Behaviors     
Healthy Eating Index (0-100)(mean) 53.2  (0.54) 55.7  (1.41) 
Smoking Status (%)     
         Current smoker 20.5  (0.95) 34.6  (4.75) * 
         Former 35.1  (0.98) 24.1  (4.01) * 
         Non-smoker 44.4  (1.16) 41.2  (4.52) 
Alcohol consumption (%)     
         Non-Drinker 31.8  (1.95) 65.7  (6.31) * 
         Moderate 59.1  (1.71) 30.7  (6.33) * 
         Above Moderate 9.1 (0.78) 3.6 (1.15) * 
 
SE = Standard Error 
aZero activity reported. bMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed 
as percentage (SE).  
Alcohol consumption:  Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day) 
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: ≥500 MET-min/wk.  
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: 500-999 MET-min/wk; High 
Active: ≥1000 MET-min/wk. 
*significantly different (p<0.05) from “Alive or non-diabetes-related mort
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Table A7.3. Demographic, Heath and Physical Activity characteristics of participants stratified by race-
ethnicity: 1999-2004 NHANES (N=3,327) 
Variables Valueb 
  
 NHW        NHB 
Physical Activity     
Met-min/wk (median) 745.5  (216.3-1770.3) 278.6   (0-1134.9)* 
Physical Activity Guideline 3 (%)     
        Inactivea 13.9  (1.30)  33.2  (2.05) * 
        Insufficiently Active 24.9  (0.92) 22.9  (1.16) 
        Active 61.2  (1.50)  43.9  (2.06) * 
Physical Activity Guideline 4 (%)   
        Inactivea 13.9  (1.30)  33.2  (2.05) * 
        Insufficiently Active 24.9  (0.93) 22.9  (1.16) 
        Active 19.4  (0.81)  16.1 (1.38)  
        High Active 41.8  (1.56) 27.8  (1.62) * 
Physical Activity Quintiles (%)     
        Inactivea 13.9  (1.30)  33.2  (2.05) * 
        Quintile 1 16.4  (0.84) 13.4  (1.05)  
        Quintile 2 17.7  (0.91) 12.8 (1.07) * 
        Quintile 3 17.4  (0.94)  13.5  (1.30)  
        Quintile 4 16.8  (0.89)  13.3  (1.03)  
        Quintile 5 17.8  (0.93)  13.8 (1.18)  
Demographics     
Age (mean) 55.9  (1.53)  53.4  (1.53) * 
Gender (%)     
        Male 51.1  (0.99) 47.6  (1.75) 
        Female 48.9  (0.99) 52.4  (1.75) 
Education (%)     
        Less than high school 17.6  (1.25)  37.2  (2.26) * 
        High school graduate 27.2  (1.35) 23.6  (1.77) 
        Some college 28.6  (1.20) 25.9  (1.58) 
        College graduate 29.6 (1.67)  13.3 (1.46) * 
Family History     
Family History of Diabetes (%)     
        Yes 23.1  (1.39)  39.2  (1.74) * 
         No 76.9  (1.39)  60.8  (1.74) * 
Metabolic Markers     
Body Mass Index (kg/m2)(mean) 28.3  (1.42) 30.2  (1.42) 
Glycemic Status (%)     
        Diabetes (A1c ≥ 6.5%) 5.8 (0.55)  14.2  (1.12) * 
        Pre-diabetes (A1c 5.7-6.5%) 15.1 (1.17) 26.8  (2.28) * 
        Euglycemic (A1c < 5.7%) 79.1  (1.37)  59.0  (1.41) * 
Health Behaviors     
Healthy Eating Index (0-100)(mean) 53.7  (1.41) 49.5  (1.41) 
Smoking Status (%)     
         Current smoker 19.4  (1.07)  30.5  (1.61) * 
         Former 36.8  (1.03)  21.4  (1.21) * 
         Non-smoker 43.8  (1.30) 48.1  (1.67) 
Alcohol consumption (%)     
         Non-Drinker  30.8 (2.29) 43.2   (1.77) * 
         Moderate 60.0  (2.02)  49.1 (2.02) * 
         Above Moderate 9.2 (0.86)  7.7 (1.17)  
 
SE = Standard Error 
aZero activity reported.  
bMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).  
Alcohol consumption:  Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day) 
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: ≥500 MET-min/wk.  
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: 500-999 MET-min/wk; High 
Active: ≥1000 MET-min/wk. 
*significantly different (p<0.05) from NHW. 
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Appendix 8 
Among the 1999-2004 NHANES, is there a dose-response relationship between self-
reported PA (3-level) and diabetes-related mortality across race-ethnic groups? 
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Using the data from the 1999-2004 NHANES, a dose-response analysis was conducted 
using the 3-level PA (PAG3) variable outlined in chapter 3. Briefly, PA was coded into three 
categories based on the 2008 PA guidelines: 0 MET-minutes/wk (Inactive), <500 MET-
minutes/wk (Insufficiently Active), ≥500 MET-minutes/wk which equates to meeting the 2008 
DHHS aerobic PA guidelines of 150 minutes of MVPA/wk. Due to the overwhelming lack of 
diabetes-related mortality deaths in MA, the 1999-2004 analyses were conducted only in NHW 
and NHB. The results of the analyses are displayed in tables A8.1, A8.2 and A8.3.  
 The results in Table A8.1 reveal significantly lower risk for diabetes-related mortality in 
those who were insufficiently active (HR 0.47, 95% CI 0.26-0.84) or active (HR 0.14, 95% CI 
0.08-0.27). Following adjustment for age and race-ethnicity, results remained significant for only 
active participants (HR 0.20, 95% CI 0.10-0.39). Following further adjustment for covariates, 
both insufficiently active (HR 0.54, 95% CI 0.34-0.86) and active (HR 0.58, 95% CI 0.36-0.94) 
participants had significantly lower risk for diabetes-related mortality.     
 Tables A8.2 and A8.3 illustrate the results of the analysis examining the relationship 
between the PAG3 and diabetes-related mortality stratified by race-ethnicity.  In the unadjusted 
analysis for NHW, participants categorized as either insufficiently active (HR 0.46, 95% CI 
0.22-0.99) or active (HR 0.14, 95% CI 0.07-0.30) had significantly lower risk for diabetes-
related mortality compared to inactive participants. In NHB, only active participants had 
significantly lower risk (HR 0.19, 95% CI 0.06-0.59). Following further adjustment for 
covariates, results remained significant only for active NHW (HR 0.28, 95% CI 0.14-0.57). 
While not statistically significant, active NHB had a pronounced risk reduction that approached 
significance (HR 0.34, 95% CI 0.11-1.02). A significant p-for-trend was found for NHW 
(p=0.001) and NHB (p=0.04).         
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 The results of the current analysis indicate that meeting the 2008 aerobic PA guidelines 
provides significant protection from diabetes-related mortality among those who are NHW. 
Among NHB, a clinically meaningful risk reduction was found among those who were active. 
However results did not attain statistical significance. Similar to the results found in the analysis 
using the NHANES III data, at a similar dose of activity (active PA), the risk reduction was 
similar between NHW and NHB. The overall low number of deaths related to diabetes and 
smaller sample size, especially in NHB, is likely contributing to the lack of significance and 
large confidence intervals found in the analysis.        
 When compared to the PA questionnaire in NHANES III, the 1999-2004 NHANES has 
the addition of duration as well as PA across different domains (i.e. transportation and domestic), 
thus providing researchers a more comprehensive examination of PA. Furthermore, the 1999-
2006 NHANES also contains a questionnaire on muscular strengthening activity (MSA). Given 
the established effect of MSA on risk factors for diabetes-related mortality such as insulin 
sensitivity and glucose intolerance, the 1999-2006 NHANES provides the ability to examine 
how MSA relates to diabetes-related mortality. As more data are added to the NDI and 
subsequently the NHANES, it is likely the confidence intervals will decrease providing a better 
illustration of how PA relates to diabetes-related mortality.   
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Table A8.1. Relationship between the Physical Activity Guideline (3-level) and diabetes-related 
mortality: 1999-2004 NHANES (N=3,324) 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Unadjusted Age and race-ethnicity adjusted Fully-adjusted 
 
Physical Activity    
Physical Activity Guideline 3    
        Inactive 1.00 1.00 1.00 
        Insufficiently Active 0.47 (0.26-0.84)* 0.63 (0.34-1.14) 0.54 (0.34-0.86)* 
        Active 0.14 (0.08-0.27)* 0.20 (0.10-0.39)* 0.58 (0.36-0.94)* 
Demographics    
Age (years)  1.07 (1.04-1.10)* 1.06 (1.01-1.11)* 
Race-ethnicity    
        NHW  1.00 1.00 
        NHB  1.79 (0.94-3.41) 0.80 (0.40-1.61) 
Gender    
        Male   1.00 
        Female   0.59 (0.33-1.05) 
Education    
        Less than high school   1.00 
        High school graduate   0.90 (0.70-1.56) 
        Some college   1.03 (0.43-2.50) 
        College graduate   0.27 (0.05-1.57) 
Family History    
Family History of Diabetes     
        Yes   1.00 
         No   0.59 (0.34-1.04) 
Body Mass Index (kg/m2)   0.99 (0.93-1.06) 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.20 (0.10-0.44)* 
        Euglycemic (A1c < 5.7%)   0.04 (0.01-0.13)* 
Health Behaviors    
Healthy Eating Index (0-100)   1.01 (0.99-1.02) 
Smoking Status    
        Current smoker   1.00 
        Former   0.28 (0.11-0.71)* 
        Non-smoker   0.44 (0.21-0.92)* 
Alcohol consumption    
        Non-drinker   1.00 
        Moderate    0.56 (0.26-1.19) 
        Above moderate   0.78 (0.25-2.45) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American.  
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: ≥500 MET-min/wk.  
Alcohol consumption:  non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day).*p<0.05 
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Table A8.2. Relationship between the Physical Activity Guideline (3-level) and diabetes-related mortality 
stratified by race-ethnicity: 1999-2004 NHANES (N=3,324)  
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW NHB 
 Unadjusted Fully-adjusted Unadjusted Fully-adjusted 
Physical Activity     
Physical Activity Guideline 3     
        Inactive 1.00 1.00 1.00 1.00 
        Insufficiently Active 0.46 (0.22-0.99)* 0.79 (0.39-1.60) 0.61 (0.25-1.49) 0.93 (0.30-2.18) 
        Active 0.14 (0.07-0.30)* 0.28 (0.14-0.57)* 0.19 (0.06-0.59)* 0.34 (0.11-1.02) 
Demographics     
Age  1.05 (0.99-1.12)*  1.08 (1.03-1.12)* 
Gender     
        Male  1.00  1.00 
        Female  0.55 (0.26-1.17)  0.98 (0.34-2.73) 
Education     
        Less than high school  1.00  1.00 
        High school graduate  1.18 (0.46-3.02)  0.51 (0.19-1.41) 
        Some college  1.52 (0.51-4.41)  0.12 (0.01-1.16) 
        College graduate  0.31 (0.04-2.60)  0.42 (0.05-3.38) 
Family History     
Family History of Diabetes      
        Yes  1.00  1.00 
         No  0.55 (0.26-1.15)  0.61 (0.24-1.55) 
Metabolic Markers     
Body Mass Index (kg/m2)  1.00 (0.93-1.08)  0.92 (0.84-1.02) 
Glycemic Status     
        Diabetes (A1c ≥ 6.5%)  1.00  1.00 
        Pre-diabetes (A1c 5.7-6.5%)  0.19 (0.07-0.49)*  0.23 (0.08-0.62)* 
        Euglycemic (A1c < 5.7%)  0.03 (0.01-0.15)*  0.12 (0.04-0.38)* 
Health Behaviors     
Healthy Eating Index   1.01 (0.99-1.03)  1.00 (0.98-1.03) 
Smoking Status     
        Current smoker  1.00  1.00 
        Former  0.31 (0.11-0.87)*  0.14 (0.04-0.53)* 
        Non-smoker  0.43 (0.16-1.15)  0.37 (0.15-0.91)* 
Alcohol consumption     
        Non-drinker  1.00  1.00 
        Moderate   0.51 (0.20-1.31)  0.70 (0.33-1.50) 
        Above moderate  0.50 (0.05-4.93)  1.10 (0.25-4.92) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American.  
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: ≥500 MET-min/wk. 
Alcohol consumption:  non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day).*p<0.05 
 
 
 
 156 
 
Table A8.3. Hazards ratios from analyses examining the relationship between physical activity (3-level) and diabetes-related 
mortality: 1999-2004 NHANES 
 Physical Activity Guideline 3  
 Inactive Insufficiently Active Active p-for-trend 
MET-min/wk 0 >0-<500 ≥500  
     
Total     
        N 699 796 1832  
        No. of deaths 29 17 16  
        Person-years 5996.58 7151.50 16828.67  
        Unadjusted HR 1.00 0.47 (0.26-0.84) 0.14 (0.08-0.27) p<0.001 
        Adjusted HRa 1.00 0.54 (0.34-0.86) 0.58 (0.36-0.94) p<0.001 
     
Non-Hispanic White     
        N 369 580 1433  
        No. of deaths 13 11 11  
        Person-years 3066.50 5226.92 13269.50  
        Unadjusted HR 1.00 0.46 (0.22-0.99) 0.14 (0.07-0.30) p<0.001 
        Adjusted HRa 1.00 0.79 (0.39-1.60) 0.28 (0.14-0.57) p=0.001 
     
Non-Hispanic Black     
        N 330 215 399  
        No. of deaths 16 6 5  
        Person-years 2930.08 1913.67 3559.17  
        Unadjusted HR 1.00 0.61 (0.25-1.49) 0.19 (0.06-0.59) p=0.002 
        Adjusted HRa 1.00 0.93 (0.30-2.18) 0.34 (0.11-1.02) p=0.04 
 
aAdjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol 
consumption. HR: Hazard Ratio. Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: 
≥500 MET-min/wk. 
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Figure A8.1. Kaplan-Meier Survival Curve: Physical Activity Guideline 3 and Non-Hispanic 
White 
PAG3 1: Inactive; PAG3 2: Insufficiently Active; PAG3 3: Active 
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Figure A8.2. Kaplan-Meier Survival Curve: Physical Activity Guideline 3 and Non-Hispanic 
Black 
PAG3 1: Inactive; PAG3 2: Insufficiently Active; PAG3 3: Active 
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Appendix 9 
Among the 1999-2004 NHANES, is there a dose-response relationship between self-
reported PA (4-level) and diabetes-related mortality across race-ethnic groups? 
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Using the data from the 1999-2004 NHNAES, a dose-response analysis was conducted 
using the 4-level PA (PAG4) variable outlined in chapter 3. Briefly, PA was coded into four 
categories based on the 2008 PA guidelines: 0 MET-minutes/wk (Inactive), <500 MET-
minutes/wk (Insufficiently Active), 500-<1000 MET-minutes/wk (Active) which equates to 
meeting the 2008 DHHS aerobic PA guidelines of 150 minutes of MVPA/wk and ≥1000 MET-
minutes/wk (High active) which equates to volumes exceeding the recommendations of ≥300 
minutes/wk of MVPA. The results of the analyses are displayed in tables A9.1, A9.2 and A9.3. 
 The results in Table A9.1 reveal significantly lower risk for diabetes-related mortality in 
those who were insufficiently active (HR 0.47, 95% CI 0.26-0.84), active (HR 0.17, 95% CI 
0.08-0.36) or high active (HR 0.13, 95% CI 0.05-0.33). Following adjustment for age and race-
ethnicity, results remained significant for insufficiently active (HR 0.24, 95% CI 0.11-0.52) and 
active participants (HR 0.18, 95% CI 0.07-0.48). Following further adjustment for covariates, 
both insufficiently active (HR 0.40, 95% CI 0.18-0.93) and active (HR 0.30, 95% CI 0.13-0.72) 
participants had significantly lower risk for diabetes-related mortality.     
 Tables A9.2 and A9.3 illustrate the results of the analysis examining the relationship 
between the PAG4 and diabetes-related mortality stratified by race-ethnicity.  In the unadjusted 
analysis for NHW, participants categorized as either insufficiently active (HR 0.46, 95% CI 
0.22-0.98), active (HR 0.14, 95% CI 0.05-0.41) or high active (HR 0.14, 95% CI 0.05-0.40) had 
significantly lower risk for diabetes-related mortality compared to inactive participants. In NHB, 
only high active participants had significantly lower risk (HR 0.05, 95% CI 0.01-0.38). 
Following further adjustment for covariates, results remained significant for high active NHW 
(HR 0.31, 95% CI 0.12-0.79) and NHB (HR 0.09, 95% CI 0.02-0.44). A significant p-for-trend 
was found for NHW (p=0.005) and NHB (p=0.01).      
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 The results of the current analysis indicate that exceeding the 2008 aerobic PA guidelines 
(≥1000 MET-min/wk) provides significant protection from diabetes-related mortality among 
those who are NHW. Furthermore, the results indicate that meeting the 2008 aerobic guidelines 
of 500 MET-min/wk is not sufficient to provide protection. However, similar to the results 
examining the PAG3, there is a sufficient lack of power due to the small sample size and low 
amount of deaths related to diabetes. However, despite the lack of statistical power, there was 
still a significant trend for both NHW and NHB across increasing dose of PA. As more data 
become available from the NDI, the ability to examine thresholds based around the current PA 
guidelines will become obtainable.  
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Table A9.1. Relationship between Physical Activity Guideline (4-level) and diabetes-related mortality: 
1999-2004 NHANES (N=3,324) 
 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Unadjusted Age and race-ethnicity adjusted Fully-adjusted 
 
Physical Activity    
Physical Activity Guideline 4    
        Inactive 1.00 1.00 1.00 
        Insufficiently Active 0.47 (0.26-0.84)* 0.63 (0.34-1.14) 0.76 (0.44-1.33) 
        Active 0.17 (0.08-0.36)* 0.24 (0.11-0.52)* 0.40 (0.18-0.93)* 
        High Active 0.13 (0.05-0.33)* 0.18 (0.07-0.48)* 0.30 (0.13-0.72)* 
Demographics    
Age (years)  1.07 (1.04-1.10)* 1.06 (1.01-1.11)* 
Race-ethnicity    
        NHW  1.00 1.00 
        NHB  1.78 (0.94-3.40) 0.80 (0.40-1.61) 
Gender    
        Male   1.00 
        Female   0.59 (0.33-1.05) 
Education    
        Less than high school   1.00 
        High school graduate   0.90 (0.70-1.56) 
        Some college   1.03 (0.43-2.50) 
        College graduate   0.27 (0.05-1.57) 
Family History    
Family History of Diabetes     
        Yes   1.00 
         No   (0.57 (0.34-1.05) 
Metabolic Markers    
Body Mass Index (kg/m2)   0.99 (0.93-1.06) 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.20 (0.10-0.44)* 
        Euglycemic (A1c < 5.7%)   0.04 (0.01-0.13)* 
Health Behaviors    
Healthy Eating Index    1.01 (0.99-1.02) 
Smoking Status    
        Current smoker   1.00 
        Former   0.28 (0.11-0.71)* 
        Non-smoker   0.44 (0.21-0.92)* 
Alcohol consumption    
        Non-drinker   1.00 
        Moderate    0.56 (0.26-1.19) 
        Above moderate   0.78 (0.25-2.45) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black;  
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: 500-999 MET-min/wk; High 
Active: ≥1000 MET-min/wk.  
Alcohol consumption:   non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day).*p<0.05 
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Table A9.2. Relationship between Physical Activity Guideline (4-level) and diabetes-related mortality 
stratified by race-ethnicity: 1999-2004 NHANES (N=3,324) 
 
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW NHB 
 Unadjusted Fully-adjusted Unadjusted Fully-adjusted 
Physical Activity     
Physical Activity Guideline 4     
        Inactive 1.00 1.00 1.00 1.00 
        Insufficiently Active 0.46 (0.22-0.98)* 0.74 (0.37-1.50) 0.61 (0.25-1.49) 0.82 (0.31-2.18) 
        Active 0.14 (0.05-0.41)* 0.34 (0.10-1.10) 0.46 (0.14-1.46) 0.86 (0.22-3.39) 
        High Active 0.14 (0.05-0.40)* 0.31 (0.12-0.79)* 0.05 (0.01-0.38)* 0.09 (0.02-0.44)* 
Demographics     
Age  1.05 (0.99-1.12)*  1.08 (1.03-1.12)* 
Gender     
        Male  1.00  1.00 
        Female  0.58 (0.26-1.18)  0.96 (0.34-2.73) 
Education     
        Less than high school  1.00  1.00 
        High school graduate  1.18 (0.46-3.01)  0.48 (0.17-1.36) 
        Some college  1.50 (0.52-4.36)  0.11 (0.01-1.24) 
        College graduate  0.31 (0.03-2.91)  0.36 (0.06-3.37) 
Family History     
Family History of Diabetes      
        Yes  1.00  1.00 
         No  0.55 (0.76-1.15)  0.61 (0.24-1.56) 
Metabolic Markers     
Body Mass Index (kg/m2)  1.00 (0.93-1.08)  0.92 (0.84-1.02) 
Glycemic Status     
        Diabetes (A1c ≥ 6.5%)  1.00  1.00 
        Pre-diabetes (A1c 5.7-6.5%)  0.19 (0.07-0.49)*  0.24 (0.08-0.68)* 
        Euglycemic (A1c < 5.7%)  0.03 (0.01-0.15)*  0.13 (0.04-0.41)* 
Health Behaviors     
Healthy Eating Index   1.01 (0.99-1.03)  1.01 (0.98-1.04) 
Smoking Status     
        Current smoker  1.00  1.00 
        Former  0.31 (0.11-0.87)*  0.14 (0.03-0.54)* 
        Non-smoker  0.43 (0.16-1.15)  0.37 (0.15-0.91)* 
Alcohol consumption     
        Non-drinker  1.00  1.00 
        Moderate   0.51 (0.20-1.31)  0.71 (0.32-1.62) 
        Above moderate  0.50 (0.05-5.14)  1.01 (0.23-4.44) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black.  
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: 500-999 MET-min/wk; High 
Active: ≥1000 MET-min/wk. 
non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 [women], >2 [men] 
drinks/day).*p<0.05 
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Table A9.3. Hazards ratios from analyses examining the relationship between physical activity (4-level) and diabetes-related 
mortality: 1999-2004 NHANES 
 Physical Activity Guideline 4   
 Inactive Insufficiently Active Active High Active p-for-trend 
MET-min/wk 0 >0-<500 500-<999 ≥1000  
      
Total      
        N 699 796 585 1247  
        No. of deaths 29 17 8 8  
        Person-years 3066.50 7151.50 5303.08 11525.58  
        Unadjusted HR 1.00 0.47 (0.26-0.84) 0.17 (0.08-0.36) 0.13 (0.05-0.33) p<0.001 
        Adjusted HRa 1.00 0.76 (0.44-1.33) 0.40 (0.18-0.93) 0.30 (0.13-0.72) p=0.002 
      
Non-Hispanic White      
        N 369 580 442 990  
        No. of deaths 13 11 4 7  
        Person-years 3066.50 5226.92 4043.42 9217.58  
        Unadjusted HR 1.00 0.46 (0.22-0.98) 0.14 (0.05-0.41) 0.14 (0.05-0.40) p<0.001 
        Adjusted HRa 1.00 0.74 (0.37-1.50) 0.34 (0.10-1.10) 0.31 (0.12-0.79) p=0.005 
      
Non-Hispanic Black      
        N 330 215 141 257  
        No. of deaths 16 6 4 1  
        Person-years 2930.08 1913.67 1239.58 2308.00  
        Unadjusted HR 1.00 0.61 (0.25-1.49) 0.46 (0.14-1.46) 0.05 (0.01-0.38) p<0.001 
        Adjusted HRa 1.00 0.82 (0.31-2.18) 0.86 (0.22-3.39) 0.09 (0.02-0.44) p=0.01 
 
aAdjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol 
consumption. HR: Hazard Ratio. Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: 
500-999 MET-min/wk; High Active: ≥1000 MET-min/wk.   
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Figure 9.1. Kaplan-Meier Survival Curve: Physical Activity Guideline 4 and Non-Hispanic 
White 
PAG4 1: Inactive; PAG4 2: Insufficiently Active; PAG4 3: Active; PAG4 4: High Active 
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Figure 9.2. Kaplan-Meier Survival Curve: Physical Activity Guideline 4 and Non-Hispanic 
Black 
PAG4 1: Inactive; PAG4 2: Insufficiently Active; PAG4 3: Active; PAG4 4: High Active 
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Appendix 10 
Among the 1999-2004 NHANES, is there a dose-response relationship between self-
reported quintiles of PA and diabetes-related mortality across race-ethnic groups? 
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Table A10.1 displays the results of the analysis examining relationship between PA 
quintiles and the risk of diabetes-related mortality using race-ethnicity as a covariate. In the 
unadjusted analysis, significantly lower risk for diabetes-related mortality was found for all 
quintiles with the exception of quintile 1. Following adjustment for age and race-ethnicity, 
significance remained the same. Following further adjustment for all covariates, results remained 
significant for quintile 4 (HR 0.24, 95% CI 0.06-0.95).        
 Tables A6.5 and A6.6 display the results of the analysis examining the effect 
modification of race-ethnicity on the relationship between PA quartiles and the risk of diabetes-
related mortality. In the unadjusted analyses, significantly lower risk for diabetes-related 
mortality was found across all quintiles in NHW except for quintile 1. Significance was only 
found in the fourth quintile in NHB. There were no deaths in quintile 5 therefore no hazard ratio 
could be calculated. Following adjustment for covariates, NHW in quartile 5 (HR 0.24, 95% CI 
0.06-0.97) had significantly lower risk for diabetes-related mortality. No significant HR were 
found for NHB following adjustment for all covariates.     
 Similar to the analyses with the NHANES III quartiles in Appendix 6, the results of this 
analysis must be interpreted with caution. First, the results of the Kaplan-Meier survival curves 
(not shown) indicated that the use of quintiles violated the proportional hazards assumption of 
the models. Second, due to the few deaths spaced across the quartiles of activity, the confidence 
intervals associated with each HR are large. In quintile 5 for NHB, there were no deaths 
therefore no HR could be calculated. Thus, understanding the dose response relationship is 
severely diminished. It can be postulated that as more data becomes available from the NDI, the 
use of a more detailed dose-response (such as the quintiles) examination will become possible. 
Because of these reasons, drawing conclusions from this analysis is not recommended. 
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Table A10.1. Relationship between physical activity quintiles and diabetes-related mortality: 1999-2004 
NHANES (N=3,324) 
 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Unadjusted Age and race-ethnicity adjusted Fully-adjusted 
 
Physical Activity    
Physical Activity Quintiles    
Inactive 1.00 1.00 1.00 
Q1 0.49 (0.24-1.02) 0.65 (0.31-1.35) 0.69 (0.33-1.43) 
Q2 0.23 (0.10-0.53)* 0.33 (0.14-0.77)* 0.67 (0.31-1.45) 
Q3 0.22 (0.10-0.49)* 0.33 (0.15-0.72)* 0.49 (0.22-1.10) 
Q4 0.14 (0.04-0.43)* 0.19 (0.06-0.60)* 0.38 (0.12-1.27) 
Q5 0.13 (0.04-0.45)* 0.17 (0.05-0.64)* 0.24 (0.06-0.95)* 
Demographics    
Age (years)  1.07 (1.04-1.10)* 1.06 (1.01-1.11)* 
Race-ethnicity    
        NHW  1.00 1.00 
        NHB  1.84 (0.97-3.51) 0.80 (0.39-1.63) 
Gender    
        Male   1.00 
        Female   0.59 (0.32-1.07) 
Education    
        Less than high school   1.00 
        High school graduate   0.88 (0.41-1.92) 
        Some college   1.03 (0.43-2.46) 
        College graduate   0.25 (0.04-1.40) 
Family History    
Family History of Diabetes     
        Yes   1.00 
         No   0.59 (0.33-1.06) 
Metabolic Markers    
Body Mass Index (kg/m2)   0.99 (0.93-1.06) 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.20 (0.09-0.44)* 
        Euglycemic (A1c < 5.7%)   0.04 (0.01-0.13)* 
Health Behaviors    
Healthy Eating Index    1.01 (0.99-1.02) 
Smoking Status    
        Current smoker   1.00 
        Former   0.27 (0.10-0.69)* 
        Non-smoker   0.43 (0.20-0.91)* 
Alcohol consumption    
        Non-drinker   1.00 
        Moderate    0.55 (0.25-1.18) 
        Above moderate   0.79 (0.26-2.41) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. Q: Quintile. 
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day).*p<0.05 
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Table A10.2. Relationship between physical activity quintiles and diabetes-related mortality stratified by 
race-ethnicity: 1999-2004 NHANES (N=3,324) 
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW NHB 
 Unadjusted Fully-adjusted Unadjusted Fully-adjusted 
Physical Activity     
Physical Activity Quintiles     
Inactive 1.00 1.00 1.00 1.00 
Q1 0.46 (0.18-1.20) 0.62 (0.25-1.57) 0.86 (0.32-2.31) 1.56 (0.55-4.43) 
Q2 0.22 (0.09-0.59)* 0.71 (0.27-1.82) 0.37 (0.09-1.59) 0.23 (0.02-3.13) 
Q3 0.21 (0.08-0.54)* 0.47 (0.18-1.22) 0.37 (0.10-1.33) 0.84 (0.19-3.74) 
Q4 0.14 (0.04-0.51)* 0.42 (0.10-1.67) 0.11 (0.02-0.78)* 0.23 (0.05-1.12) 
Q5 0.15 (0.04-0.56)* 0.24 (0.06-0.97)* N/A N/A 
Demographics     
Age  1.05 (0.99-1.12)*  1.08 (1.04-1.12)* 
Gender     
        Male  1.00  1.00 
        Female  0.55 (0.26-1.17)  1.04 (0.33-3.22) 
Education     
        Less than high school  1.00  1.00 
        High school graduate  1.16 (0.45-3.01)  0.41 (0.12-1.42) 
        Some college  1.49 (0.52-4.29)  0.10 (0.01-1.20) 
        College graduate  0.26 (0.03-2.36)  0.39 (0.04-3.67) 
Family History     
Family History of Diabetes      
        Yes  1.00  1.00 
         No  0.54 (0.26-1.17)  0.61 (0.24-1.55) 
Metabolic Markers     
Body Mass Index (kg/m2)  1.00 (0.93-1.08)  0.92 (0.83-1.02) 
Glycemic Status     
        Diabetes (A1c ≥ 6.5%)  1.00  1.00 
        Pre-diabetes (A1c 5.7-6.5%)  0.18 (0.07-0.48)*  0.21 (0.07-0.67)* 
        Euglycemic (A1c < 5.7%)  0.03 (0.01-0.14)*  0.12 (0.04-0.33)* 
Health Behaviors     
Healthy Eating Index   1.01 (0.99-1.03)  1.01 (0.98-1.02) 
Smoking Status     
        Current smoker  1.00  1.00 
        Former  0.29 (0.10-0.81)*  0.12 (0.03-0.47)* 
        Non-smoker  0.40 (0.15-1.11)  0.35 (0.14-0.88)* 
Alcohol consumption     
        Non-drinker  1.00  1.00 
        Moderate   0.50 (0.19-1.31)  0.71 (0.31-1.63) 
        Above moderate  0.51 (0.05-5.00)  0.91 (0.17-4.92) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. Q: Quintile 
Alcohol consumption:  non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day).*p<0.05 
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Table A10.3. Hazards ratios from analyses examining the relationship between physical activity (Quintiles) and diabetes-related 
mortality: 1999-2004 NHANES 
 Physical Activity Quintiles   
 Inactive Q1 Q2 Q3 Q4 Q5 p-for-trend 
Total        
        MET-min/wk 0 >0-<312.34 ≥312.34-<673.79 ≥673.79-<1245.09 ≥1245.09-<2382.52 ≥2382.52  
        N 699 515 528 512 514 559  
        No. of deaths 29 11 7 8 4 3  
        Person-years 5996.58 4546.58 4839.08 4748.00 4686.25 5160.25  
        Unadjusted HR 1.00 0.49 (0.24-1.02) 0.23 (0.10-0.53) 0.22 (0.10-0.49) 0.14 (0.04-0.43) 0.13 (0.04-0.45) p<0.001 
        Adjusted HRa 1.00 0.69 (0.33-1.43) 0.67 (0.31-1.45) 0.49 (0.22-1.10) 0.38 (0.12-1.27) 0.24 (0.06-0.95) p=0.002 
        
Non-Hispanic White        
        MET-min/wk 0 >0-<307.42 ≥307.42-<682.35 ≥682.35-<1258.91 ≥1258.91-<2339.65 ≥2339.65  
        N 369 388 409 394 392 431  
        No. of deaths 13 6 5 5 3 3  
        Person-years 3066.50 3433.25 3766.83 3696.17 3596.50 4014.58  
        Unadjusted HR 1.00 0.46 (0.18-1.20) 0.22 (0.09-0.59) 0.21 (0.08-0.54) 0.14 (0.04-0.51) 0.15 (0.04-0.56) p<0.001 
        Adjusted HRa 1.00 0.62 (0.25-1.57) 0.71 (0.27-1.82) 0.47 (0.18-1.22) 0.42 (0.10-1.67) 0.24 (0.06-0.97) p=0.008 
        
Non-Hispanic Black        
        MET-min/wk 0 >0-<233.11 ≥233.11-<560.52 ≥560.52-<1022.72 ≥1022.72-<2077.38 ≥2077.38  
        N 330 127 119 118 122 128  
        No. of deaths 16 5 2 3 1 0  
        Person-years 2930.08 1113.33 1072.25 1051.83 1089.75 1145.67  
        Unadjusted HR 1.00 0.86 (0.32-2.31) 0.37 (0.09-1.59) 0.37 (0.10-1.33) 0.11 (0.02-0.78) - p=0.002 
        Adjusted HRa 1.00 1.56 (0.55-4.43) 0.23 (0.02-3.13) 0.84 (0.19-3.74) 0.23 (0.05-1.12) - p=0.009 
 
aAdjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol 
consumption. HR: Hazard Ratio. Q: Quintile 
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Table A11.1. Baseline demographic, Heath and Physical Activity characteristics of the participants: 2003-
2006 NHANES (N=2,595) 
Variables Valuea  
   
Physical Activity   
MVPA 760 (median) 95.2 (61.4–136.8) 
MVPA 2020 (median) 13.8  (5.2-28.9) 
Total Activity Counts/d (%)   
       Quartile 1 27.0 (1.0) 
       Quartile 2 26.1 (1.4) 
       Quartile 3 23.7 (1.1) 
       Quartile 4 23.2 (1.3) 
Demographics   
Age (mean) 55.6 (0.2) 
Gender (%)   
        Male 48.1 (1.0) 
        Female 51.9 (1.0) 
Education (%)   
        Less than high school 11.9 (1.5) 
        High school graduate 27.4 (0.9) 
        Some college 32.3 (1.2) 
        College graduate 28.4 (1.8) 
Metabolic Markers   
Body Mass Index (kg/m2)(mean) 28.6  (0.2) 
Glycemic Status (%)   
        Diabetes (A1c ≥ 6.5%) 7.7 (0.8) 
        Pre-diabetes (A1c 5.7-6.5%) 19.5 (0.9) 
        Euglycemic (A1c < 5.7%) 72.8  (1.2) 
Health Behaviors   
Healthy Eating Index (0-100)(mean) 53.2  (0.5) 
Smoking Status (%)   
         Current smoker 20.0  (1.2) 
         Former 33.7 (1.2) 
         Non-smoker 46.3 (1.2) 
Alcohol consumption (%)   
         Non-Drinker 31.5  (2.0) 
         Moderate 59.7  (1.7) 
         Above Moderate 8.8 (0.7) 
 
SE = Standard Error. MVPA 760 = moderate-to-vigorous minutes physical activity (≥760 counts/min). MVPA 2020 = moderate-to-vigorous 
minutes physical activity (≥2020 counts/min).  
aMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).  
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day)  
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Table A11.2. Demographic, Heath and Physical Activity characteristics of participants stratified by 
diabetes-related mortality status: 2003-2006 NHANES (N=2,595) 
Variables Valuec 
  
 Alive or non-diabetes-related mortality (n=2,572) 
Diabetes-related 
mortality  
(n=23) 
Physical Activity     
MVPA 760 (median) 95.7 (61.8-136.9) 31.0   (22.3-35.3)* 
MVPA 2020 (median) 13.8 (5.3-28.9) 1.7 (1.2-3.6) * 
Total Activity Counts/d (%)     
       Quartile 1 26.6 (1.0) 83.5 (2.7) * 
       Quartile 2 26.2 (1.4) 2.7 (0.2) * 
       Quartile 3 23.9 (1.1) 1.7 (1.8) * 
       Quartile 4 23.3 (1.3) 12.1 (1.0) * 
Demographics     
Age (mean) 55.8 (0.4) 65.8 (0.7) * 
Gender (%)     
        Male 48.0 (1.0) 62.9 (7.8) 
        Female 52.0 (1.0) 37.1 (7.8) 
Education (%)     
        Less than high school 11.7 (1.4) 53.1 (5.2) * 
        High school graduate 27.5 (0.9) 22.0 (1.7) 
        Some college 32.3 (1.2) 22.5 (5.6) 
        College graduate 28.6 (1.8) 2.4 (0.2) * 
Metabolic Markers     
Body Mass Index (kg/m2)(mean) 29.0  (0.2) 28.7  (0.8) 
Glycemic Status (%)     
        Diabetes (A1c ≥ 6.5%) 7.4 (0.7) 66.5 (7.5) * 
        Pre-diabetes (A1c 5.7-6.5%) 19.4 (0.9) 31.7 (7.6) 
        Euglycemic (A1c < 5.7%) 73.2  (1.2) 1.8  (0.1) * 
Health Behaviors     
Healthy Eating Index (0-100)(mean) 49.1  (0.5) 43.5  (2.1) 
Smoking Status (%)     
         Current smoker 20.0  (1.2) 30.7  (4.6) 
         Former 33.7 (1.2) 27.7 (6.1) 
         Non-smoker 46.3 (1.2) 41.6 (5.1) 
Alcohol consumption (%)     
         Non-Drinker 31.2  (2.0) 76.8  (7.2) * 
         Moderate 59.9  (1.7) 21.3  (7.2) * 
         Above Moderate 8.9 (0.7) 1.9 (0.2) * 
 
SE = Standard Error. MVPA 760 = moderate-to-vigorous physical activity (≥760 counts/min). MVPA 2020 = moderate-to-vigorous physical 
activity (≥2020 counts/min).  
aMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).  
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day).  
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Table A11.3. Demographic, Heath and Physical Activity characteristics of participants stratified by race-
ethnicity: 2003-2006 NHANES (N=2,595) 
Variables Valuec 
  
     NHW (n=1892)  NHB (n=703) 
Physical Activity     
MVPA 760 (median) 95.6 (62.0-136.9) 92.7   (53.4-134.8) 
MVPA 2020 (median) 14.3 (5.4-29.4) 11.1 (4.2-25.1)  
Total Activity Counts/d (%)     
       Quartile 1 26.4 (1.1) 31.5 (1.7) 
       Quartile 2 26.1 (1.6) 26.4 (1.5) 
       Quartile 3 23.8 (1.2) 23.7 (1.8) 
       Quartile 4 23.7 (1.4) 18.4 (1.3) 
Demographics     
Age (mean) 56.0 (0.4) 54.2 (0.4) * 
Gender (%)     
        Male 48.6 (1.0) 43.5 (1.8) 
        Female 51.4 (1.0) 56.6 (1.8) 
Education (%)     
        Less than high school 10.4 (1.6) 25.2 (1.7) * 
        High school graduate 27.8 (1.0) 24.5 (1.7) 
        Some college 32.3 (1.3) 31.7 (1.2) 
        College graduate 29.5 (1.9) 18.6 (1.7) * 
Metabolic Markers     
Body Mass Index (kg/m2)(mean) 28.8  (0.2) 30.8  (0.3) * 
Glycemic Status (%)     
        Diabetes (A1c ≥ 6.5%) 6.7 (0.8) 16.2 (1.8) * 
        Pre-diabetes (A1c 5.7-6.5%) 18.1 (1.0) 31.7 (1.8) * 
        Euglycemic (A1c < 5.7%) 75.2  (1.3) 52.1  (2.4) * 
Health Behaviors     
Healthy Eating Index (0-100)(mean) 49.4  (0.5) 46.6  (0.8) * 
Smoking Status (%)     
         Current smoker 19.5  (1.3) 25.0  (2.3) 
         Former 34.7 (1.3) 24.7 (1.3) * 
         Non-smoker 45.8 (1.4) 50.3 (2.4) 
Alcohol consumption (%)     
         Non-Drinker 29.8  (2.2) 45.7  (1.7) * 
         Moderate 60.9  (1.9) 48.9  (1.9) * 
         Above Moderate 9.3 (0.8) 5.4 (0.9) * 
 
SE = Standard Error. MVPA 760 = moderate-to-vigorous physical activity (≥760 counts/min). MVPA 2020 = moderate-to-vigorous physical 
activity (≥2020 counts/min).  
aMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).  
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day)  
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Appendix 12 
 
3B. Is there a dose-response relationship between quartiles of accelerometer-derived total 
activity counts/day (TAC/d) and diabetes-related mortality across race-ethnic groups? 
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 The results of the analysis addressing research question 3B are displayed in tables 12.1, 
12.2, and 12.3. In the unadjusted as well as the age and race-ethnicity adjusted analyses, 
significantly lower risk for diabetes-related mortality was found across all quartiles. Following 
further adjustment for covariates, significance remained only in quartile 3. In the race-ethnicity 
stratified analyses, a significantly lower risk for diabetes-related mortality was found only for 
quartile 4 in NHW. No relationships were found for NHB. Following further adjustment for 
covariates, results remained the same. Due to the significant lack of deaths, there was no ability 
to calculate hazard ratios in quartiles 2 and 3 for NHW and quartile 4 for NHB. This removes the 
ability to interpret the results in any way.   
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Table A12.1. Relationship between physical activity and diabetes-related mortality: 2003-2006 NHANES 
(N=2,595) 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Unadjusted Age and race-ethnicity adjusted Fully-adjusted 
 
Physical Activity    
Total Activity Counts/day    
        Quartile 1 1.00 1.00 1.00 
        Quartile 2 0.03 (0.01-0.17)* 0.03 (0.01-0.18)* 0.04 (0.01-0.19) 
        Quartile 3 0.02 (0.00-0.23)* 0.02 (0.00-0.25)* 0.04 (0.01-0.35)* 
        Quartile 4 0.17 (0.03-0.86)* 0.18 (0.04-0.88)* 0.30 (0.05-1.62) 
Demographics    
Age (years)  1.09 (1.04-1.15)* 1.06 (1.01-1.12)* 
Race-ethnicity    
        NHW  1.00 1.00 
        NHB  1.82 (0.51-6.56) 0.80 (0.40-1.61) 
Gender    
        Male   1.00 
        Female   0.48 (0.17-1.41) 
Education    
        Less than high school   1.00 
        High school graduate   0.24 (0.70-1.56) 
        Some college   0.51 (0.08-3.42) 
        College graduate   0.07 (0.01-1.02) 
Metabolic Markers    
Body Mass Index    0.91 (0.85-0.98)* 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.21 (0.07-0.66)* 
        Euglycemic (A1c < 5.7%)   0.01 (0.00-0.04)* 
Health Behaviors    
Healthy Eating Index    0.97 (0.92-1.02) 
Smoking Status    
        Current smoker   1.00 
        Former   0.65 (0.16-2.68) 
        Non-smoker   1.58 (0.57-4.47) 
Alcohol consumption    
        Non-drinker   1.00 
        Moderate    0.45 (0.10-2.02) 
        Above moderate   0.70 (0.06-8.53) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black. 
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day). 
*p<0.05 
 
 
 
 
 
 
 
 
 
 179 
 
Table A12.2. Relationship between physical activity and diabetes-related mortality stratified by race-
ethnicity: 2003-2006 NHANES (N=2,595) 
 
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW NHB 
 Unadjusted Fully-adjusted Unadjusted Fully-adjusted 
Physical Activity     
Total Activity Counts/day     
        Quartile 1 1.00 1.00 1.00 1.00 
        Quartile 2 No deaths No deaths 0.25 (0.06-1.04) 0.18 (0.01-2.73) 
        Quartile 3 No deaths No deaths 0.18 (0.02-1.78) 0.29 (0.03-2.59) 
        Quartile 4 0.20 (0.04-1.06)* 0.31 (0.12-0.79)* No deaths No deaths 
Demographics     
Age  1.06 (0.99-1.13)  1.12 (1.03-1.21)* 
Gender     
        Male  1.00  1.00 
        Female  0.33 (0.10-1.11)  3.80 (1.27-11.43)* 
Education     
        Less than high school  1.00  1.00 
        High school graduate  0.12 (0.01-1.00)*  1.34 (0.13-13.47) 
        Some college  0.53 (0.04-6.78)  0.34 (0.02-4.88) 
        College graduate  No deaths  3.36 (0.06-193.48) 
Metabolic Markers     
Body Mass Index   0.93 (0.83-1.03)  0.87 (0.80-0.94)* 
Glycemic Status     
        Diabetes (A1c ≥ 6.5%)  1.00  1.00 
        Pre-diabetes (A1c 5.7-6.5%)  0.19 (0.07-0.49)*  0.24 (0.06-1.00)* 
        Euglycemic (A1c < 5.7%)  No deaths  0.03 (0.00-0.84)* 
Health Behaviors     
Healthy Eating Index   0.96 (0.90-1.03)  1.01 (0.98-1.05) 
Smoking Status     
        Current smoker  1.00  1.00 
        Former  0.85 (0.09-7.91)  0.96 (0.29-3.18) 
        Non-smoker  3.43 (1.00-11.83)  0.03 (0.00-0.75)* 
Alcohol consumption     
        Non-drinker  1.00  1.00 
        Moderate   0.40 (0.05-3.08)  0.71 (0.32-1.62) 
        Above moderate  No deaths  1.01 (0.23-4.44) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black.  
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day). 
*p<0.05 
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Table A12.3. The relationship between total activity counts/day quartiles and diabetes-related mortality: NHANES III 
 
aAdjusted for: age, gender, education, body mass index, glycemic status, healthy eating index, smoking status, alcohol consumption. HR: Hazard 
Ratio. Q: Quartile 
 
 
 Total Activity Counts/day quartiles  
 Q1 Q2 Q3 Q4 p-for-trend 
Total      
 
        N 757 668 609 561  
        No. of deaths 18 2 1 2  
        Person-years 4776.00 4492.08 4063.50 3713.33  
        Unadjusted HR 1.00 0.03 (0.01-0.17) 0.02 (0.00-0.23) 0.17 (0.03-0.86) p=0.03 
        Adjusted HRa 1.00 0.04 (0.01-0.20) 0.04 (0.01-0.35) 0.30 (0.05-1.63) p=0.07 
      
Non-Hispanic White      
      
        N 532 476 444 440  
        No. of deaths 12 0 0 2  
        Person-years 3356.50 3215.17 2962.58 2897.42  
        Unadjusted HR 1.00 0.00 (0.00-0.00) 0.00 (0.00-0.00) 0.20 (0.03-1.06) p=0.08 
        Adjusted HRa 1.00 0.00 (0.00-0.00) 0.00 (0.00-0.00) 0.37 (0.07-2.84) p=0.12 
      
Non-Hispanic Black      
      
        N 225 192 165 121  
        No. of deaths 6 2 1 0  
        Person-years 1419.50 1276.92 1100.92 815.92  
        Unadjusted HR 1.00 0.25 (0.06-1.04) 0.18 (0.02-1.78) 0.00 (0.00-0.00) p=0.02 
        Adjusted HRa 1.00 0.18 (0.01-2.73) 0.29 (0.03-2.59) 0.00 (0.00-0.00) p=0.13 
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Appendix 13 
3A. Is there a dose-response relationship between accelerometer-derived minutes of MVPA 
(2020) and diabetes-related mortality across race-ethnic groups? 
 
 
 
 
 
 
 
 
 
 
 
 
 182 
 
Using the NHANES accelerometer cutpoint of 2020 cpm (1) the dose-response relationship 
between accelerometer-derived minutes of MVPA2020 and diabetes-related mortality was examined. 
MVPA was examined continuously in 10-minute increments. Tables A13.1, A13.2 and A13.3 display the 
results of these analyses. Across all analyses, no significant reductions in risk were found for every 10 
minute accrued of MVPA2020. Due to the lack of deaths related to diabetes as well as the low number of 
mean minutes of MVPA, the confidence intervals were large. Thus, no relationships were found.  
 
1. National Health and Nutrition Examination Survey (NHANES) 2003-2004 documentation, 
codebook, and frequencies, MEC exam component: physical activity monitor examination data. Atlanta, 
GA: Centers for Disease Control and Prevention; 2007. 
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Table A13.1. Relationship between accelerometer-derived MVPA (2020) and diabetes-related mortality: 
2003-2006 NHANES (N=2,557) 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Unadjusted Age and race-ethnicity adjusted Fully-adjusted 
 
Physical Activity    
MVPA 2020 (Every 10 minutes) 0.33 (0.08-1.30) 0.48 (0.12-1.97) 0.65 (0.24-1.78) 
Demographics    
Age (years)  1.06 (0.98-1.15) 1.04 (0.97-1.11) 
Race-ethnicity    
        NHW  1.00 1.00 
        NHB  1.76 (0.49-6.33) 0.68 (0.17-2.65) 
Gender    
        Male   1.00 
        Female   0.52 (0.20-1.33) 
Education    
        Less than high school   1.00 
        High school graduate   0.31 (0.07-1.01) 
        Some college   0.45 (0.08-2.59) 
        College graduate   0.09 (0.01-1.10) 
Metabolic Markers    
Body Mass Index    0.93 (0.86-1.00)* 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.23 (0.08-0.71)* 
        Euglycemic (A1c < 5.7%)   0.01 (0.00-0.05)* 
Health Behaviors    
Healthy Eating Index    0.97 (0.93-1.02) 
Smoking Status    
        Current smoker   1.00 
        Former   0.57 (0.19-1.67) 
        Non-smoker   1.07 (0.40-2.85) 
Alcohol consumption    
        Non-drinker   1.00 
        Moderate    0.38 (0.10-1.52) 
        Above moderate   0.64 (0.05-7.71) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black. 
MVPA 2020: Moderate-to-vigorous physical activity (≥2020 counts/min).  
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day). 
*p<0.05 
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Table A13.2. Relationship between accelerometer-derived MVPA (2020) and diabetes-related mortality 
stratified by race-ethnicity: 2003-2006 NHANES (N=2,595) 
 
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW NHB 
 Unadjusted Fully-adjusted Unadjusted Fully-adjusted 
Physical Activity     
MVPA 2020 (Every 10 minutes) 0.37 (0.09-1.49) 0.77 (0.30-1.99) 0.09 (0.00-1.95) 0.43 (0.11-1.65) 
Demographics     
Age(years)  1.04 (0.97-1.11)  1.10 (1.02-1.19)* 
Gender     
        Male  1.00  1.00 
        Female  0.38 (0.14-1.06)  2.79 (0.66-11.82) 
Education     
        Less than high school  1.00  1.00 
        High school graduate  0.20 (0.04-0.87)*  1.69 (0.34-8.47) 
        Some college  0.35 (0.05-2.70)  0.51 (0.06-4.51) 
        College graduate  No deaths  5.51 (0.14-220.81) 
Metabolic Markers     
Body Mass Index   0.92 (0.83-1.02)  0.87 (0.83-0.92)* 
Glycemic Status     
        Diabetes (A1c ≥ 6.5%)  1.00  1.00 
        Pre-diabetes (A1c 5.7-6.5%)  0.24 (0.06-0.97)*  0.24 (0.09-0.64)* 
        Euglycemic (A1c < 5.7%)  No deaths  0.03 (0.00-1.65) 
Health Behaviors     
Healthy Eating Index   0.96 (0.91-1.02)  1.01 (0.97-1.05) 
Smoking Status     
        Current smoker  1.00  1.00 
        Former  0.75 (0.13-4.22)  0.72 (0.17-2.98) 
        Non-smoker  2.08 (0.63-6.90)  0.03 (0.00-1.65) 
Alcohol consumption     
        Non-drinker  1.00  1.00 
        Moderate   0.35 (0.07-1.65)  0.57 (0.07-4.50) 
        Above moderate  No deaths  2.78 (0.51-15.27) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black. 
MVPA 2020: Moderate-to-vigorous physical activity (≥2020 counts/min).  
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day). 
*p<0.05 
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Appendix 14 
3A. Is there a dose-response relationship between accelerometer-derived minutes of MVPA 
(760) and diabetes-related mortality across race-ethnic groups? 
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Using the Matthews et al. (1) cutpoint of 760 counts per minute (cpm) the dose-response 
relationship between accelerometer-derived minutes of MVPA760 and diabetes-related mortality was 
examined. MVPA was examined continuously in 10-minute increments. Tables A14.1, A14.2 and A14.3 
display the results of these analyses. As displayed in table A14.1, in the analysis adjusting for age and 
race-ethnicity, a significant reduction in risk was found for every 10-minutes of MVPA760 accrued. 
Following adjustment for covariates, results were attenuated and significance was lost.   
  In unadjusted analyses stratifying by race-ethnicity, both NHW (HR 0.70, 95% CI 0.55-0.90) and 
NHB (HR 0.67, 95% CI 0.46-0.96) had significant reductions in risk. Following adjustment for 
covariates, significance was lost for NHW (HR 0.78, 95% CI 0.57-1.07) and NHB (HR 0.77, 95% CI 
0.50-1.17).            
 The results of the analysis are promising in that the reduction in risk associated with every 10-
minyes accrued of MVPA760 was 22% in NHW and 27% in NHB. However, the results were not 
statistically significant. As discussed in the previous appendices using the continuous NHANES, as more 
data are available within the NDI, the ability to examine more robust measures of PA (i.e. accelerometer-
derived MVPA) and their relationship with diabetes-related mortality will become plausible.   
 
1. Matthews CE. Calibration of accelerometer output for adults. Med Sci Sports Exerc. 2005;37(11 
Suppl):S512-22. 
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Table A14.1. Relationship between accelerometer-derived MVPA (760) and diabetes-related mortality: 
2003-2006 NHANES (N=2,595) 
Variables  Hazard Ratio (95% Confidence Interval) 
   
 Unadjusted Age and race-ethnicity adjusted Fully-adjusted 
 
Physical Activity    
MVPA 760 (Every 10 minutes) 0.70 (0.56-0.87)* 0.74 (0.55-0.99)* 0.78 (0.60-1.02) 
Demographics    
Age (years)  1.04 (0.96-1.12) 1.02 (0.96-1.09) 
Race-ethnicity    
        NHW  1.00 1.00 
        NHB  1.62 (0.46-5.81) 0.63 (0.16-2.51) 
Gender    
        Male   1.00 
        Female   0.38 (0.14-1.04) 
Education    
        Less than high school   1.00 
        High school graduate   0.26 (0.07-1.01) 
        Some college   0.52 (0.11-2.53) 
        College graduate   0.08 (0.01-0.99)* 
Metabolic Markers    
Body Mass Index    0.91 (0.85-0.98)* 
Glycemic Status    
        Diabetes (A1c ≥ 6.5%)   1.00 
        Pre-diabetes (A1c 5.7-6.5%)   0.23 (0.08-0.70)* 
        Euglycemic (A1c < 5.7%)   0.01 (0.00-0.05)* 
Health Behaviors    
Healthy Eating Index    0.97 (0.93-1.01) 
Smoking Status    
        Current smoker   1.00 
        Former   0.53 (0.18-1.60) 
        Non-smoker   1.31 (0.59-2.92) 
Alcohol consumption    
        Non-drinker   1.00 
        Moderate    0.46 (0.13-1.61) 
        Above moderate   0.77 (0.06-9.88) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black.  
MVPA 760: Moderate-to-vigorous physical activity (≥760 counts/min).  
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day). 
*p<0.05 
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Table A14.2. Relationship between accelerometer-derived MVPA (760) and diabetes-related mortality 
stratified by race-ethnicity: 2003-2006 NHANES (N=2,595) 
 
Variables Hazard Ratio (95% Confidence Interval) 
 Race-Ethnicity 
 NHW NHB 
 Unadjusted Fully-adjusted Unadjusted Fully-adjusted 
Physical Activity     
MVPA 760 (Every 10 minutes) 0.70 (0.55-0.90)* 0.78 (0.57-1.07) 0.67 (0.46-0.96)* 0.77 (0.51-1.17) 
Demographics     
Age  1.02 (0.96-1.09)  1.07 (0.98-1.16) 
Gender     
        Male  1.00  1.00 
        Female  0.27 (0.09-0.82)*  2.57 (0.75-8.73) 
Education     
        Less than high school  1.00  1.00 
        High school graduate  0.13 (0.02-1.07)  1.52 (0.29-7.93) 
        Some college  0.46 (0.08-2.86)  0.45 (0.07-2.96) 
        College graduate  No deaths  4.45 (0.13-152.65) 
Metabolic Markers     
Body Mass Index   0.91 (0.83-1.00)*  0.87 (0.82-0.92)* 
Glycemic Status     
        Diabetes (A1c ≥ 6.5%)  1.00  1.00 
        Pre-diabetes (A1c 5.7-6.5%)  0.21 (0.05-0.86)*  0.25 (0.08-0.80)* 
        Euglycemic (A1c < 5.7%)  No deaths  0.03 (0.00-1.10) 
Health Behaviors     
Healthy Eating Index   0.96 (0.90-1.02)  1.01 (0.97-1.05) 
Smoking Status     
        Current smoker  1.00  1.00 
        Former  0.71 (0.14-3.67)  0.84 (0.25-2.83) 
        Non-smoker  2.78 (1.01-7.63)  0.03 (0.00-0.50)* 
Alcohol consumption     
        Non-drinker  1.00  1.00 
        Moderate   0.46 (0.11-1.96)  0.72 (0.11-4.85) 
        Above moderate  No deaths  2.43 (0.45-13.34) 
 
NHW: non-Hispanic white; NHB: non-Hispanic black.  
MVPA 760: Moderate-to-vigorous physical activity (≥760 counts/min).  
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 
[women], >2 [men] drinks/day). 
*p<0.05 
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Appendix 15 
Mortality Tables: NHANES III, 1999-2004 NHANES, 2003-2006 NHANES 
 
 
 
 
 
 
 
 190 
 
NHANES III mortality rates: all-cause, non-diabetes related, and diabetes-related 
 
Table A15.1. Mortality rate for diabetes-related mortality by race-ethnic group: NHANES III 
RACE  N Death events 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality 
rate  
(per 10,000 person-
years) 
Age-standardized 
mortality rate  
(per 10,000 person-years) 
Non-Hispanic White 4563 127 62.1 (0.8) 75.1 (1.2) 81,008.34 15.7 12.3 
Non-Hispanic Black 3057 88 58.0 (1.0) 69.7 (1.0) 54,841.50 16.0 18.1 
Mexican American 3097 116 54.6 (1.3) 68.3 (1.3) 58,086.08 19.9 26.6 
 
Table A15.2. Mortality rate for non-diabetes related mortality* by race-ethnic group: NHANES III 
RACE  N Death events 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality 
rate  
(per 10,000 person-
years) 
Age-standardized 
mortality rate  
(per 10,000 person-years) 
Non-Hispanic White 4563 1216 60.6 (0.7) 73.2 (0.6) 81,008.34 150.1 117.1 
Non-Hispanic Black 3057 634 54.0 (0.7) 65.8 (0.8) 54,841.50 115.4 136.5 
Mexican American 3097 433 51.2 (0.8) 64.1 (0.8) 58,086.08 74.5 96.3 
*Mortality from heart disease, cancer, respiratory diseases, accidents, cerebrovascular disease, Alzheimer’s, influenza and pneumonia, kidney disease, or residual 
causes 
Table A15.3. Mortality rate for all-cause mortality by race-ethnic group: NHANES III 
RACE  N Death events 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality 
rate  
(per 10,000 person-
years) 
Age-standardized 
mortality rate  
(per 10,000 person-years) 
Non-Hispanic White 4563 1343 60.8 (0.6) 73.4 (0.6) 81,008.34 165.7 129.5 
Non-Hispanic Black 3057 722 54.5 (0.6) 66.3 (0.6) 54,841.50 131.5 154.7 
Mexican American 3097 549 51.8 (0.8) 64.8 (0.8) 58,086.08 94.5 122.8 
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1999-2004 NHANES mortality rates: all-cause, non-diabetes related, and diabetes-related 
 
Table A15.4. Mortality rate for diabetes-related mortality by race-ethnic group: 1999-2004 NHANES 
RACE  N # of deaths 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality rate  
(per 10,000 person-
years) 
Age-adjusted mortality 
rate  
(per 10,000 person-
years) 
Non-Hispanic White 2383 35 64.5 (1.8) 70.7 (1.8) 21,573.84 16.2 15.4 
Non-Hispanic Black 944 27 61.5 (1.6) 67.6 (1.7) 8402.92 32.1 44.5 
 
Table A15.5. Mortality rate for non-diabetes related mortality by race-ethnic group: 1999-2004 NHANES 
RACE  N # of deaths 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality rate  
(per 10,000 person-
years) 
Age-adjusted mortality 
rate  
(per 10,000 person-
years) 
Non-Hispanic White 2383 358 65.7 (0.6) 71.7 (0.6) 21,573.84 165.9 156.1 
Non-Hispanic Black 944 164 59.5 (1.2) 64.6 (1.3) 8402.92 195.2 232.9 
*Mortality from heart disease, cancer, respiratory diseases, accidents, cerebrovascular disease, Alzheimer’s, influenza and pneumonia, kidney disease, or residual 
causes 
Table A15.6.  Mortality rate for all-cause mortality by race-ethnic group: 1999-2004 NHANES 
RACE  N # of deaths 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality rate  
(per 10,000 person-
years) 
Age-adjusted mortality 
rate  
(per 10,000 person-
years) 
Non-Hispanic White 2383 393 65.6 (0.7) 71.6 (0.7) 21,573.84 182.2 171.5 
Non-Hispanic Black 944 191 59.7 (0.9) 65.0 (1.0) 8402.92 227.3 277.5 
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2003-2006 NHANES mortality rates: all-cause, non-diabetes related, and diabetes-related 
 
Table A15.7. Mortality rate for diabetes-related mortality by race-ethnic group: 2003-2006 NHANES 
RACE  N # of deaths 
Baseline age 
mean  
Death age 
mean  
Total person-
years 
Crude mortality rate  
(per 10,000 person-
years) 
Age-adjusted mortality 
rate  
(per 10,000 person-
years) 
Non-Hispanic White 1892 14 65.5  70.7  12,431.67 11.3 10.7 
Non-Hispanic Black 703 9 67.6  71.3  4,613.25 19.5 33.4 
 
Table A15.8. Mortality rate for non-diabetes related mortality by race-ethnic group: 2003-2006 NHANES 
RACE  N # of deaths 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality rate  
(per 10,000 person-
years) 
Age-adjusted mortality 
rate  
(per 10,000 person-
years) 
Non-Hispanic White 1892 150 65.1 (0.6) 69.2 (0.6) 12,431.67 120.7 115.4 
Non-Hispanic Black 703 64 61.6 (1.3) 65.6 (1.5) 4,613.25 138.7 160.4 
*Mortality from heart disease, cancer, respiratory diseases, accidents, cerebrovascular disease, Alzheimer’s, influenza and pneumonia, kidney disease, or residual 
causes 
Table A15.9. Mortality rate for all-cause mortality by race-ethnic group: 2003-2006 NHANES 
RACE  N # of deaths 
Baseline age mean 
(SE) 
Death age mean 
(SE) 
Total person-
years 
Crude mortality rate  
(per 10,000 person-
years) 
Age-adjusted mortality 
rate  
(per 10,000 person-
years) 
Non-Hispanic White 1892 164 65.2 (0.7) 69.2 (0.7) 12,431.67 131.9 126.1 
Non-Hispanic Black 703 73 62.3 (1.1) 66.3 (1.3) 4,613.25 158.2 193.8 
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